id,entrez_name,entrez_id,name,description,gene_id,type,variant_types/0/id,variant_types/0/name,variant_types/0/display_name,variant_types/0/so_id,variant_types/0/description,variant_types/0/url,coordinates/chromosome,coordinates/start,coordinates/stop,coordinates/reference_bases,coordinates/variant_bases,coordinates/representative_transcript,coordinates/chromosome2,coordinates/start2,coordinates/stop2,coordinates/representative_transcript2,coordinates/ensembl_version,coordinates/reference_build,variant_types/1/id,variant_types/1/name,variant_types/1/display_name,variant_types/1/so_id,variant_types/1/description,variant_types/1/url
1,ABL1,25,BCR-ABL,"The BCR-ABL fusion protein, commonly referred to as the Philadelphia chromosome, is one of the most studied fusion genes in cancer. It has widely been considered the initiating event in chronic myelogenous leukemia (CML). However, despite its ability to initiate disease in mice, its status as an initiating mutation is in dispute. In what is commonly used as the poster-child for targeted therapeutics, the development and use of imatinib in the clinic has led to profound improvements in the prognosis of the disease. However, imatinib resistance is still seen in patients with mutations in the ABL kinase domain of the fusion, most notably the T315I variant. In patients resistant to imatinib, either acquired or otherwise, second generation BCR-ABL TKI's (dasatinib and nilotinib) have seen some success in delivering a tumor response. Third generation ABL1 inhibitor ponatinib is the only FDA approved drug with activity against T315I . However due to risk of life-threatening blood clots and severe narrowing of blood vessels ponatinib is ONLY approved for T315I-positive CML or T315I-positive Ph+ ALL or in cases of CML, Ph+ ALL with resistance or intolerance to other approved ABL1 inhibitors.",4,variant,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886,22,23522397,23632600,,,ENST00000305877.8,9,133729451,133763063,ENST00000318560.5,75,GRCh37,,,,,,
2,ABL1,25,BCR-ABL T334I,"While the efficacy of imatinib has revolutionized chronic myelogenous leukemia (CML) treatment, it is still not a cure-all. Both initial resistance and acquired resistance as a result of selection have been seen in a small subset of CML patients. The ABL kinase domain mutation T315I (aka T334I) has been shown to be one such mutation that confers resistance to imatinib. Second generation TKI's (dasatinib and ponatinib) specific to BCR-ABL have shown efficacy in treating resistant cases.",4,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,9,133748283,133748283,C,T,ENST00000372348.2,,,,,75,GRCh37,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886
3,ABL1,25,BCR-ABL E255K,"While the efficacy of imatinib has revolutionized chronic myelogenous leukemia (CML) treatment, it is still not a cure-all. Both initial resistance and acquired resistance as a result of selection have been seen in a small subset of CML patients. The ABL kinase domain mutation E255K has been shown to be one such mutation that confers resistance to imatinib. Second generation TKI's (dasatinib and nilotinib) specific to BCR-ABL have shown efficacy in treating resistant cases.",4,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,9,133738363,133738363,G,A,ENST00000318560.5,,,,,75,GRCh37,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886
4,AKT1,207,E17K,"AKT1 E17K is a recurrent mutation that has been observed in breast, colorectal, lung, and ovarian cancer. It has been convincingly shown to be an activating mutation resulting in PI3K/AKT/mTOR pathway activity. It has been suggested that this mutation decreases the cell's sensitivity to AKT1 allosteric kinase inhibitors. This, and other AKT1 mutations, are the subject of much research and development for therapeutics.",2,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,14,105246551,105246551,C,T,ENST00000407796.2,,,,,75,GRCh37,,,,,,
5,ALK,238,EML4-ALK,"The EML4-ALK fusion variant 1 consisting of ALK kinase domain (exons 20-29) fused to EML4 exons 1-13 is the most common EML4-ALK variant, and was discovered in non-small cell lung cancer. Multiple EML4 breakpoint shave been described with differential sensitivity to inhibitors with variant 1 showing greater sensitivity than 3a in cell lines. EML4-ALK is crizotinib sensitive; however, several mutations that confer resistance mutations have been described in case studies. In the only clinical trial for crizotinib that included determination of EML4-ALK variant type in a subset of its participants, a very high response rate was observed, although the numbers were insufficient to validate correlation of variant type to outcome. Preclinical studies with this variant have indicated sensitivity to Hsp90 inhibitors.",1,variant,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886,2,42396490,42522656,,,ENST00000318522.5,2,29415640,29446394,ENST00000389048.3,75,GRCh37,,,,,,
6,ALK,238,EML4-ALK C1156Y,"In patients with non-small cell lung cancer exhibiting EML4-ALK fusion, C1156Y has been shown to confer resistance to crizotinib. Case reports indicate that secondary mutations can modulate drug sensitivity. EML4-ALK C1156Y/L1196M maintained crizotinib resistance while the lorlatinib resistant combination EML4-ALK C1156Y/L1198F re-sensitized the tumor to crizotinib treatment.",1,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,2,29445258,29445258,C,T,ENST00000389048.3,,,,,75,GRCh37,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886
7,ALK,238,EML4-ALK L1196M,"In patients with non-small cell lung cancer exhibiting EML4-ALK fusion, L1196M has been shown to confer resistance to crizotinib. This was also true in a patient with both EML4-ALK C1156Y & L1196M.",1,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,2,29443631,29443631,G,T,ENST00000389048.3,,,,,75,GRCh37,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886
8,ALK,238,F1174L,"ALK F1174L has been observed as recurrent in neuroblastoma, non-small cell lung cancer (NSCLC), and other cancer types. Neuroblastoma cells containing this mutation have shown resistance to low doses of criztonib. However, increased dosage can overcome this resistance in cell lines studies. TAE684 has also proven effective in both NSCLC and neuroblastoma F1174L containing cells.",1,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,2,29443695,29443695,G,T,ENST00000389048.3,,,,,75,GRCh37,,,,,,
9,ALK,238,R1275Q,"ALK R1275Q has been observed as a recurrent mutation in  neuroblastoma, non-small cell lung cancer (NSCLC), as well as other cancer types. Neuroblastoma cells with this mutation have shown sensitivity to the ALK-inhibitor TAE684. This and the geldanamycin deriviative 17-DMAG have been shown to be effective in NSCLC cell lines.",1,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,2,29432664,29432664,C,T,ENST00000389048.3,,,,,75,GRCh37,,,,,,
10,ARAF,369,S214C,"ARAF S214C has been found to be a recurrent oncogenic mutation in non-small cell lung cancer. It has been shown to confer sensitivity to sorafenib and trametenib in cell lines. In a case study of advanced stage lung adenocarcinoma harboring this mutation, sorafenib also acheived near-complete clinical remission. This case has brought more interest to the variant from a research and clinical perspective.",3,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,X,47426121,47426121,C,G,ENST00000377045.4,,,,,75,GRCh37,,,,,,
11,BRAF,673,V600D,"Patients harboring mutations in valine 600 residue of BRAF have been shown to be sensitive to dabrafenib. For more information on the V600 locus, see the V600E entry.",5,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,7,140453135,140453136,CA,TA,ENST00000288602.6,,,,,75,GRCh37,,,,,,
12,BRAF,673,V600E,"BRAF V600E has been shown to be recurrent in many cancer types. It is one of the most widely studied variants in cancer. This variant is correlated with poor prognosis in certain cancer types, including colorectal cancer and papillary thyroid cancer. The targeted therapeutic dabrafenib has been shown to be effective in clinical trials with an array of BRAF mutations and cancer types. Dabrafenib has also shown to be effective when combined with the MEK inhibitor trametinib in colorectal cancer and melanoma. However, in patients with TP53, CDKN2A and KRAS mutations, dabrafenib resistance has been reported. Ipilimumab, regorafenib, vemurafenib, and a number of combination therapies have been successful in treating V600E mutations. However, cetuximab and panitumumab have been largely shown to be ineffective without supplementary treatment.",5,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,7,140453136,140453136,A,T,ENST00000288602.6,,,,,75,GRCh37,,,,,,
13,BRAF,673,V600E+V600M,"A case study of a single patient harboring both a V600E and a V600M mutation, dabrafenib was shown to acheive clinical response.",5,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,7,140453135,140453137,,,ENST00000288602.6,,,,,75,GRCh37,,,,,,
14,BRAF,673,V600E AMPLIFICATION,"Amplification of BRAF V600E has been shown to confer resistance to MEK inhibitors. For more information on the V600 locus, see the V600E entry.",5,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,7,140434279,140624564,,,ENST00000288602.6,,,,,75,GRCh37,123,transcript_amplification,Transcript Amplification,SO:0001889,A feature amplification of a region containing a transcript.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001889
17,BRAF,673,V600,"BRAF mutations of the valine 600 residue have been shown to be recurrent in many cancer types. Of the V600 mutations, V600E is the most widely researched. V600 mutations as a whole have been correlated to poorer prognosis in colorectal and papilarry thyroid cancers. V600 mutations have also been shown to confer sensitivity to the BRAF inhibitor dabrafenib. For a more detailed summary, click the individual mutations.",5,variant,103,protein_altering_variant,Protein Altering Variant,SO:0001818,A sequence_variant which is predicted to change the protein encoded in the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001818,7,140453136,140453137,,,ENST00000288602.6,,,,,75,GRCh37,,,,,,
18,CCND1,595,AMPLIFICATION,CCND1 amplification has been implicated in poorer prognosis in non-small cell lung cancer.,8,variant,123,transcript_amplification,Transcript Amplification,SO:0001889,A feature amplification of a region containing a transcript.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001889,11,69455855,69469242,,,ENST00000227507.2,,,,,75,GRCh37,,,,,,
19,CCND1,595,EXPRESSION,"CCND1 expression, and its prognositc impact, is still in dispute. Three experiments in non-small cell lung cancer have shown it to have no impact on survival, but three additional studies have shown it results in poorer prognosis. There is also some ambiguity in how the boundaries between expression and overexpression are defined.",8,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,11,69455855,69469242,,,ENST00000227507.2,,,,,75,GRCh37,,,,,,
20,CCND1,595,OVEREXPRESSION,"Cyclin D has been shown in many cancer types to be misregulated. Well established for their oncogenic properties, the cyclins and the cyclin-dependent kinases (CDK's) they activate have been the focus of major research and development efforts over the past decade. The methods by which the cyclins are misregulated are widely variable, and range from genomic amplification to promoter methylation changes. While Cyclin D2 has only been found to be significantly misregulated in glioma, Cyclin D1 in particular seems to be a pan-cancer actor. Cyclin D misregulation has been shown to lead to poorer outcomes in a number of studies, and currently there are no FDA-approved targeted therapies.",8,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,11,69455855,69469242,,,ENST00000227507.2,,,,,75,GRCh37,,,,,,
21,CCND2,894,OVEREXPRESSION,"Cyclin D has been shown in many cancer types to be misregulated. Well established for their oncogenic properties, the cyclins and the cyclin-dependent kinases (CDK's) they activate have been the focus of major research and development efforts over the past decade. The methods by which the cyclins are misregulated are widely variable, and range from genomic amplification to promoter methylation changes. While Cyclin D2 has only been found to be significantly misregulated in glioma, Cyclin D1 in particular seems to be a pan-cancer actor. Cyclin D misregulation has been shown to lead to poorer outcomes in a number of studies, and currently there are no FDA-approved targeted therapies.",9,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,12,4382938,4414516,,,ENST00000261254.3,,,,,75,GRCh37,,,,,,
22,CCND2,894,PROMOTER DEMETHYLATION,"Cyclin D has been shown in many cancer types to be misregulated. Well established for their oncogenic properties, the cyclins and the cyclin-dependent kinases (CDK's) they activate have been the focus of major research and development efforts over the past decade. The methods by which the cyclins are misregulated are widely variable, and range from genomic amplification to promoter methylation changes. While Cyclin D2 has only been found to be significantly misregulated in glioma, Cyclin D1 in particular seems to be a pan-cancer actor. Cyclin D misregulation has been shown to lead to poorer outcomes in a number of studies, and currently there are no FDA-approved targeted therapies.",9,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,12,4381437,4382937,,,ENST00000261254.3,,,,,75,GRCh37,,,,,,
23,CCND3,896,LOSS,"Cyclin D has been shown in many cancer types to be misregulated. Well established for their oncogenic properties, the cyclins and the cyclin-dependent kinases (CDK's) they activate have been the focus of major research and development efforts over the past decade. The methods by which the cyclins are deregulated are widely variable, and range from genomic amplification to promoter methylation changes. Cyclin D3 loss has been reported in T-cell acute lymphoblastic leukemia (T-ALL), a seemingly unique trend when compared to the amplifcations and overexpressions of the other cyclin D's. Treating cyclin D3 knockout mice with the targeted therapeutic palbociclib significantly increased the median survival of a Notch-driven model of T-ALL.",10,variant,161,loss_of_function_variant,Loss Of Function Variant,SO:0002054,A sequence variant whereby the gene product has diminished or abolished function.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002054,6,41902671,41909586,,,ENST00000372991.4,,,,,75,GRCh37,,,,,,
24,CCNE1,898,OVEREXPRESSION,"Cyclin E, while currenly not as widely implicated as its counterpart, cyclin D, has been implicated in various carcinomas, including breast, gastric, stomach and colorectal. High levels of cyclin E, either by gene amplification or overexpression, are correlated with later stage disease and have been shown to lead to poorer prognosis in gastic carcinoma. It has also been shown, in lung cancer specifically, that neoplastic cells with higher levels of the cyclin E/CDK2 complex are more radiosensitive than their lowly expressed counterparts.",11,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,19,30302805,30315215,,,ENST00000262643.3,,,,,75,GRCh37,,,,,,
25,CDK4,1019,EXPRESSION,"CDK4, along with its partner CDK6, are key players in cell cycle progression. The complex has been implicated in a number of cancer types, and is the focus of therapeutic research and development. One targeted therapy for CDK inhibition is palbociclib, which may slow the growth of advanced stage breast cancers. It has also been shown, in mouse, that CDK inhibition may sensitize mutant PIK3CA tumors to PI3K inhibitors.",13,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,12,58141510,58146304,,,ENST00000257904.6,,,,,75,GRCh37,,,,,,
27,CDKN2A,1029,PROMOTER HYPERMETHYLATION,"CDKN2A loss has been shown to be a significant event in a number of cancer types. One mechanism by which this can occur is by hypermethylation of the CDKN2A promoter region. While no targeted therapeutic has been engaged in clinical trials, the prognostic impact has been studied by a number of meta-analyses. The prognostic impact of promoter hypermethylation has been relatively ambiguous. Many studies have shown significant p-values suggesting poorer prognostic outcomes for patients with hypermethylation in colorectal, liver, and younger lung cancer patients. This being said, there is still research to be done before this becomes a widely-accepted prognostic indicator.",14,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,9,21974827,21994591,,,ENST00000498124.1,,,,,75,GRCh37,,,,,,
28,CEBPA,1050,N-TERMINAL FRAME SHIFT,"CEBPA N-terminal frame shift mutations that result in a premature stop codon are associated with cytogenetically normal acute myeloid leukemia (CN-AML). CEBPA mutations are associated with a favorable prognosis; however, NPM1 and FLT3 mutations should also be assessed in CN-AML patients as concurrent mutations may have prognostic implications. N-terminal frame shift mutations within amino acids 1-120 have been shown to disrupt expression of the full-length 42kDa isoform while maintaining expression of a 30kDa isoform (translated from the AUG at full-length protein isoform amino acid M120). This 30kDa isoform exhibits dominant negative activity.",15,variant,134,frameshift_truncation,Frameshift Truncation,SO:0001910,A frameshift variant that causes the translational reading frame to be shortened relative to the reference feature.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001910,19,33792961,33793470,,,ENST00000498907.2,,,,,75,GRCh37,159,dominant_negative_variant,Dominant Negative Variant,SO:0002052,A variant where the mutated gene product adversely affects the other (wild type) gene product.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002052
29,CEBPA,1050,MUTATION,"CEBPA mutations are associated with cytogenetically normal acute myeloid leukemia (CN-AML) and a favorable prognosis. However, NPM1 and FLT3 mutations should also be assessed in CN-AML patients as concurrent mutations may have prognostic implications.",15,variant,42,transcript_variant,Transcript Variant,SO:0001576,A sequence variant that changes the structure of the transcript.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001576,19,33790840,33793470,,,ENST00000498907.2,,,,,75,GRCh37,161,loss_of_function_variant,Loss Of Function Variant,SO:0002054,A sequence variant whereby the gene product has diminished or abolished function.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002054
30,CSF1R,1436,MEF2D-CSF1R,"MEF2D-CSF1R is a fusion that has been observed in acute lymphocytic leukemia. In cell lines harboring this event, treatment with imatinib has shown notable sensitivity.",33,variant,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886,1,156446804,156470620,,,ENST00000348159.4,5,149433787,149441412,ENST00000286301.3,75,GRCh37,,,,,,
31,PRKACA,5566,DNAJB1-PRKACA,"This fusion has been found to be very recurrent in the rare form of adolescent liver cancer, fibrolamellar hepatocellular carcinoma. In one study, this fusion was observed in 15/15 FL-HCC cases examined and functional studies found that the fusion retained kinase activity. The presence of this fusion may be used as a diagnostic marker for this rare tumor type.",17,variant,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886,19,14628951,14629232,,,ENST00000254322.2,19,14202500,14218221,ENST00000308677.4,75,GRCh37,,,,,,
32,DNMT3A,1788,R882,"DNMT3A R882 mutations are associated with cytogenetically normal acute myeloid leukemia (CN-AML) with R882H as the most common form. Mutations in DNMT3A have largely been associated with poorer prognosis, however this is not consistent across all studies. This may be a result of patient age or combining R882 and non-R882 mutations during analysis as studies have indicated independent mechanisms of action and differential prognostic implications for these mutation types. One study that independently analyzed R882 and non-R882 mutations showed R882 mutations were associated with poorer prognosis than patients with wildtype and non-R882 mutations, but only in older patients with AML.",18,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,2,25457241,25457243,,,ENST00000264709.3,,,,,75,GRCh37,,,,,,
33,EGFR,1956,L858R,"EGFR L858R has long been recognized as a functionally significant mutation in cancer, and is one of the most prevalent single mutations in lung cancer. Best described in non-small cell lung cancer (NSCLC), the mutation seems to confer sensitivity to first and second generation TKI's like gefitinib and neratinib. NSCLC patients with this mutation treated with TKI's show increased overall and progression-free survival, as compared to chemotherapy alone. Third generation TKI's are currently in clinical trials that specifically focus on mutant forms of EGFR, a few of which have shown efficacy in treating patients that failed to respond to earlier generation TKI therapies.",19,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,7,55259515,55259515,T,G,ENST00000275493.2,,,,,75,GRCh37,,,,,,
34,EGFR,1956,T790M,"EGFR T790M was one of the very first mutations recognized to confer resistance to targeted therapies in non-small cell lung cancer. While successful in amplified EGFR, the efficacy of the first and second generation TKI's (erlotinib, gefitinib, neratinib) in treating patients harboring this mutation before treatment is notably lower. This lack of efficacy can likely be to blame for the poorer prognosis for patients with this mutation as compared to patients with wildtype EGFR or other types of EGFR mutations. Approximately half of EGFR mutant tumors with acquired resistance to TKI inhibition have been shown to harbor this mutation, implicating it as a mechanism of acquired therapy resistence. A third generation TKI (osimertinib) has been approved for the treatment of EGFR T790M mutant NSCLC. Patients positive for T790M in a plasma-based test have similar outcomes like those with tumor biopsy testing.",19,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,7,55249071,55249071,C,T,ENST00000275493.2,,,,,75,GRCh37,,,,,,
35,ERBB2,2064,D769H,"ERBB2 D769H was one of the first ERBB2 variants to be functionally classified (Bose et al. 2013). This mutation was shown to be an activating mutation in an in vitro assay. In the same paper, this mutation (along with other ERBB2 activating mutations) in MCF10A breast cancer cell lines were shown to be sensitive to the kinase inhibitor neratinib. More recent evidence may show that HER2 activating mutations confer sensitivity to a host of tyrosine kinase inhibitors, which is the topic of current clinical trials and research.",20,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,17,37880261,37880261,G,C,ENST00000269571.5,,,,,75,GRCh37,,,,,,
36,ERBB2,2064,D769Y,"ERBB2 D769Y was one of the first ERBB2 variants to be functionally classified (Bose et al., 2013). This mutation was shown to be an activating mutation in an in vitro assay. In the same paper, this mutation (along with other ERBB2 activating mutations) in MCF10A breast cancer cell lines have been shown to be sensitive to the kinase inhibitor neratinib. More recent evidence may show that HER2 acitivating mutations confer sensitivity to a host of tyrosine kinase inhibitors, which is the topic of current clinical trials and research.",20,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,17,37880261,37880261,G,T,ENST00000269571.5,,,,,75,GRCh37,,,,,,
37,ERBB2,2064,DEL 755-759,"ERBB2 in-frame deletion of 755-759 was one of the first ERBB2 variants to be functionally classified (Bose et al. 2013). This mutation was shown to be an activating mutation in an in vitro assay. In the same paper, this mutation (along with other ERBB2 activating mutations) in MCF10A breast cancer cell lines have been shown to be sensitive to the kinase inhibitor neratinib. More recent evidence may show that HER2 acitivating mutations confer sensitivity to a host of tyrosine kinase inhibitors, which is the topic of current clinical trials and research.",20,variant,107,inframe_deletion,Inframe Deletion,SO:0001822,An inframe non synonymous variant that deletes bases from the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001822,17,37880219,37880233,TTGAGGGAAAACACA,,ENST00000269571.5,,,,,75,GRCh37,,,,,,
38,ERBB2,2064,G309A,"ERBB2 G309A was one of the first ERBB2 variants to be functionally classified (Bose et al. 2013). This mutation was shown to be an activating mutation in an in vitro assay. In the same paper, this mutation (along with other ERBB2 activating mutations) in MCF10A breast cancer cell lines have been shown to be sensitive to the kinase inhibitor neratinib. More recent evidence may show that HER2 acitivating mutations confer sensitivity to a host of tyrosine kinase inhibitors, which is the topic of current clinical trials and research.",20,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,17,37868205,37868205,G,C,ENST00000269571.5,,,,,75,GRCh37,,,,,,
39,ERBB2,2064,L755S,"ERBB2 L755S was one of the first ERBB2 variants to be functionally classified (Bose et al. 2013). This mutation was not shown to be an activating mutation, unlike many of the other variants queried. This mutation was also shown to confer resistance to the tyrosine kinase inhibitor lapatinib in MCF10A cell lines.",20,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,17,37880220,37880220,T,C,ENST00000269571.5,,,,,75,GRCh37,,,,,,
40,ERBB2,2064,L755W,"ERBB2 L755W was one of the first ERBB2 variants to be functionally classified (Bose et al., 2013). This mutation was shown to be an activating mutation in an in vitro assay. In the same paper, this mutation (along with other ERBB2 activating mutations) in MCF10A breast cancer cell lines have been shown to be sensitive to the kinase inhibitor neratinib. More recent evidence may show that HER2 acitivating mutations confer sensitivity to a host of tyrosine kinase inhibitors, which is the topic of current clinical trials and research.",20,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,17,37880220,37880220,T,G,ENST00000269571.5,,,,,75,GRCh37,,,,,,
41,ERBB2,2064,P780INS,"ERBB2 P780 insertion was one of the first ERBB2 variants to be functionally classified (Bose et al. 2013). This mutation was shown to be an activating mutation in an in vitro assay. In the same paper, this mutation (along with other ERBB2 activating mutations) in MCF10A breast cancer cell lines have been shown to be sensitive to the kinase inhibitor neratinib. More recent evidence may show that HER2 activating mutations confer sensitivity to a host of tyrosine kinase inhibitors, which is the topic of current clinical trials and research.",20,variant,106,inframe_insertion,Inframe Insertion,SO:0001821,An inframe non synonymous variant that inserts bases into in the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001821,17,37881011,37881012,,GGCTCCCCA,ENST00000269571.5,,,,,75,GRCh37,,,,,,
42,ERBB2,2064,R678Q,"ERBB2 R678Q was shown to have NO functional effect in tissue culture assay (Bose et al 2013). This conclusion was confirmed by a second, independent lab.",20,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,17,37879658,37879658,G,A,ENST00000269571.5,,,,,75,GRCh37,,,,,,
43,ERBB2,2064,R896C,"ERBB2 R896C was one of the first ERBB2 variants to be functionally classified (Bose et al. 2013). This mutation was shown to be an activating mutation in an in vitro assay. In the same paper, this mutation (along with other ERBB2 activating mutations) in MCF10A breast cancer cell lines have been shown to be sensitive to the kinase inhibitor neratinib. More recent evidence may show that HER2 acitivating mutations confer sensitivity to a host of tyrosine kinase inhibitors, which is the topic of current clinical trials and research.",20,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,17,37881616,37881616,C,T,ENST00000269571.5,,,,,75,GRCh37,,,,,,
44,ERBB2,2064,V777L,"ERBB2 V777L was one of the first ERBB2 variants to be functionally classified (Bose et al. 2013). This mutation was shown to be an activating mutation in an in vitro assay. In the same paper, this mutation (along with other ERBB2 activating mutations) in MCF10A breast cancer cell lines have been shown to be sensitive to the kinase inhibitor neratinib. More recent evidence may show that HER2 acitivating mutations confer sensitivity to a host of tyrosine kinase inhibitors, which is the topic of current clinical trials and research.",20,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,17,37881000,37881000,G,T,ENST00000269571.5,,,,,75,GRCh37,,,,,,
45,ERBB2,2064,V842I,"ERBB2 V842I was one of the first ERBB2 variants to be functionally classified (Bose et al. 2013). This mutation was shown to be an activating mutation in an in vitro assay. In the same paper, this mutation (along with other ERBB2 activating mutations) in MCF10A breast cancer cell lines have been shown to be sensitive to the kinase inhibitor neratinib. More recent evidence may show that HER2 acitivating mutations confer sensitivity to a host of tyrosine kinase inhibitors, which is the topic of current clinical trials and research.",20,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,17,37881332,37881332,G,A,ENST00000269571.5,,,,,75,GRCh37,,,,,,
46,ESR1,2099,L536Q,"ESR1 biology has become a central focus in breast cancer therapy. In ER+ tumors, mutations in the ESR1 ligand binding domain have been shown to confer resistance to hormone therapy. This evidence has led to an increased use of targeted sequencing of the estrogen receptor in breast and ovarian cancer. Y536Q is one of these ligand binding domain mutations, and is commonly implicated in this hormone resistance. Preliminary data suggests ER-degrading agents, such as fulvestrant, may be beneficial in treating ESR1 mutant, hormone resistant breast cancers.",21,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,6,152419920,152419921,TC,AG,ENST00000440973.1,,,,,75,GRCh37,,,,,,
47,ESR1,2099,D538G,"ESR1 biology has become a central focus in breast cancer therapy. In ER+ tumors, mutations in the ESR1 ligand binding domain have been shown to confer resistance to hormone therapy. This evidence has led to an increased use of targeted sequencing of the estrogen receptor in breast and ovarian cancer. D538G is one of these ligand binding domain mutations, and is commonly implicated in this hormone resistance. Preliminary data suggests ER-degrading agents, such as fulvestrant, may be beneficial in treating ESR1 mutant, hormone resistant breast cancers.",21,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,6,152419926,152419926,A,G,ENST00000206249.3,,,,,75,GRCh37,,,,,,
48,ESR1,2099,Y537C,"ESR1 biology has become a central focus in breast cancer therapy. In ER+ tumors, mutations in the ESR1 ligand binding domain have been shown to confer resistance to hormone therapy. This evidence has led to an increased use of targeted sequencing of the estrogen receptor in breast and ovarian cancer. Y537C is one of these ligand binding domain mutations, and is commonly implicated in this hormone resistance. Preliminary data suggests ER-degrading agents, such as fulvestrant, may be beneficial in treating ESR1 mutant, hormone resistant breast cancers.",21,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,6,152419923,152419923,A,G,ENST00000206249.3,,,,,75,GRCh37,,,,,,
49,ESR1,2099,Y537N,"ESR1 biology has become a central focus in breast cancer therapy. In ER+ tumors, mutations in the ESR1 ligand binding domain have been shown to confer resistance to hormone therapy. This evidence has led to an increased use of targeted sequencing of the estrogen receptor in breast and ovarian cancer. Y537N is one of these ligand binding domain mutations, and is commonly implicated in this hormone resistance. Preliminary data suggests ER-degrading agents, such as fulvestrant, may be beneficial in treating ESR1 mutant, hormone resistant breast cancers.",21,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,6,152419922,152419922,T,A,ENST00000206249.3,,,,,75,GRCh37,,,,,,
50,ESR1,2099,Y537S,"ESR1 biology has become a central focus in breast cancer therapy. In ER+ tumors, mutations in the ESR1 ligand binding domain have been shown to confer resistance to hormone therapy. This evidence has led to an increased use of targeted sequencing of the estrogen receptor in breast and ovarian cancer. Y537S is one of these ligand binding domain mutations, and is commonly implicated in this hormone resistance. Preliminary data suggests ER-degrading agents, such as fulvestrant, may be beneficial in treating ESR1 mutant, hormone resistant breast cancers.",21,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,6,152419923,152419923,A,C,ENST00000206249.3,,,,,75,GRCh37,,,,,,
52,FGFR2,2263,FGFR2-MGEA5,"In a clinical sequencing program for advanced stage cancers, Wu et al (2013, Cancer Discovery) has idenified a number of FGFR fusions in patients with many different cancer types. These fusions were also found to retain oligomerization capability, and result in enhanced cell proliferation. Cell lines harboring these fusions were shown to respond to pazopanib. Additionally, tumor size reduction was achieved by both ponatinib and pazopanib treatments administered separately in a single patient with intrahepatic cholangiocarcinoma and this fusion. The authors use these cases to highlight the need for enhanced clinical sequencing efforts.",22,variant,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886,10,123243212,123357917,,,ENST00000457416.2,10,103544209,103552700,ENST00000361464.3,75,GRCh37,,,,,,
53,FGFR3,2261,FGFR3-BAIAP2L1,"In a clinical sequencing program for advanced stage cancers, Wu et al (2013, Cancer Discovery) has identified a number of FGFR fusions in patients with many different cancer types. These fusions were also found to retain oligomerization capability, and result in enhanced cell proliferation. These fusions were shown to respond to pazopanib. The authors use these cases to highlight the need for enhanced clinical sequencing efforts.",23,variant,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886,4,1795039,1810599,,,ENST00000340107.4,7,97991744,97920963,ENST00000005260.8,75,GRCh37,,,,,,
54,FGFR2,2263,FGFR2-TACC3,"In a clinical sequencing program for advanced stage cancers, Wu et al has identified a number of FGFR fusions in patients with many different cancer types. These fusions were also found to retain oligomerization capability, and result in enhanced cell proliferation. These fusions were shown to respond to pazopanib. The authors use these cases to highlight the need for enhanced clinical sequencing efforts.",22,variant,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886,4,123243212,123357598,,,ENST00000358487.5,4,1723266,1741505,ENST00000313288.4,75,GRCh37,,,,,,
55,FLT3,2322,ITD,"FLT3-ITD (internal tandem duplications) frequently occur in patients with hematologic malignancies such as chronic myelogenous leukemia, acute myeloid leukemia (AML) and myelodysplastic syndrome, but particularly in cytogenetically normal AML (CN-AML). These duplication events disrupt the juxtamembrane domain of FLT3 and can be the result of a duplication of internal FLT3 sequence or other unrelated sequence resulting in an in-frame duplication event. The length of these duplications can vary widely which may have prognostic consequences, but this has not been conclusively determined. FLT3-ITD mutations overall have generally been associated with poor prognosis. Additional genes associated with CN-AML such as NPM1 may modulate the prognosis associated with this variant.",24,variant,106,inframe_insertion,Inframe Insertion,SO:0001821,An inframe non synonymous variant that inserts bases into in the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001821,13,28608219,28608351,,,ENST00000241453.7,,,,,75,GRCh37,,,,,,
56,FLT3,2322,TKD MUTATION,"FLT3 tyrosine kinase domain mutations (FLT3-TKD) are much less common than FLT3-ITD (internal tandem duplication) mutations and may not confer the same prognostic impact. Although the majority of mutations are point mutations effecting D835 (most frequently D835Y), a small proportion involve an in-frame deletion of I836. These mutations are within the activation loop of the second tyrosine kinase domain of FLT3 and thought to result in constitutive activation of the receptor.",24,variant,145,nonsynonymous_variant,Nonsynonymous Variant,SO:0001992,"A non-synonymous variant is an inframe, protein altering variant, resulting in a codon change.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001992,13,28592642,28592642,C,A,ENST00000241453.7,,,,,75,GRCh37,,,,,,
57,GATA2,2624,EXPRESSION,"GATA2 misregulation has been observed in a number of hematologic malignancies, as well as non-small cell lung cancer. Treatment of over-active GATA2 pathways using the proteasome inhibitor bortezomib has shown dramatic tumor regression in lung cancer.",25,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,3,128198270,128212028,,,ENST00000341105.2,,,,,75,GRCh37,,,,,,
58,IDH1,3417,R132,"IDH1 R132 mutations have been observed in a number of cancer types, and appear to behave quite differently in different environments. In myelodysplastic syndromes, IDH1 R132 mutations have been shown to be associated with worse outcome and shorter overall survival. They have also been linked to cytogenetically normal AML, an intermediate risk subtype of the disease. However, in glioblastoma and astrocytoma, patients with IDH1 mutations have shown better overall survival than patients with wild-type IDH1. Also in contrast to AML, in glioblastoma, IDH1 mutations have been associated with the specific cytogenetic abnormalities, 1p and 19q deletions.",26,variant,103,protein_altering_variant,Protein Altering Variant,SO:0001818,A sequence_variant which is predicted to change the protein encoded in the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001818,2,209113111,209113113,,,ENST00000415913.1,,,,,75,GRCh37,,,,,,
59,IDH1,3417,R132C,"IDH1 R132 mutations have been observed in a number of cancer types, and appear to behave quite differently in different environments. In myelodysplastic syndromes and acute myeloid leukemia (AML), IDH1 R132 mutations have been shown to be associated with worse outcome and shorter overall survival. They have also been linked to cytogenetically normal AML, an intermediate risk subtype of the disease. However, in glioblastoma and astrocytoma, patients with IDH1 mutations have shown better overall survival than patients with wild-type IDH1. Also in contrast to AML, in glioblastoma, IDH1 mutations have been associated with the specific cytogenetic abnormalities, 1p and 19q deletions.",26,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,2,209113113,209113113,G,A,ENST00000415913.1,,,,,75,GRCh37,,,,,,
62,IDH2,3418,R140,"IDH2 mutations have been observed in a number of hematologic malignancies. In acute myeloid leukemia, the R140 mutants show mixed results affecting overall survival as compared to their wild-type counterparts. In myelodysplastic syndromes, however, no prognostic link was discovered between IDH2 mutation status and overall survival.",27,variant,103,protein_altering_variant,Protein Altering Variant,SO:0001818,A sequence_variant which is predicted to change the protein encoded in the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001818,15,90631934,90631934,,,ENST00000330062.3,,,,,75,GRCh37,,,,,,
63,IDH2,3418,R172K,"IDH2 mutations have been observed in a number of hematologic malignancies. In acute myeloid leukemia, the R172K mutation has been linked with poorer prognosis and worse overall survival than IDH2 wild-type patients. However, in myelodisplastic syndromes, studies did not find a prognostic association between this variant and patient outcomes.",27,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,15,90631838,90631838,C,T,ENST00000330062.3,,,,,75,GRCh37,,,,,,
64,JAK2,3717,V617F,"JAK2 V617F is a highly recurrent mutation in myeloproliferative diseases. It is found in around 98% of patients with polycythemia vera, and just over half of the patients with essential thrombocythemia and primary myelofibrosis. While less associated with cancer, when it is seen, it is more likely to be in myeloid leukemias than lymphoid leukemias. The V617F mutation is an activating mutation, resulting in increased kinase activity. The mutation seems to be restricted to hematologic malignancies. Treatment of JAK mutant diseases with ruxolitinib has seen some clinical success.",28,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,9,5073770,5073770,G,T,ENST00000381652.3,,,,,75,GRCh37,160,gain_of_function_variant,Gain Of Function Variant,SO:0002053,A sequence variant whereby new or enhanced function is conferred on the gene product.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002053
65,KIT,3815,D816V,KIT D816V is a mutation observed in acute myeloid leukemia (AML). This variant has been linked to poorer prognosis and worse outcome in AML patients.,29,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,4,55599321,55599321,A,T,ENST00000288135.5,,,,,75,GRCh37,,,,,,
66,KIT,3815,EXON 11 MUTATION,"c-KIT mutations in exon 11 lie within the juxtamembrane domain, and are very recurrent in gastrointestinal stromal tumors, often bearing a poorer prognosis than other KIT mutations. Cells harboring exon 11 mutations have shown sensitivity to the tyrosine kinase inhibitor imatinib, offering a better prognosis to patients treated with the drug in the first year. Small cohorts of melanoma patients harboring exon 11 KIT mutations have shown response to imatinib and sunitinib.",29,variant,45,coding_sequence_variant,Coding Sequence Variant,SO:0001580,A sequence variant that changes the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001580,4,55593582,55593708,,,ENST00000288135.5,,,,,75,GRCh37,,,,,,
67,KIT,3815,INTERNAL DUPLICATION,"c-KIT internal duplications have been observed in exon 11, within the juxtamembrane domain. In a case study of an anal melanoma patient harboring this event, imatinib confered marked response. Also, cells harboring exon 11 mutations have shown sensitivity to the tyrosine kinase inhibitor imatinib, offering a better prognosis to patients treated with the drug in the first year.",29,variant,106,inframe_insertion,Inframe Insertion,SO:0001821,An inframe non synonymous variant that inserts bases into in the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001821,4,55593582,55593708,,,ENST00000288135.5,,,,,75,GRCh37,,,,,,
69,KIT,3815,EXON 14 MUTATION,"c-KIT exon 14 mutations lie within the tyrosine kinase domain of the protein. While relatively rare in primary gastrointestinal tumors, they are notably more prevalent in refractory disease, suggesting a role in imatinib resistance. Unlike mutations in other KIT exons, exon 14 mutations seem relatively rare in melanoma.",29,variant,99,exon_variant,Exon Variant,SO:0001791,A sequence variant that changes exon sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001791,4,55595501,55595651,,,ENST00000288135.5,,,,,75,GRCh37,,,,,,
72,KIT,3815,L576P,"KIT L576P is an exon 11 mutation that lies within the juxtamembrane domain. It is one of the most recurrent KIT mutations in melanoma, and both in vitro and in vivo studies have shown sensitivity to imatinib.",29,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,4,55593661,55593661,T,C,ENST00000288135.5,,,,,75,GRCh37,,,,,,
73,KIT,3815,V654A,"KIT V654A is an exon 13 mutation that lies within the tyrosine kinase 1 domain of the protein. It has been shown to be an activating mutation by in vitro studies. This mutation is associated with imatinib resistance in melanoma patients. However, second generation TKI's such as sunitinib and midostaurin (PKC 412) have seen success in acheiving tumor response.",29,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,4,55594258,55594258,T,C,ENST00000288135.5,,,,,75,GRCh37,,,,,,
75,KRAS,3845,EXON 2 MUTATION,Exon 2 mutations have been associated with reduced response rates or resistance to EGFR inhibitors in non-small cell lung and colorectal cancer. The NCCN guidelines for colorectal cancer contain recommendations that the targeted therapies cetuximab and panitumumab should only be used in the context of wild type KRAS.,30,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,12,25398208,25398329,,,ENST00000256078.4,,,,,75,GRCh37,99,exon_variant,Exon Variant,SO:0001791,A sequence variant that changes exon sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001791
76,KRAS,3845,G12,"While the KRAS G12 region is a widely studied recurrent region in cancer, its impact on clinical action is still debated. Often associated with tumors that are wild-type for other drivers (EGFR and ALK specifically), the prognosis for patients with this mutation seems to be worse than the KRAS wild-type cohort in patients with colorectal and pancreatic cancer, however this hypothesis is in need of further validation. This mutation, along with the mutations affecting the neighboring G13 position, may result in a less responsive tumor when treated with first-generation TKI's like gefitinib. However, cetuximab treatment was shown to extend survival in a cohort of colorectal patients.",30,variant,103,protein_altering_variant,Protein Altering Variant,SO:0001818,A sequence_variant which is predicted to change the protein encoded in the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001818,12,25398284,25398285,,,ENST00000256078.4,,,,,75,GRCh37,,,,,,
77,KRAS,3845,G12/G13,"While the KRAS G12 region is a widely studied recurrent region in cancer, its impact on clinical action is still debated. Often associated with tumors that are wild-type for other drivers (EGFR and ALK specifically), the prognosis for patients with this mutation seems to be worse than the KRAS wild-type cohort in patients with colorectal and pancreatic cancer, however this hypothesis is in need of further validation. This mutation, along with the mutations affecting the neighboring G13 position, may result in a less responsive tumor when treated with first-generation TKI's like gefitinib. However, cetuximab treatment was shown to extend survival in a cohort of colorectal patients.",30,variant,103,protein_altering_variant,Protein Altering Variant,SO:0001818,A sequence_variant which is predicted to change the protein encoded in the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001818,12,25398280,25398285,,,ENST00000256078.4,,,,,75,GRCh37,,,,,,
78,KRAS,3845,G12C,"While the KRAS G12 region is a widely studied recurrent region in cancer, its impact on clinical action is still debated. Often associated with tumors that are wild-type for other drivers (EGFR and ALK specifically), the prognosis for patients with this mutation seems to be worse than the KRAS wild-type cohort in patients with colorectal and pancreatic cancer, however this hypothesis is in need of further validation. This mutation, along with the mutations affecting the neighboring G13 position, may result in a less responsive tumor when treated with first-generation TKI's like gefitinib. However, cetuximab treatment was shown to extend survival in a cohort of colorectal patients.",30,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,12,25398285,25398285,C,A,ENST00000256078.4,,,,,75,GRCh37,,,,,,
79,KRAS,3845,G12D,"While the KRAS G12 region is a widely studied recurrent region in cancer, its impact on clinical action is still actively debated. Often associated with tumors that are wild-type for other drivers (EGFR and ALK specifically), the prognosis for patients with this mutation seems to be worse than the KRAS wild-type cohort in patients with colorectal and pancreatic cancer, however this hypothesis is in need of further validation. This mutation, along with the mutations affecting the neighboring G13 position, may result in a less responsive tumor when treated with first-generation TKI's like gefitinib. The NCCN guidelines for colorectal cancer contain recommendations that the targeted therapies cetuximab and panitumumab should only be used in the context of wild type KRAS. However, cetuximab treatment was shown to extend survival in a single cohort of colorectal patients with G12D mutations. Overall, the interpretation for KRAS mutations in most clinical scenarios is still undecided.",30,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,12,25398284,25398284,C,T,ENST00000256078.4,,,,,75,GRCh37,,,,,,
80,KRAS,3845,G13,"While the KRAS G13 region is a widely studied recurrent region in cancer, its impact on clinical action is still debated. Often associated with tumors that are wild-type for other drivers (EGFR and ALK specifically), the prognosis for patients with this mutation seems to be worse than the KRAS wild-type cohort in patients with colorectal and pancreatic cancer, however this hypothesis is in need of further validation. This mutation, along with the mutations affecting the neighboring G12 position, may result in a less responsive tumor when treated with first-generation TKI's like gefitinib. However, cetuximab treatment was shown to extend survival in a cohort of colorectal patients.",30,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,12,25398281,25398282,,,ENST00000256078.4,,,,,75,GRCh37,106,inframe_insertion,Inframe Insertion,SO:0001821,An inframe non synonymous variant that inserts bases into in the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001821
81,KRAS,3845,G13D,"While the KRAS G13 region is a widely studied recurrent region in cancer, its impact on clinical action is still debated. Often associated with tumors that are wild-type for other drivers (EGFR and ALK specifically), the prognosis for patients with this mutation seems to be worse than the KRAS wild-type cohort. This mutation, along with the mutations affecting the neighboring G12 position, may result in a less responsive tumor when treated with first-generation TKI's like gefitinib. However, results are conflicting with retrospective analyses suggesting a better response to EGFR-Inhibition. A recent prospective phase-II study (12 patients, Schirripa et. al. 2015) could not reproduce this finding and another prospective phase II trial is currently ongoing.",30,variant,45,coding_sequence_variant,Coding Sequence Variant,SO:0001580,A sequence variant that changes the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001580,12,25398281,25398281,C,T,ENST00000256078.4,,,,,75,GRCh37,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583
82,MAP2K1,5604,P124S,"MAP2K1 P124S is a recurrent mutation in melanoma, and is seen in bladder and colon cancer to a lesser degree. The P124S mutation has been shown to contribute to AZD6244 resistance in melanoma cell lines, but considerably less so than its Q56P counterpart.",31,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,15,66729162,66729162,C,T,ENST00000307102.5,,,,,75,GRCh37,,,,,,
83,MAP2K1,5604,Q56P,MAP2K1 Q56P is a recurrent mutation in melanoma and gastric cancer. This mutation has been shown to confer considerable resistance to AZD6244 treatment of melanoma cell lines.,31,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,15,66727451,66727451,A,C,ENST00000307102.5,,,,,75,GRCh37,,,,,,
85,MGMT,4255,PROMOTER METHYLATION,"MGMT promoter methylation has been observed to impact tumor progression in glioblastoma multiforme. In patients exhibiting promoter methylation, the akylating agent carmustine has shown efficacy. In patients lacking methylation, combining carmustine with the MGMT inhibitor O(6)-benzylguanine may be effective, but more experiments are required. Clinical trials have also shown selective sensitivity of promoter methylation-positive patients to temozolomide, making a case for wider methylation screening in GBM patients.",34,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,10,131264495,131265656,,,ENST00000306010.7,,,,,75,GRCh37,,,,,,
86,NPM1,4869,EXON 12 MUTATION,"NPM1 exon 12 mutations are frequently identified in patients with cytogenetically normal acute myeloid leukemia (AML) and often co-occur with FLT3-ITD. FLT3 status should also be evaluated as co-occurence with FLT3-ITD may impact prognosis. Exon 12 mutations have been identified as a predictor of good prognostic outcomes in the absence of FLT3-ITD. Due to their high frequency, NPM1 mutations have been retrospectively analyzed in the context of a number of therapies including variable results following ATRA treatment as well as improved response to high-dose daunorubicin or valproic acid. Additionally, multiple groups have shown increased surface expression of CD33 associated with NPM1 mutation, suggesting these patients may respond to anti-CD33 therapy. Cytoplasmic sequestration of NPM1 (NPM1c) is associated with a good response to induction therapy.",35,variant,99,exon_variant,Exon Variant,SO:0001791,A sequence variant that changes exon sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001791,5,170837531,170837569,,,ENST00000517671.1,,,,,75,GRCh37,,,,,,
87,NPM1,4869,W288FS,"NPM1 W288fs (aka NPM1-A) is located in exon 12 of NPM1 and is the most common NPM1 mutation identified in acute myeloid leukemia. This mutation results in cytoplasmic localization of NPM1 (NPM1c) which is associated with a good response to induction therapy. Although it is the most extensively studied NPM1 exon 12 mutation, it is generally grouped with other exon 12 mutations for patient analysis (see NPM1 Exon 12 variants for more information).",35,variant,133,frameshift_elongation,Frameshift Elongation,SO:0001909,A frameshift variant that causes the translational reading frame to be extended relative to the reference feature.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001909,5,170837547,170837548,,TCTG,ENST00000517671.1,,,,,75,GRCh37,,,,,,
92,NRAS,4893,G12,"While the NRAS G12 region is a widely studied recurrent region in cancer, its impact on clinical action is still debated.",36,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,1,115258747,115258748,,,ENST00000369535.4,,,,,75,GRCh37,,,,,,
93,NRAS,4893,G13D,"While the NRAS G12 region is a widely studied recurrent region in cancer, its impact on clinical action is still debated.",36,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,1,115258744,115258744,C,T,ENST00000369535.4,,,,,75,GRCh37,,,,,,
94,NRAS,4893,Q61,"NRAS Q61 mutations have been found in multiple myeloma, gastrointestinal stromal tumors, melanoma, and others. Two melanoma patients, each harboring mutations at this locus (Q61L and Q61R), responded to treatment with the akylating agent temozolomide. However, in colorectal cancer patients, mutations at this locus have been shown to confer resistance to cetuximab. The prognostic impact of mutations at this locus is currently under study.",36,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,1,115256528,115256530,,,ENST00000369535.4,,,,,75,GRCh37,,,,,,
95,NRAS,4893,Q61L,"NRAS Q61 mutations have been found in multiple myeloma, gastrointestinal stromal tumors, melanoma, and others. A melanoma patient harboring a mutation at this locus responded to treatment with the akylating agent temozolomide. However, in colorectal cancer patients, mutations at this locus have been shown to confer resistance to cetuximab. The prognostic impact of mutations at this locus is currently under study.",36,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,1,115256529,115256529,T,A,ENST00000369535.4,,,,,75,GRCh37,,,,,,
96,NRAS,4893,Q61R,"NRAS Q61 mutations have been found in multiple myeloma, gastrointestinal stromal tumors, melanoma, and others. A melanoma patient harboring a mutation at this locus responded to treatment with the akylating agent temozolomide. However, in colorectal cancer patients, mutations at this locus have been shown to confer resistance to cetuximab. The prognostic impact of mutations at this locus is currently under study.",36,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,1,115256529,115256529,T,C,ENST00000369535.4,,,,,75,GRCh37,,,,,,
98,PDGFRA,5156,D842I,"PDGFRA D842 mutations are characterized broadly as imatinib resistance mutations. This is most well characterized in gastrointestinal stromal tumors, but other cell lines containing these mutations have been shown to be resistant as well. In imatinib resistant cell lines, a number of other therapeutics have demonstrated efficacy. These include; crenolanib, sirolimus, and midostaurin (PKC412).",38,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,4,55152092,55152093,GA,AT,ENST00000257290.5,,,,,75,GRCh37,,,,,,
99,PDGFRA,5156,D842V,"PDGFRA D842 mutations are characterized broadly as imatinib resistance mutations. This is most well characterized in gastrointestinal stromal tumors, but other cell lines containing these mutations have been shown to be resistant as well. Exogenous expression of the A842V mutation resulted in constitutive tyrosine phosphorylation of PDGFRA in the absence of ligand in 293T cells and cytokine-independent proliferation of the IL-3-dependent Ba/F3 cell line, both evidence that this is an activating mutation. In imatinib resistant cell lines, a number of other therapeutics have demonstrated efficacy. These include; crenolanib, sirolimus, and midostaurin (PKC412).",38,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,4,55152093,55152093,A,T,ENST00000257290.5,,,,,75,GRCh37,,,,,,
100,PDGFRA,5156,D842Y,"PDGFRA D842 mutations are characterized broadly as imatinib resistance mutations. This is most well characterized in gastrointestinal stromal tumors, but other cell lines containing these mutations have been shown to be resistant as well. In imatinib resistant cell lines, a number of other therapeutics have demonstrated efficacy. These include; crenolanib, sirolimus, and midostaurin (PKC412).",38,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,4,55152092,55152092,G,T,ENST00000257290.5,,,,,75,GRCh37,,,,,,
101,PDGFRA,5156,I843DEL,"PDGFRA D842 mutations are characterized broadly as imatinib resistance mutations. This is most well characterized in gastrointestinal stromal tumors, but other cell lines containing these mutations have been shown to be resistant as well. In imatinib resistant cell lines, a number of other therapeutics have demonstrated efficacy. These include; crenolanib, sirolimus, and midostaurin (PKC412).",38,variant,107,inframe_deletion,Inframe Deletion,SO:0001822,An inframe non synonymous variant that deletes bases from the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001822,4,55152095,55152097,ATC,,ENST00000257290.5,,,,,75,GRCh37,,,,,,
102,PDGFRA,5156,DI842-843VM,"PDGFRA D842 mutations are characterized broadly as imatinib resistance mutations. The DI842-843VM variant is the result of a double point mutation. This is most well characterized in gastrointestinal stromal tumors, but other cell lines containing these mutations have been shown to be resistant as well. In imatinib resistant cell lines, a number of other therapeutics have demonstrated efficacy. These include; crenolanib, sirolimus, and midostaurin (PKC412).",38,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,4,55152093,55152097,ACATC,TCATG,ENST00000257290.5,,,,,75,GRCh37,,,,,,
103,PIK3CA,5290,E542K,"PIK3CA E545K/E542K are the second most recurrent PIK3CA mutations in breast cancer, and are highly recurrent mutations in many other cancer types. E545K, and possibly the other mutations in the E545 region, may present patients with a poorer prognosis than patients with other PIK3CA variants or wild-type PIK3CA. There is also data to suggest that E545/542 mutations may confer resistance to EGFR inhibitors like cetuximab. While very prevalent, targeted therapies for variants in PIK3CA are still in early clinical trial phases.",37,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,3,178936082,178936082,G,A,ENST00000263967.3,,,,,75,GRCh37,,,,,,
104,PIK3CA,5290,E545K,"PIK3CA E545K/E542K are the second most recurrent PIK3CA mutations in breast cancer, and are highly recurrent mutations in many other cancer types. E545K, and possibly the other mutations in the E545 region, may present patients with a poorer prognosis than patients with either patients with other PIK3CA variant or wild-type PIK3CA. There is also data to suggest that E545/542 mutations may confer resistance to EGFR inhibitors like cetuximab. While very prevalent, targeted therapies for variants in PIK3CA are still in early clinical trial phases.",37,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,3,178936091,178936091,G,A,ENST00000263967.3,,,,,75,GRCh37,,,,,,
105,PIK3CA,5290,EXON 21 MUTATION,"PIK3CA Exon 21 Mutations (e.g., H1047R; often referred to as Exon 20 mutations if counting only coding exons) are among the most recurrent mutations in cancer, especially breast cancer. Of PIK3CA mutant breast cancers, over half harbor this mutation. Meta-analyses have shown that patients harboring this mutation may have worse overall survival, but other studies have shown no difference between Exon 21 and other PIK3CA mutants from a prognostic standpoint. While very prevalent, targeted therapies for this particular mutation are still in early clinical trial phases.",37,variant,99,exon_variant,Exon Variant,SO:0001791,A sequence variant that changes exon sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001791,3,178951882,178952495,,,ENST00000263967.3,,,,,75,GRCh37,,,,,,
106,PIK3CA,5290,EXON 10 MUTATION,"PIK3CA Exon 10 Mutations (e.g. E545K/E542K; often referred to as Exon 9 mutations if counting only coding exons) are the second most recurrent PIK3CA mutations in breast cancer, and highly recurrent mutations in many other cancer types. E545K, and possibly the other mutations in the E545 region, may present patients with a poorer prognosis than patients with either patients with other PIK3CA variant or wild-type PIK3CA. There is also data to suggest that exon 10 mutations may confer resistance to EGFR inhibitors like cetuximab. While very prevalent, targeted therapies for variants in PIK3CA are still in early clinical trial phases.",37,variant,99,exon_variant,Exon Variant,SO:0001791,A sequence variant that changes exon sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001791,3,178935998,178936122,,,ENST00000263967.3,,,,,75,GRCh37,,,,,,
107,PIK3CA,5290,H1047R,"PIK3CA H1047R is one of the most recurrent single nucleotide variants in cancer, especially breast cancer. Of PIK3CA-mutant breast cancers, over half harbor this mutation. Meta-analyses have shown that patients harboring this mutation may have worse overall survival, but other studies have shown no difference between H1047R and other PIK3CA mutants from a prognostic standpoint. While very prevalent, targeted therapies for this particular mutation are still in early clinical trial phases.",37,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,3,178952085,178952085,A,G,ENST00000263967.3,,,,,75,GRCh37,,,,,,
108,PML,5371,PML-RARA,"The PML-RARA fusion is seen as a diagnostic event in acute promyelocytic leukemia (APL). Both in vitro and in vivo studies have shown sensitivity to ATRA in APL patients harboring the PML-RARa fusion. Recent interest has been shown in combining ATRA and arsenic trioxide for treating these patients, and early results seem promising.",39,variant,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886,15,74287058,74325755,,,ENST00000268058.3,17,38504568,38513048,ENST00000254066.5,75,GRCh37,,,,,,
110,PTEN,5728,R233*,"PTEN R233* has been shown to be a loss of function mutation, and PTEN loss has been the subject of considerable research in breast cancer. PTEN loss may sensitize cells to PI3K-mTOR inhibition. While still being debated, there is data to support that PTEN loss is both associated with poorer prognosis, and no change in prognosis.",41,variant,50,stop_gained,Stop Gained,SO:0001587,"A sequence variant whereby at least one base of a codon is changed, resulting in a premature stop codon, leading to a shortened polypeptide.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001587,10,89717672,89717672,C,T,ENST00000371953.3,,,,,75,GRCh37,161,loss_of_function_variant,Loss Of Function Variant,SO:0002054,A sequence variant whereby the gene product has diminished or abolished function.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002054
112,RET,5979,C634W,"RET C634W has been implicated as an alternate mechanism of activating RET in medullary thyroid cancer. While there currently are no RET-specific inhibiting agents, promiscuous kinase inhibitors have seen some success in treating RET overactivity. Data suggests however, that the C634W mutation may lead to drug resistance, especially against the VEGFR-inhibitor motesanib.",42,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,10,43609950,43609950,C,G,ENST00000355710.3,,,,,75,GRCh37,,,,,,
113,RET,5979,M918T,"RET M819T is the most common somatically acquired mutation in medullary thyroid cancer (MTC). While there currently are no RET-specific inhibiting agents, promiscuous kinase inhibitors have seen some success in treating RET overactivity. Data suggests however, that the M918T mutation may lead to drug resistance, especially against the VEGFR-inhibitor motesanib. It has also been suggested that RET M819T leads to more aggressive MTC with a poorer prognosis.",42,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,10,43617416,43617416,T,C,ENST00000355710.3,,,,,75,GRCh37,,,,,,
114,SF3B1,23451,K666N,"SF3B1 K666N is a variant found in myelodysplastic syndromes, chronic leukemias, and more recently, breast cancer. This somatic mutation has been linked to better overall outcome and event-free survival in MDS patients.",44,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,2,198267359,198267359,C,A,ENST00000335508.6,,,,,75,GRCh37,,,,,,
116,TP53,7157,R175H,"While loss-of-function events in TP53 are very common in cancer, the R175H variant seems not only to result in loss of tumor-suppression, but also acts as a gain-of-function mutation that promotes tumorigenesis in mouse models. Cell lines harboring this mutant is also more responsive to treatment with doxorubicin than its wild-type counterparts. While the prognostic impact of individual TP53 mutations is influenced by the cohort being studied, it has been shown that the R175H mutation is correlated with worse overall survival than wild-type TP53, but is not as detrimental as the R248W variant.",45,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,17,7578406,7578406,C,T,ENST00000269305.4,,,,,75,GRCh37,,,,,,
117,TP53,7157,R248Q,"While loss-of-function events in TP53 are very common in cancer, the R248 variants seem not only to result in loss of tumor-suppression, but also act as a gain-of-function mutation that can promote tumorigenesis in mouse models. This mutant is also more responsive to treatment with doxorubicin than its wild-type counterparts. While the prognostic impact of individual TP53 mutations is influenced by the cohort being studied, R248 mutations have been shown to confer worse overall survival. The R248Q mutation has also shown an increased invasive behavior in cell lines. This is specific to the 248Q variant.",45,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,17,7577538,7577538,C,T,ENST00000269305.4,,,,,75,GRCh37,,,,,,
118,TP53,7157,R248W,"While loss-of-function events in TP53 are very common in cancer, the R248 variants seem not only to result in loss of tumor-suppression, but also act as a gain-of-function mutation that can promote tumorigenesis in mouse models. This mutant is also more responsive to treatment with doxorubicin than its wild-type counterparts. While the prognostic impact of individual TP53 mutations is influenced by the cohort being studied, R248 mutations have been shown to confer worse overall survival.",45,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,17,7577539,7577539,G,A,ENST00000269305.4,,,,,75,GRCh37,,,,,,
119,TP53,7157,R249,"This mutant is also more responsive to treatment with doxorubicin than its wild-type counterparts. While the prognostic impact of individual TP53 mutations is influenced by the cohort being studied, it has been suggested that the R249 mutants have been correlated with worse overall survival in breast cancer patients when compared to wild-type.",45,variant,103,protein_altering_variant,Protein Altering Variant,SO:0001818,A sequence_variant which is predicted to change the protein encoded in the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001818,17,7577535,7577535,C,G,ENST00000269305.4,,,,,75,GRCh37,,,,,,
121,TP53,7157,R273C,"While loss-of-function events in TP53 are very common in cancer, the R273 variants seem not only to result in loss of tumor-suppression, but also act as a gain-of-function mutation that can promote tumorigenesis in mouse models. This mutant is also more responsive to treatment with doxorubicin than its wild-type counterparts. While the prognostic impact of individual TP53 mutations is influenced by the cohort being studied, it has been suggested that the R273 mutants have been correlated with worse overall survival in breast cancer patients when compared to wild-type.",45,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,17,7577121,7577121,G,A,ENST00000269305.4,,,,,75,GRCh37,,,,,,
122,TP53,7157,R273H,"While loss-of-function events in TP53 are very common in cancer, the R273 variants seem not only to result in loss of tumor-suppression, but also act as a gain-of-function mutation that can promote tumorigenesis in mouse models. This mutant is also more responsive to treatment with doxorubicin than its wild-type counterparts. While the prognostic impact of individual TP53 mutations is influenced by the cohort being studied, it has been suggested that the R273 mutants have been correlated with worse overall survival in breast cancer patients when compared to wild-type.",45,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,17,7577120,7577120,C,T,ENST00000269305.4,,,,,75,GRCh37,,,,,,
124,TSC1,7248,FRAMESHIFT TRUNCATION,"In a small cohort study of bladder cancer, patients with TSC1 mutations showed better responses to and increased treatment duration tolerance with the mTOR inhibitor everolimus. Additionally, patient-derived bladder cancer cell lines with TSC1 or TSC2 mutations are much more sensitive to everolimus treatment than TSC1/TSC2 wildtype cells.",46,variant,134,frameshift_truncation,Frameshift Truncation,SO:0001910,A frameshift variant that causes the translational reading frame to be shortened relative to the reference feature.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001910,9,135766735,135820008,,,ENST00000298552.3,,,,,75,GRCh37,,,,,,
125,TSC1,7248,LOSS-OF-FUNCTION,"In a small cohort study of bladder cancer, patients with TSC1 mutations showed better responses to and increased treatment duration tolerance with the mTOR inhibitor everolimus. Additionally, patient-derived bladder cancer cell lines with TSC1 or TSC2 mutations are much more sensitive to everolimus treatment than TSC1/TSC2 wildtype cells.",46,variant,161,loss_of_function_variant,Loss Of Function Variant,SO:0002054,A sequence variant whereby the gene product has diminished or abolished function.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002054,9,135766735,135820008,,,ENST00000298552.3,,,,,75,GRCh37,,,,,,
127,U2AF1,7307,Q157P/R,"U2AF1 Q157P/R has been shown to be a recurrent mutation in acute myeloid leukemia (AML), myelodysplastic syndromes (MDS) and lung adenocarcinomas. This mutation is less common than the S34F mutation, occurs in the second zinc finger domain of U2AF1 and has been demonstrated to alter splicing. The impact of U2AF1 mutations on overall survival in MDS has been debated, however, patients with U2AF1 mutations were shown to be at an increased risk of transformation to secondary AML. The presence of this mutation was not associated with a specific prognostic outcome in AML when compared to U2AF1 wildtype patients.",48,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,21,44514777,44514777,T,G,ENST00000291552.4,,,,,75,GRCh37,,,,,,
128,U2AF1,7307,S34Y/F,"U2AF1 S34Y/F has been shown to be a recurrent mutation in acute myeloid leukemia (AML), myelodysplastic syndromes (MDS) and lung adenocarcinomas. This mutation is the most commonly identified variant in MDS, occurs in the first zinc finger domain of U2AF1 and has been demonstrated to alter splicing. The impact of U2AF1 mutations on overall survival in MDS has been debated, however, patients with U2AF1 mutations were shown to be at an increased risk of transformation to secondary AML. The presence of this mutation was not associated with a specific prognostic outcome in AML when compared to U2AF1 wildtype patients.",48,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,21,44524456,44524456,G,A,ENST00000291552.4,,,,,75,GRCh37,,,,,,
129,WT1,7490,EXON 7 MUTATION,"WT1 exon 7 mutations have been shown to be recurrent in acute myeloid leukemia. Many sources have examined the prognostic impact of these, agreeing that the mutant exon 7 cohort is correlated with worse overall survival and a number of poor prognistic outcomes. This may be the result of an overall poor response to chemotherapy from WT1 mutant tumors.",49,variant,99,exon_variant,Exon Variant,SO:0001791,A sequence variant that changes exon sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001791,11,32417803,32417953,,,ENST00000332351.3,,,,,75,GRCh37,,,,,,
130,WT1,7490,EXON 9 MUTATION,"WT1 exon 9 mutations have been shown to be recurrent in acute myeloid leukemia, although at a less frequent rate than their exon 7 counterparts. Many sources have examined the prognostic impact of these, agreeing that the mutant exon 9 cohort is correlated with worse overall survival and a number of poor prognistic outcomes. This may be the result of an overall poor response to chemotherapy from WT1 mutant tumors.",49,variant,99,exon_variant,Exon Variant,SO:0001791,A sequence variant that changes exon sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001791,11,32413518,32413610,,,ENST00000332351.3,,,,,75,GRCh37,,,,,,
131,BRCA1,672,LOSS-OF-FUNCTION,BRCA1 loss of function mutations have been shown to increase risk of breast and ovarian cancer in those carrying the allele in their germline. Treating BRCA mutant patients with PARP inhibitors such as Olaparib has led to significant response.,6,variant,97,loss_of_heterozygosity,Loss Of Heterozygosity,SO:0001786,A functional variant whereby the sequence alteration causes a loss of function of one allele of a gene.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001786,17,41196312,41277387,,,ENST00000357654.3,,,,,75,GRCh37,161,loss_of_function_variant,Loss Of Function Variant,SO:0002054,A sequence variant whereby the gene product has diminished or abolished function.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002054
132,BRCA2,675,LOSS-OF-FUNCTION,BRCA2 loss of function mutations have been shown to increase risk of breast and ovarian cancer in those carrying the allele in their germline. Treating BRCA mutant patients with PARP inhibitors such as Olaparib has led to significant response.,7,variant,161,loss_of_function_variant,Loss Of Function Variant,SO:0002054,A sequence variant whereby the gene product has diminished or abolished function.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002054,13,32889611,32973347,,,ENST00000380152.3,,,,,75,GRCh37,,,,,,
133,EGFR,1956,EXON 19 DELETION,"Deletions within exon 19 of EGFR are most common in lung cancer. These deletions, in non-small cell lung cancer, have been shown to be sensitive to the EGFR tyrosine kinase inhibitors gefitinib, afatinib, and erlotinib. There is also data to suggest that this event is a good prognostic marker in lung adenocarcinoma.",19,variant,107,inframe_deletion,Inframe Deletion,SO:0001822,An inframe non synonymous variant that deletes bases from the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001822,7,55242415,55242513,,,ENST00000275493.2,,,,,75,GRCh37,,,,,,
134,EGFR,1956,G719S,"While not as recurrent as the L858R mutation, EGFR G719S has also been shown to be an activating mutation. In lung cancer cell lines, it also confers sensitivity to the tyrosine kinase inhibitors gefitinib and erlotinib.",19,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,7,55241707,55241707,G,A,ENST00000275493.2,,,,,75,GRCh37,,,,,,
135,NOTCH1,4851,D1642H,"Activating mutations in NOTCH1, including D1642H, have been shown to be poor prognostic markers in lung cancer.",50,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,9,139399219,139399219,C,G,ENST00000277541.6,,,,,75,GRCh37,,,,,,
136,NOTCH1,4851,R2327W,"Activating mutations in NOTCH1, including R2327W, have been shown to be poor prognostic markers in lung cancer.",50,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,9,139391212,139391212,G,A,ENST00000277541.6,,,,,75,GRCh37,,,,,,
137,NOTCH1,4851,V2444FS,"Activating mutations in NOTCH1, including a frameshift insertion at V2444, have been shown to be poor prognostic markers in lung cancer.",50,variant,51,frameshift_variant,Frameshift Variant,SO:0001589,"A sequence variant which causes a disruption of the translational reading frame, because the number of nucleotides inserted or deleted is not a multiple of three.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001589,9,139390861,139390861,G,TGT,ENST00000277541.6,,,,,75,GRCh37,,,,,,
138,NOTCH1,4851,S2275FS,"Activating mutations in NOTCH1, including a frameshift insertion at S2275, have been shown to be poor prognostic markers in lung cancer.",50,variant,55,plus_1_frameshift_variant,Plus 1 Frameshift Variant,SO:0001594,"A sequence variant which causes a disruption of the translational reading frame, by shifting one base backward.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001594,9,139391369,139391370,,A,ENST00000277541.6,,,,,75,GRCh37,,,,,,
139,DDR2,4921,L63V,"Activating mutations in DDR2, including L63V, has been shown to be sensitive to dasatinib in cell lines.",51,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,1,162724415,162724415,C,G,ENST00000367922.3,,,,,75,GRCh37,,,,,,
140,DDR2,4921,L239R,"Activating mutations in DDR2, including L239R, has been shown to be sensitive to dasatinib in cell lines.",51,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,1,162729630,162729630,T,G,ENST00000367922.3,,,,,75,GRCh37,,,,,,
141,DDR2,4921,G253C,"Activating mutations in DDR2, including G253C, has been shown to be sensitive to dasatinib in cell lines.",51,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,1,162729671,162729671,G,T,ENST00000367922.3,,,,,75,GRCh37,,,,,,
142,DDR2,4921,G505S,"Activating mutations in DDR2, including G505S, has been shown to be sensitive to dasatinib in cell lines.",51,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,1,162741822,162741822,G,A,ENST00000367922.3,,,,,75,GRCh37,,,,,,
143,DDR2,4921,I638F,"DDR2 I638F has been shown to be a loss of function mutation, but also confers sensitivity to dasatinib in cell lines.",51,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,1,162745497,162745497,A,T,ENST00000367922.3,,,,,75,GRCh37,,,,,,
144,DDR2,4921,G774V,"Activating mutations in DDR2, including G774V, has been shown to be sensitive to dasatinib in cell lines.",51,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,1,162748407,162748407,G,T,ENST00000367922.3,,,,,75,GRCh37,,,,,,
145,DDR2,4921,S768R,"Activating mutations in DDR2, including S768R, has been shown to be sensitive to dasatinib in cell lines.",51,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,1,162748390,162748390,T,A,ENST00000367922.3,,,,,75,GRCh37,,,,,,
148,KRAS,3845,G12A,"KRAS G12A, like EGFR T790M, has been shown to be capable of driving acquired resistance to tyrosine kinase inhibitors in lung adenocarcinoma.",30,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,12,25398284,25398284,C,G,ENST00000256078.4,,,,,75,GRCh37,,,,,,
151,BCL2,596,IGH-BCL2,"The typically reciprocal t(14;18)(q32;q21) translocation involves rearrangement between the immunoglobulin heavy chain locus on chromosome 14 and the 3' UTR of BCL2 on chromosome 18, leading to the overexpression of BCL2. This rearrangment is observed in >80% of patients with follicular lymphoma.",59,variant,124,transcript_regulatory_region_fusion,Transcript Regulatory Region Fusion,SO:0001890,A feature fusion where the deletion brings together a regulatory region and a transcript region.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001890,14,106032614,107288051,,,,18,60794268,60987019,ENST00000333681.4,75,GRCh37,,,,,,
152,BCL2,596,EXPRESSION,,59,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,18,60790579,60987361,,,ENST00000398117.1,,,,,75,GRCh37,,,,,,
153,FOXP1,27086,AMPLIFICATION,Amplication in FOXP1 has been shown to be associated with the ABC subtype of DLBCL.,56,variant,123,transcript_amplification,Transcript Amplification,SO:0001889,A feature amplification of a region containing a transcript.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001889,3,71003844,71633140,,,ENST00000318789.4,,,,,75,GRCh37,,,,,,
154,REL,5966,AMPLIFICATION,,57,variant,123,transcript_amplification,Transcript Amplification,SO:0001889,A feature amplification of a region containing a transcript.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001889,2,61108709,61149800,,,ENST00000295025.8,,,,,75,GRCh37,,,,,,
155,RUNX1,861,MUTATION,"RUNX1 mutations are associated with poor prognosis in patients with acute myeloid leukemia or adult T-cell acute lymphocytic leukemia. In younger (<60 years old) AML patients, allogeneic stem cell transplant at complete remission led to much better relapse-free survival than repetitive cycles of high-dose cytarabine.",43,variant,42,transcript_variant,Transcript Variant,SO:0001576,A sequence variant that changes the structure of the transcript.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001576,21,36160098,36421641,,,ENST00000300305.3,,,,,75,GRCh37,161,loss_of_function_variant,Loss Of Function Variant,SO:0002054,A sequence variant whereby the gene product has diminished or abolished function.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002054
156,IGF2,3481,OVEREXPRESSION,,60,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,11,2150348,2170833,,,ENST00000300632.5,,,,,75,GRCh37,,,,,,
157,TET2,54790,MUTATION,"TET2 mutations are commonly found in acute myeloid leukemia occurring in 9-23% of cases with many occurring in the elderly. Generally these mutations are loss-of-function which have been shown in mouse models to impair hematopoietic stem cell differentiation and cause aberrant hematopoiesis. These mutations have been found to be mutually exclusive with MLL and IDH1/2 mutations and have been associated with shortened event-free-survival and disease-free-survival when co-occurring with NPM1+/FLT3- genotypes. Overall Survival has been found to be shorter when occurring with NPM1+/FLT3+ genotypes. Studies involving ""CN AML"" and ""de novo AML"" however have been unable to elucidate a clinical impact.",55,variant,30,gene_variant,Gene Variant,SO:0001564,A sequence variant where the structure of the gene is changed.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001564,4,106067450,106200973,,,ENST00000513237.1,,,,,75,GRCh37,161,loss_of_function_variant,Loss Of Function Variant,SO:0002054,A sequence variant whereby the gene product has diminished or abolished function.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002054
158,AURKA,6790,EXPRESSION,,61,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,20,54944446,54967393,,,ENST00000395913.3,,,,,75,GRCh37,,,,,,
159,VHL,7428,LOSS-OF-FUNCTION,,58,variant,161,loss_of_function_variant,Loss Of Function Variant,SO:0002054,A sequence variant whereby the gene product has diminished or abolished function.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002054,3,10182692,10193904,,,ENST00000256474.2,,,,,75,GRCh37,,,,,,
160,VHL,7428,MUTATION,,58,variant,30,gene_variant,Gene Variant,SO:0001564,A sequence variant where the structure of the gene is changed.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001564,3,10182692,10193904,,,ENST00000256474.2,,,,,75,GRCh37,161,loss_of_function_variant,Loss Of Function Variant,SO:0002054,A sequence variant whereby the gene product has diminished or abolished function.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002054
161,PBRM1,55193,MUTATION,,62,variant,15,transcription_variant,Transcription Variant,SO:0001549,A variant that changes alters the transcription of a transcript with respect to a reference sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001549,3,52581857,52719852,,,ENST00000394830.3,,,,,75,GRCh37,161,loss_of_function_variant,Loss Of Function Variant,SO:0002054,A sequence variant whereby the gene product has diminished or abolished function.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002054
163,EZH2,2146,MUTATION,,63,variant,103,protein_altering_variant,Protein Altering Variant,SO:0001818,A sequence_variant which is predicted to change the protein encoded in the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001818,7,148504477,148581370,,,ENST00000320356.2,,,,,75,GRCh37,,,,,,
164,FLI1,2313,EWSR1-FLI1 Type 1,"Although multiple fusion transcripts have been described, type 1 consists of EWSR1 exon 7 fused to FLI1 exon 6, the most common arrangement in Ewings Sarcoma.",53,variant,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886,22,29664007,29683123,,,ENST00000397938.2,11,128675261,128683162,ENST00000527786.2,75,GRCh37,,,,,,
165,EZH2,2146,Y646,"Mutations of Y646 are associated with a diagnosis of Germinal Center B type DLBCL and Follicular non-Hodgkin Lymphoma. In vitro experimental findings suggest that this may be due to reduced methyltransferase activity of EZH2 on protein H3K27 (Morin et al., 2010).",63,variant,103,protein_altering_variant,Protein Altering Variant,SO:0001818,A sequence_variant which is predicted to change the protein encoded in the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001818,7,148508726,148508728,,,ENST00000320356.2,,,,,75,GRCh37,,,,,,
167,KMT2D,8085,LOSS-OF-FUNCTION,,64,variant,161,loss_of_function_variant,Loss Of Function Variant,SO:0002054,A sequence variant whereby the gene product has diminished or abolished function.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002054,12,49412758,49449107,,,ENST00000301067.7,,,,,75,GRCh37,,,,,,
168,BTK,695,C481S,,65,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,X,100611165,100611165,A,T,ENST00000308731.7,,,,,75,GRCh37,,,,,,
169,AKT1,207,Q79K,,2,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,14,105243048,105243048,G,T,ENST00000407796.2,,,,,75,GRCh37,,,,,,
170,ALK,238,EML4-ALK AMPLIFICATION,,1,variant,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886,2,42396490,42528380,,,ENST00000318522.5,2,29415640,29446394,ENST00000389048.3,75,GRCh37,123,transcript_amplification,Transcript Amplification,SO:0001889,A feature amplification of a region containing a transcript.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001889
171,ALK,238,ALK FUSION G1202R,"ALK fusion with G1202R mutation in the ALK kinase domain was first identified in a lung adenocarcinoma patient who had progressed after 10 months of responding to crizotinib. Further characterization of this variant verified crizotinib resistance and additionally demonstrated resistance to multiple next generation ALK inhibitors including ceritinib, alectinib and brigatinib. Experiments using the HSP90 inhibitor  17-AAG have indicated potential sensitivity of EML4-ALK G1202R to this drug, suggesting this variant may be an HSP90 client protein.",1,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,2,29443613,29443613,C,T,ENST00000389048.3,,,,,75,GRCh37,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886
172,ALK,238,EML4-ALK S1206Y,,1,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,2,29443600,29443600,G,T,ENST00000389048.3,,,,,75,GRCh37,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886
173,ALK,238,EML4-ALK T1151INST,"The ALK fusion variant with insertion of T at amino acid 1151 was found in an ALK rearranged lung adenocarcinoma which had progressed after responding to crizotinib treatment. The mutation was absent in tumor sample taken before crizotinib treatment. Characterization of the variant using cell lines expressing EML4-ALK with 1151 T insert found the variant to be highly crizotinib resistant, and other work demonstrated resistance to next generation inhibitor alectinib, while resistance to tool compound TAE684 indicates potential resistance to the next generation ALK inhibitor ceritinib which is derived from TAE684. Other experiments suggest theraputic potential for HSP90 inhibitors, as EML4-ALK T1151 Tins sensitivity to 17-AAG has been observed.",1,variant,106,inframe_insertion,Inframe Insertion,SO:0001821,An inframe non synonymous variant that inserts bases into in the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001821,2,29445271,29445272,,CGT,ENST00000389048.3,,,,,75,GRCh37,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886
174,APC,324,MUTATION,,66,variant,,,,,,,5,112043218,112181936,,,ENST00000457016.1,,,,,75,GRCh37,,,,,,
175,AR,367,F877L,,67,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,X,66943549,66943549,T,C,ENST00000374690.3,,,,,75,GRCh37,,,,,,
176,AR,367,W742,,67,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,X,66937370,66937372,,,ENST00000374690.3,,,,,75,GRCh37,,,,,,
177,ASXL1,171023,MUTATION,ASXL1 mutations are most frequently observed in the absence of FLT3-ITD and NPM1 mutations in acute myeloid leukemia (AML) patients and seem to be enriched in older patients (>60 years). These mutations are associated with poor prognosis with respect to both survival and compete remission rates.,68,variant,103,protein_altering_variant,Protein Altering Variant,SO:0001818,A sequence_variant which is predicted to change the protein encoded in the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001818,20,30946155,31027122,,,ENST00000375687.4,,,,,75,GRCh37,,,,,,
178,ATM,472,MUTATION,,69,variant,15,transcription_variant,Transcription Variant,SO:0001549,A variant that changes alters the transcription of a transcript with respect to a reference sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001549,11,108093559,108239826,,,ENST00000278616.4,,,,,75,GRCh37,161,loss_of_function_variant,Loss Of Function Variant,SO:0002054,A sequence variant whereby the gene product has diminished or abolished function.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002054
179,ATM,472,UNDEREXPRESSION,,69,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,11,108093559,108239826,,,ENST00000278616.4,,,,,75,GRCh37,,,,,,
180,AURKA,6790,AMPLIFICATION,,61,variant,123,transcript_amplification,Transcript Amplification,SO:0001889,A feature amplification of a region containing a transcript.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001889,20,54944446,54967393,,,ENST00000395913.3,,,,,75,GRCh37,,,,,,
181,AURKA,6790,OVEREXPRESSION,,61,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,20,54944446,54967393,,,ENST00000395913.3,,,,,75,GRCh37,,,,,,
182,BAP1,8314,EXPRESSION,,70,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,3,52435029,52444366,,,ENST00000460680.1,,,,,75,GRCh37,,,,,,
183,BAP1,8314,MUTATION,"BAP1 is a tumor suppressor gene, mutations in this gene have been observed in a number of cancers including melanoma, and renal cancers. These mutations generally lead to loss-of-function and mutations in the UHC domain of BAP1 have been shown to lead to structural instability and -amyloid aggregation in models. Germline mutations are associated with an increased risk of tumorgenesis and can lead to the development of ""atypical Spitz tumours (ASTs), cutaneous melanoma (CM), epithelioid malignant mesothelioma (MM) and clear cell RCC"".",70,variant,103,protein_altering_variant,Protein Altering Variant,SO:0001818,A sequence_variant which is predicted to change the protein encoded in the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001818,3,52435029,52444366,,,ENST00000460680.1,,,,,75,GRCh37,161,loss_of_function_variant,Loss Of Function Variant,SO:0002054,A sequence variant whereby the gene product has diminished or abolished function.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002054
184,BRAF,673,AKAP9-BRAF,,5,variant,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886,7,91570181,91625114,,,ENST00000356239.3,7,140434279,140487384,ENST00000288602.6,75,GRCh37,,,,,,
185,BRCA1,672,MUTATION,,6,variant,30,gene_variant,Gene Variant,SO:0001564,A sequence variant where the structure of the gene is changed.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001564,17,41196312,41277387,,,ENST00000357654.3,,,,,75,GRCh37,161,loss_of_function_variant,Loss Of Function Variant,SO:0002054,A sequence variant whereby the gene product has diminished or abolished function.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002054
186,BRCA2,675,MUTATION,,7,variant,30,gene_variant,Gene Variant,SO:0001564,A sequence variant where the structure of the gene is changed.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001564,13,32889611,32973347,,,ENST00000380152.3,,,,,75,GRCh37,161,loss_of_function_variant,Loss Of Function Variant,SO:0002054,A sequence variant whereby the gene product has diminished or abolished function.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002054
187,CCNE1,898,AMPLIFICATION,,11,variant,123,transcript_amplification,Transcript Amplification,SO:0001889,A feature amplification of a region containing a transcript.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001889,19,30302805,30315215,,,ENST00000262643.3,,,,,75,GRCh37,,,,,,
189,DNMT3A,1788,MUTATION,"DNMT3A mutations occur in a variety of myeloid malignancies. These mutations are associated with adverse prognosis in acute myeloid leukemia (AML), particularly in the context of NPM1 and FLT3-ITD mutations, which often co-occur. Early results indicate AML patients with DNMT3A mutations may respond better to decitabine than those with wild-type. Shorter survival has been indicated in patients with T-cell acute lymphoblastic leukemia and myelodysplastic syndrome, however, larger cohorts are required to verify this finding. DNMT3A mutations have been suggested as a pre-leukemic lesion and found in older individuals with clonal hematopoiesis but no overt malignancy.",18,variant,42,transcript_variant,Transcript Variant,SO:0001576,A sequence variant that changes the structure of the transcript.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001576,2,25455845,25565459,,,ENST00000264709.3,,,,,75,GRCh37,,,,,,
190,EGFR,1956,AMPLIFICATION,,19,variant,123,transcript_amplification,Transcript Amplification,SO:0001889,A feature amplification of a region containing a transcript.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001889,7,55086794,55279321,,,ENST00000275493.2,,,,,75,GRCh37,,,,,,
191,EGFR,1956,COPY NUMBER VARIATION,,19,variant,29,copy_number_change,Copy Number Change,SO:0001563,A sequence variant where copies of a feature (CNV) are either increased or decreased.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001563,7,55086794,55279321,,,ENST00000275493.2,,,,,75,GRCh37,,,,,,
193,EGFR,1956,OVEREXPRESSION,,19,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,7,55086794,55279321,,,ENST00000275493.2,,,,,75,GRCh37,,,,,,
194,ERG,2078,EWSR1-ERG,"EWSR1-ERG is found in 5% of patients with Ewing Sarcoma and considered to be diagnostic of this disease, a small tumor more often found in bone, but less frequently in soft tissue. To better identify EWSR1-ERG in patients, conventional cytogenetics methods were analyzed: FISH and RT-PCR. Ultimately concluding that more than one method is needed to accurately diagnose patients due to the strengths and weaknesses of each individual method.",71,variant,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886,22,29664007,29683123,,,ENST00000397938.2,21,39751949,39755845,ENST00000398907.1,75,GRCh37,,,,,,
195,ERG,2078,TMPRSS2-ERG,"TMPRSS2 fusions are prevalent in Prostate Cancer. TMPRSS2 fusion with ETS family members such as ERG are among the most common. Fusion of TMPRSS2 with ERG may result in overexpression of ERG driven by the TMPRSS2 androgen-responsive promoter elements. Due to the high prevalence of this fusion, it may have diagnostic utility for prostate cancer, especially ERG expression positive prostate cancer.",71,variant,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886,21,42879877,42879992,,,ENST00000398585.3,21,39751949,39817544,ENST00000398910.1,75,GRCh37,,,,,,
196,FGFR3,2261,Y375C,,23,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,4,1806099,1806099,A,G,ENST00000340107.4,,,,,75,GRCh37,,,,,,
197,FLI1,2313,EWSR1-FLI1,,53,variant,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886,22,29664007,29683123,,,ENST00000397938.2,11,128651853,128683162,ENST00000527786.2,75,GRCh37,,,,,,
198,FOXL2,668,C134W,"The variant C134W on the FOXL2 gene was revealed to have a high frequency (95-97%) in the adult form of granulosa cell tumors that comprises 5% of ovarian cancers. Due to the mutation's high frequency, future therapeutics might target for this single apparent mechanism. However, the consequence of this mutation remain unknown.",72,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,3,138665163,138665163,G,C,ENST00000330315.3,,,,,75,GRCh37,,,,,,
199,IDH2,3418,R172,"IDH2 R172 is a gain-of-function mutation commonly observed in acute myeloid leukemia and is enriched in those patients which are cytogenetically normal. R172 is analogous to IDH1 R132 mutations and leads to neomorphic enzymatic activity. Specifically this mutation ""catalyzes the conversion of alpha ketoglurarate to beta-hydrozyglutarate"" leading to increased levels of beta-hydrozyglutarate. This in turn leads to hypermethylation of target genes and an inhibition of cellular differentiation. R172 mutations generally lead to worse overall survival and higher rates of relapse compared to the most common IDH2 mutations in AML (R140).",27,variant,103,protein_altering_variant,Protein Altering Variant,SO:0001818,A sequence_variant which is predicted to change the protein encoded in the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001818,15,90631837,90631839,,,ENST00000330062.3,,,,,75,GRCh37,,,,,,
200,IKZF1,10320,DELETION,"IKZF1 deletions have been reported in a variety of cancer types including pediatric B-cell precursor acute lymphoblastic leukemia (BCP ALL), Chronic Myeloid Leukemia, diffuse large B-cell lymphoma, myelodysplastic syndrome, T-cell ALL as well as solid tumors of the large intestine, lung, and liver. The clinical impact of these deletions is unknown for many cancer types however a poor outcome has been observed in leukemia based disease. This gene has been strongly implicated as a regulator for ""normal  hematopoiesis"". In regards to BCP ALL, mouse models have shown that mutations in IKZF1 are not sufficient in and of themselves to cause disease.  Haploinsuffeciency in combination with BCR-ABL1 however, will accelerate leukemiagenesis possibly indicating that at least in regards to BCP ALL these are secondary events that may be necessary for the development of leukaemic clones.",73,variant,127,transcript_ablation,Transcript Ablation,SO:0001893,A feature ablation whereby the deleted region includes a transcript feature.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001893,7,50344378,50472799,,,ENST00000331340.3,,,,,75,GRCh37,,,,,,
201,KIT,3815,M541L,,29,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,4,55593464,55593464,A,C,ENST00000288135.5,,,,,75,GRCh37,,,,,,
202,KIT,3815,V560DEL,,29,variant,63,amino_acid_deletion,Amino Acid Deletion,SO:0001604,A sequence variant within a CDS resulting in the loss of an amino acid from the resulting polypeptide.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001604,4,55593612,55593614,GTT,,ENST00000288135.5,,,,,75,GRCh37,107,inframe_deletion,Inframe Deletion,SO:0001822,An inframe non synonymous variant that deletes bases from the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001822
203,KRAS,3845,Q61,,30,variant,103,protein_altering_variant,Protein Altering Variant,SO:0001818,A sequence_variant which is predicted to change the protein encoded in the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001818,12,25380275,25380277,,,ENST00000256078.4,,,,,75,GRCh37,,,,,,
204,NCOA3,8202,AMPLIFICATION,,74,variant,123,transcript_amplification,Transcript Amplification,SO:0001889,A feature amplification of a region containing a transcript.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001889,20,46130646,46285621,,,ENST00000372004.3,,,,,75,GRCh37,,,,,,
205,NCOA3,8202,OVEREXPRESSION,,74,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,20,46130646,46285621,,,ENST00000372004.3,,,,,75,GRCh37,,,,,,
206,NOTCH1,4851,MUTATION,,50,variant,103,protein_altering_variant,Protein Altering Variant,SO:0001818,A sequence_variant which is predicted to change the protein encoded in the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001818,9,139388896,139440314,,,ENST00000277541.6,,,,,75,GRCh37,,,,,,
207,NOTCH1,4851,P2514FS,"This mutation disrupts the C-terminal PEST domain that in normal conditions promotes degradation,  resulting in accumulation of an active NOTCH1 isoform sustaining deregulated signaling.",50,variant,134,frameshift_truncation,Frameshift Truncation,SO:0001910,A frameshift variant that causes the translational reading frame to be shortened relative to the reference feature.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001910,9,139390649,139390650,,,ENST00000277541.6,,,,,75,GRCh37,,,,,,
208,NRAS,4893,MUTATION,,36,variant,42,transcript_variant,Transcript Variant,SO:0001576,A sequence variant that changes the structure of the transcript.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001576,1,115247090,115259515,,,ENST00000369535.4,,,,,75,GRCh37,160,gain_of_function_variant,Gain Of Function Variant,SO:0002053,A sequence variant whereby new or enhanced function is conferred on the gene product.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002053
209,PAX8,7849,PAX8-PPARG,PAX8-PPAR gamma is a oncogene caused by a translocation between 2q13 and 3p25 resulting in an in-frame fusion between the two genes. It has been observed in Follicular Thyroid Cancer (FTC) and is one of two known fusion products involving PPAR gamma in FTC indicating this region may be a breakpoint hotspot. Studies have indicated that the fusion product increases cell viability and proliferation and decreases apoptosis.,75,variant,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886,2,114036521,113992971,,,ENST00000429538.3,3,12329400,12475810,ENST00000397015.2,75,GRCh37,,,,,,
210,PGR,5241,EXPRESSION,,76,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,11,100900355,101001255,,,ENST00000325455.5,,,,,75,GRCh37,,,,,,
212,PIK3CA,5290,AMPLIFICATION,,37,variant,123,transcript_amplification,Transcript Amplification,SO:0001889,A feature amplification of a region containing a transcript.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001889,3,178866311,178957881,,,ENST00000263967.3,,,,,75,GRCh37,,,,,,
213,PTEN,5728,DELETION,,41,variant,127,transcript_ablation,Transcript Ablation,SO:0001893,A feature ablation whereby the deleted region includes a transcript feature.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001893,10,89622870,89731687,,,ENST00000371953.3,,,,,75,GRCh37,,,,,,
214,PTEN,5728,LOSS,,41,variant,161,loss_of_function_variant,Loss Of Function Variant,SO:0002054,A sequence variant whereby the gene product has diminished or abolished function.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002054,10,89622870,89731687,,,ENST00000371953.3,,,,,75,GRCh37,,,,,,
215,SF3B1,23451,MUTATION,,44,variant,103,protein_altering_variant,Protein Altering Variant,SO:0001818,A sequence_variant which is predicted to change the protein encoded in the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001818,2,198254508,198299815,,,ENST00000335508.6,,,,,75,GRCh37,,,,,,
216,SMAD4,4089,MUTATION,,77,variant,42,transcript_variant,Transcript Variant,SO:0001576,A sequence variant that changes the structure of the transcript.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001576,18,48556583,48611409,,,ENST00000342988.3,,,,,75,GRCh37,161,loss_of_function_variant,Loss Of Function Variant,SO:0002054,A sequence variant whereby the gene product has diminished or abolished function.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002054
217,SMARCA4,6597,MUTATION,,78,variant,30,gene_variant,Gene Variant,SO:0001564,A sequence variant where the structure of the gene is changed.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001564,19,11071598,11172958,,,ENST00000358026.2,,,,,75,GRCh37,161,loss_of_function_variant,Loss Of Function Variant,SO:0002054,A sequence variant whereby the gene product has diminished or abolished function.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002054
218,SMARCA4,6597,INACTIVATING MUTATION,,78,variant,161,loss_of_function_variant,Loss Of Function Variant,SO:0002054,A sequence variant whereby the gene product has diminished or abolished function.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002054,19,11071598,11172958,,,ENST00000358026.2,,,,,75,GRCh37,,,,,,
219,TERT,7015,AMPLIFICATION,,79,variant,123,transcript_amplification,Transcript Amplification,SO:0001889,A feature amplification of a region containing a transcript.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001889,5,1253282,1295162,,,ENST00000310581.5,,,,,75,GRCh37,,,,,,
220,TERT,7015,PROMOTER MUTATION,"TERT promoter mutations are activating and commonly found at two hotspots within the TERT promoter region which occur 124 and 146 base pairs (hg19) upstream of the translation start site. These hotspots, termed C228T and C250T are observed in many cancer types and have a particularly high prevalence in glioblastoma (83%), melanoma (71%), bladder cancer (66%) and hepatocelluar carcinoma (HCC) (47%). The two mutations are usually heterozygous and mutually exclusive and result in an increased similarity to an ETS binding domain and may act as a binding site to an ETS transcription factor. These mutations are thought to be early events in tumorgenesis and aid in cellular immortality. Decreased overall survival in patients with these mutations have been observed in medulloblastoma, thyroid cancer, urogenital cancer, melanoma, and laryngeal tumors. The presence of these mutations has also been shown to be predictive of malignant/premalignant nodules in HCC and meningiomas.",79,variant,32,regulatory_region_variant,Regulatory Region Variant,SO:0001566,A sequence variant located within a regulatory region.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001566,5,1295161,1295373,,,ENST00000310581.5,,,,,75,GRCh37,,,,,,
221,TP53,7157,DELETERIOUS MUTATION,"Deleterious mutations are mutations of TP53 with prior characterization demonstrating significant deleterious effect on TP53 protein function.
Inactivating TP53 mutations prevent on target activity and efficacy of MDM2-TP53 interaction inhibitors.",45,variant,,,,,,,17,7571720,7590856,,,ENST00000269305.4,,,,,75,GRCh37,,,,,,
222,TP53,7157,MUTATION,,45,variant,103,protein_altering_variant,Protein Altering Variant,SO:0001818,A sequence_variant which is predicted to change the protein encoded in the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001818,17,7571720,7590856,,,ENST00000269305.4,,,,,75,GRCh37,,,,,,
223,TP53,7157,TRUNCATING MUTATION,,45,variant,134,frameshift_truncation,Frameshift Truncation,SO:0001910,A frameshift variant that causes the translational reading frame to be shortened relative to the reference feature.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001910,17,7573998,7579714,,,ENST00000269305.4,,,,,75,GRCh37,,,,,,
224,TTF1,7270,AMPLIFICATION,,80,variant,123,transcript_amplification,Transcript Amplification,SO:0001889,A feature amplification of a region containing a transcript.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001889,9,135251008,135282209,,,ENST00000334270.2,,,,,75,GRCh37,,,,,,
230,CHEK2,11200,LOSS-OF-FUNCTION,,8950,variant,161,loss_of_function_variant,Loss Of Function Variant,SO:0002054,A sequence variant whereby the gene product has diminished or abolished function.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002054,22,29083732,29137832,,,ENST00000328354.6,,,,,75,GRCh37,,,,,,
236,CDK12,51755,LOSS-OF-FUNCTION,,12112,variant,161,loss_of_function_variant,Loss Of Function Variant,SO:0002054,A sequence variant whereby the gene product has diminished or abolished function.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002054,17,37618292,37691399,,,ENST00000447079.4,,,,,75,GRCh37,,,,,,
238,NT5C2,22978,R367Q,,9189,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,10,104852955,104852955,C,T,ENST00000343289.5,,,,,75,GRCh37,,,,,,
239,NT5C2,22978,K359Q,,9189,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,10,104852980,104852980,T,G,ENST00000343289.5,,,,,75,GRCh37,,,,,,
240,NT5C2,22978,D407A,,9189,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,10,104850745,104850745,T,G,ENST00000343289.5,,,,,75,GRCh37,,,,,,
241,ABL1,25,BCR-ABL F317L,"BCR-ABL F317L, like the similar BCR-ABL T315I mutation, is becoming a common clinical marker for resistance to front-line therapies in CML. It has been shown to confer resistance to dasatinib, but responds well to ponatinib and other second generation inhibitors.",4,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,9,133748288,133748288,T,C,ENST00000318560.5,,,,,75,GRCh37,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886
242,TP53,7157,DNA BINDING DOMAIN MUTATION,,45,variant,1337,DNA_binding_site,Dna Binding Site,SO:0001429,"A binding site that, in the molecule, interacts selectively and non-covalently with DNA.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001429,17,7577149,7578443,,,ENST00000269305.4,,,,,75,GRCh37,,,,,,
243,ATM,472,V2288FS*1,A frameshift mutation predicted to cause truncation before the C-terminal phosphoinositide 3-kinase (PI3K) catalytic domain.,69,variant,134,frameshift_truncation,Frameshift Truncation,SO:0001910,A frameshift variant that causes the translational reading frame to be shortened relative to the reference feature.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001910,11,108196840,108196841,TC,,ENST00000278616.4,,,,,75,GRCh37,,,,,,
244,ATM,472,N2875H,A missense mutation within the C-terminal phosphoinositide 3-kinase (PI3K) catalytic domain,69,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,11,108218044,108218044,A,C,ENST00000278616.4,,,,,75,GRCh37,,,,,,
245,NF2,4771,Y177FS,,3870,variant,133,frameshift_elongation,Frameshift Elongation,SO:0001909,A frameshift variant that causes the translational reading frame to be extended relative to the reference feature.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001909,22,30051593,30051594,,T,ENST00000338641.4,,,,,75,GRCh37,,,,,,
247,PDGFRA,5156,V561A,,38,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,4,55141036,55141036,T,C,ENST00000257290.5,,,,,75,GRCh37,,,,,,
248,TERT,7015,C228T,,79,variant,32,regulatory_region_variant,Regulatory Region Variant,SO:0001566,A sequence variant located within a regulatory region.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001566,5,1295228,1295228,G,A,ENST00000310581.5,,,,,75,GRCh37,,,,,,
249,XRCC1,7515,R194W,,6144,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,19,44057574,44057574,G,A,ENST00000262887.5,,,,,75,GRCh37,,,,,,
250,GSTP1,2950,DELETION,,2473,variant,127,transcript_ablation,Transcript Ablation,SO:0001893,A feature ablation whereby the deleted region includes a transcript feature.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001893,11,67351066,67354131,,,ENST00000398606.3,,,,,75,GRCh37,,,,,,
251,BIRC7,79444,AMPLIFICATION,,14842,variant,123,transcript_amplification,Transcript Amplification,SO:0001889,A feature amplification of a region containing a transcript.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001889,20,61867235,61871859,,,ENST00000217169.3,,,,,75,GRCh37,,,,,,
252,EGFR,1956,EXON 4 DELETION,,19,variant,38,exon_loss_variant,Exon Loss Variant,SO:0001572,A sequence variant whereby an exon is lost from the transcript.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001572,7,55214299,55214433,,,ENST00000275493.2,,,,,75,GRCh37,,,,,,
253,EGFR,1956,3' UTR MUTATION,,19,variant,83,3_prime_UTR_variant,3 Prime UTR Variant,SO:0001624,A UTR variant of the 3' UTR.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001624,,,,,,,,,,,,,,,,,,
254,KRAS,3845,RS61764370,Germline variant in the 3' UTR of KRAS that predicts resistance to platinum-based therapy.,30,variant,83,3_prime_UTR_variant,3 Prime UTR Variant,SO:0001624,A UTR variant of the 3' UTR.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001624,12,25360224,25360224,A,C,ENST00000311936.3,,,,,75,GRCh37,,,,,,
255,ERCC5,2073,RS751402,,1741,variant,82,5_prime_UTR_variant,5 Prime UTR Variant,SO:0001623,A UTR variant of the 5' UTR.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001623,13,103498198,103498199,A,G,ENST00000355739.4,,,,,75,GRCh37,738,SNP,Snp,SO:0000694,"SNPs are single base pair positions in genomic DNA at which different sequence alternatives exist in normal individuals in some population(s), wherein the least frequent variant has an abundance of 1% or greater.",http://www.sequenceontology.org/browser/current_svn/term/SO:0000694
256,KIT,3815,3' UTR MUTATION,,29,variant,83,3_prime_UTR_variant,3 Prime UTR Variant,SO:0001624,A UTR variant of the 3' UTR.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001624,4,55604724,55606881,,,ENST00000288135.5,,,,,75,GRCh37,,,,,,
257,EZH2,2146,INTRON 6 MUTATION,,63,variant,85,intron_variant,Intron Variant,SO:0001627,A transcript variant occurring within an intron.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001627,7,148524359,148525831,,,ENST00000320356.2,,,,,75,GRCh37,,,,,,
258,MTHFR,4524,A222V,,3672,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,1,11856378,11856378,G,A,ENST00000376592.1,,,,,75,GRCh37,,,,,,
259,GSTP1,2950,I105V,,2473,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,11,67352689,67352689,A,G,ENST00000398606.3,,,,,75,GRCh37,,,,,,
260,ABCG2,9429,Q141K,,7451,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,4,89052323,89052323,G,T,ENST00000237612.3,,,,,75,GRCh37,,,,,,
261,XRCC1,7515,Q399R,,6144,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,19,44055726,44055726,T,C,ENST00000262887.5,,,,,75,GRCh37,,,,,,
262,ABCB1,5243,S893T,,4244,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,7,87160618,87160618,A,T,ENST00000265724.3,,,,,75,GRCh37,,,,,,
263,ABCB1,5243,I1145I,,4244,variant,104,synonymous_variant,Synonymous Variant,SO:0001819,A sequence variant where there is no resulting change to the encoded amino acid.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001819,7,87138645,87138645,A,G,ENST00000265724.3,,,,,75,GRCh37,,,,,,
264,ERCC2,2068,K751Q,,1736,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,19,45854919,45854919,T,G,ENST00000391945.4,,,,,75,GRCh37,,,,,,
265,TYMS,7298,5' TANDEM REPEAT,,5971,variant,82,5_prime_UTR_variant,5 Prime UTR Variant,SO:0001623,A UTR variant of the 5' UTR.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001623,18,657604,657742,,,ENST00000323274.10,,,,,75,GRCh37,1742,short_tandem_repeat_variation,Short Tandem Repeat Variation,SO:0002096,A kind of sequence variant whereby a tandem repeat is expanded or contracted with regard to a reference.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002096
266,LRP1B,53353,EXON 1222 DELETION,,12146,variant,38,exon_loss_variant,Exon Loss Variant,SO:0001572,A sequence variant whereby an exon is lost from the transcript.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001572,2,141665446,141777671,,,ENST00000389484.3,,,,,75,GRCh37,,,,,,
267,FGFR1,2260,AMPLIFICATION,"FGFR1 amplifications are the most common aberrations of the FGFR family in cancer. One study reports FGFR1 aberrations in 3.5% of 4,853 patients of which most are FGFR1 amplifications (Helsten et. al., 2016). Preclinically, FGFR1 amplifications have also been shown to confer sensitivity to FGFR1 inhibitors (Weiss et. al., 2010). Clinical studies are currently ongoing (e.g. NCT01004224).",1885,variant,123,transcript_amplification,Transcript Amplification,SO:0001889,A feature amplification of a region containing a transcript.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001889,8,38268656,38325363,,,ENST00000425967.3,,,,,75,GRCh37,,,,,,
268,FGFR1,2260,EXPRESSION,"FGFR1 high expression has been reported in 11.8% (178 patients) of oral squamous cell carcinoma patients, and was enriched in early stages (Freier et. al., 2007). Another study reports FGFR1 expression in 35% of primary HNSSC (353 patients) (Gke et. al., 2015). In both studies, FGFR1 gene amplification and expression do not correlate well with about 35% of samples with FGFR1 amplification overexpressing FGFR1 (Gke et. al., 2015). FGFR1 expression also correlated with sensitivity to FGFR1 inhibitors in preclinical models of lung cancer (Wynes et. al., 2014), HNSSC (Gke et. al., 2015) and urothelial carcinoma (Lamont et. al., 2011).",1885,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,8,38268656,38325363,,,ENST00000425967.3,,,,,75,GRCh37,,,,,,
269,ROS1,6098,REARRANGEMENT,"ROS1 is a receptor tyrosine kinase that frequently forms gene fusions in several cancer types. Approximately 2% of NSCLC patients harbor a ROS1 gene fusion. Several fusion partners have been described with a constant ROS1-breakpoint, maintaining the kinase domain (Solomon B, 2015). Following case-studies and retrospective analyses, an expansion cohort of a phase-1 study showed clinical benefit of crizotinib in ROS1 rearranged NSCLC. The benefit was independent of the type of ROS1-rearrangement (Shaw et. al.,2014).",4941,variant,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886,6,117609463,117747018,,,ENST00000368508.3,,,,,75,GRCh37,,,,,,
270,MET,4233,AMPLIFICATION,,52,variant,123,transcript_amplification,Transcript Amplification,SO:0001889,A feature amplification of a region containing a transcript.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001889,7,116312459,116436396,,,ENST00000318493.6,,,,,75,GRCh37,,,,,,
271,ATR,545,I774FS,"Single A insertion or deletion in the 10 A mononucleotide run in exon 10 of ATR results in a frameshift of codon I774. In patients with endometrial cancer, this mutation has only been observed in patients with microsatellite instability.",524,variant,134,frameshift_truncation,Frameshift Truncation,SO:0001910,A frameshift variant that causes the translational reading frame to be shortened relative to the reference feature.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001910,3,142274740,142274740,,,ENST00000350721.4,,,,,75,GRCh37,,,,,,
272,CDKN2A,1029,p16 EXPRESSION,"CDKN2A (p16) expression is a surrogate marker of HPV infection in oropharyngeal squamous cell carcinoma. CDKN2A and p53 are inactivated through HPV proteins E6 and E7 and therefore not altered in expression level in HPV-associated carcinomas. However, there is no perfect overlap between p16 expression and HPV status with some 10-12.5% of HPV-negative tumors expressing p16. (Seiwert, T JCO, 2014). p16 positivity is a well-established positive prognostic factor in squamous cell cancer of the head and neck in the primary and, as increasing evidence suggests, recurrent/metastatic disease settings. Predictive information from HPV status have not been established to date. A lack of benefit from EGFR-inhibitors has been proposed by some studies. Other studies were not able to reproduce this finding.",14,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,9,21968055,21974865,,,ENST00000498124.1,,,,,75,GRCh37,,,,,,
273,RET,5979,KIF5B-RET,"In a study by Takeuchi et. al. a fusion screen was performed in 1529 lung cancer samples. 14 adenocarcinomas with KIF5B-RET and CCDC6-RET fusions were identified. (Takeuchi K et. al., 2012)",42,variant,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886,10,32306071,32345359,,,ENST00000302418.4,10,43609928,43625799,ENST00000355710.3,75,GRCh37,,,,,,
274,HRAS,3265,G13D,,2747,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,11,534285,534285,C,T,ENST00000451590.1,,,,,75,GRCh37,,,,,,
275,HRAS,3265,MUTATION,,2747,variant,137,coding_transcript_variant,Coding Transcript Variant,SO:0001968,A transcript variant of a protein coding gene.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001968,11,533873,534289,,,ENST00000451590.1,,,,,75,GRCh37,,,,,,
276,CD274,29126,EXPRESSION,,11335,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,9,5450525,5470547,,,ENST00000381577.3,,,,,75,GRCh37,,,,,,
277,MTOR,2475,MUTATION,,2073,variant,103,protein_altering_variant,Protein Altering Variant,SO:0001818,A sequence_variant which is predicted to change the protein encoded in the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001818,1,11166592,11322564,,,ENST00000361445.4,,,,,75,GRCh37,,,,,,
278,AKT2,208,EXPRESSION,,254,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,19,40736224,40791302,,,ENST00000392038.2,,,,,75,GRCh37,,,,,,
279,NF2,4771,K159FS*16,,3870,variant,134,frameshift_truncation,Frameshift Truncation,SO:0001910,A frameshift variant that causes the translational reading frame to be shortened relative to the reference feature.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001910,22,30050673,30050675,,,ENST00000338641.4,,,,,75,GRCh37,,,,,,
281,FBXW7,55294,MUTATION,,12903,variant,103,protein_altering_variant,Protein Altering Variant,SO:0001818,A sequence_variant which is predicted to change the protein encoded in the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001818,4,153245446,153332714,,,ENST00000281708.4,,,,,75,GRCh37,161,loss_of_function_variant,Loss Of Function Variant,SO:0002054,A sequence variant whereby the gene product has diminished or abolished function.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002054
282,SMAD4,4089,UNDEREXPRESSION,,77,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,18,48556583,48611409,,,ENST00000342988.3,,,,,75,GRCh37,,,,,,
283,MTOR,2475,H1968Y,,2073,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,1,11188519,11188519,G,A,ENST00000361445.4,,,,,75,GRCh37,160,gain_of_function_variant,Gain Of Function Variant,SO:0002053,A sequence variant whereby new or enhanced function is conferred on the gene product.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002053
284,MTOR,2475,P2213S,,2073,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,1,11184580,11184580,G,A,ENST00000361445.4,,,,,75,GRCh37,160,gain_of_function_variant,Gain Of Function Variant,SO:0002053,A sequence variant whereby new or enhanced function is conferred on the gene product.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002053
285,BRAF,673,AGK-BRAF,,5,variant,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886,7,141250989,141255367,,,ENST00000355413.4,7,140434279,140494267,ENST00000288602.6,75,GRCh37,,,,,,
286,BRAF,673,PAPSS1-BRAF,,5,variant,31,gene_fusion,Gene Fusion,SO:0001565,A sequence variant whereby a two genes have become joined.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001565,4,108603171,108641608,,,ENST00000265174.4,7,140434279,140487384,ENST00000288602.6,75,GRCh37,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886
287,BRAF,673,TRIM24-BRAF,,5,variant,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886,7,138145079,138239711,,,ENST00000343526.4,7,140434279,140487384,ENST00000288602.6,75,GRCh37,,,,,,
288,BRAF,673,L597R,,5,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,7,140453145,140453145,A,C,ENST00000288602.6,,,,,75,GRCh37,,,,,,
289,ERBB3,2065,OVEREXPRESSION,,1733,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,12,56473645,56497289,,,ENST00000267101.3,,,,,75,GRCh37,,,,,,
290,NT5E,4907,OVEREXPRESSION,,3976,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,6,86159809,86205496,,,ENST00000257770.3,,,,,75,GRCh37,,,,,,
291,EZH2,2146,OVEREXPRESSION,,63,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,7,148504477,148581370,,,ENST00000320356.2,,,,,75,GRCh37,,,,,,
292,MYD88,4615,OVEREXPRESSION,,3742,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,3,38179969,38184510,,,ENST00000417037.2,,,,,75,GRCh37,,,,,,
294,PIK3CA,5290,P471L,,37,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,3,178928226,178928226,C,T,ENST00000263967.3,,,,,75,GRCh37,,,,,,
295,RET,5979,EXPRESSION,,42,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,10,43572475,43625799,,,ENST00000355710.3,,,,,75,GRCh37,,,,,,
296,RIT1,6016,OVEREXPRESSION,,4875,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,1,155870065,155880706,,,ENST00000368322.3,,,,,75,GRCh37,,,,,,
297,RIT1,6016,MUTATION,,4875,variant,42,transcript_variant,Transcript Variant,SO:0001576,A sequence variant that changes the structure of the transcript.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001576,1,155870065,155880706,,,ENST00000368322.3,,,,,75,GRCh37,,,,,,
298,MYCN,4613,AMPLIFICATION,,3741,variant,123,transcript_amplification,Transcript Amplification,SO:0001889,A feature amplification of a region containing a transcript.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001889,2,16080686,16087129,,,ENST00000281043.3,,,,,75,GRCh37,,,,,,
299,SMO,6608,D473H,,5365,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,7,128849189,128849189,G,C,ENST00000249373.3,,,,,75,GRCh37,,,,,,
300,SMO,6608,MUTATION,,5365,variant,137,coding_transcript_variant,Coding Transcript Variant,SO:0001968,A transcript variant of a protein coding gene.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001968,7,128828713,128853386,,,ENST00000249373.3,,,,,75,GRCh37,,,,,,
301,PTCH1,5727,MUTATION,,4645,variant,30,gene_variant,Gene Variant,SO:0001564,A sequence variant where the structure of the gene is changed.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001564,9,98205262,98270943,,,ENST00000331920.6,,,,,75,GRCh37,161,loss_of_function_variant,Loss Of Function Variant,SO:0002054,A sequence variant whereby the gene product has diminished or abolished function.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002054
302,PTCH1,5727,LOH,,4645,variant,97,loss_of_heterozygosity,Loss Of Heterozygosity,SO:0001786,A functional variant whereby the sequence alteration causes a loss of function of one allele of a gene.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001786,9,98205262,98270943,,,ENST00000331920.6,,,,,75,GRCh37,,,,,,
303,STK11,6794,EXON 1-2 MUTATION,,5534,variant,99,exon_variant,Exon Variant,SO:0001791,A sequence variant that changes exon sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001791,19,1205740,1218499,,,ENST00000326873.7,,,,,75,GRCh37,,,,,,
304,STK11,6794,UNDEREXPRESSION,,5534,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,19,1205740,1228428,,,ENST00000326873.7,,,,,75,GRCh37,,,,,,
305,SYK,6850,OVEREXPRESSION,,5572,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,9,93564069,93660831,,,ENST00000375754.4,,,,,75,GRCh37,,,,,,
306,ERBB2,2064,AMPLIFICATION,"Her2 (ERBB2) amplifications are seen in up to 20% of breast cancers and were associated with aggressive disease and poor prognosis when discovered. Trastuzumab first found considerable success, and was approved for treatment, in HER2 positive metastatic breast cancer (MBC) which had progressed under chemotherapy.  These metastatic cancers nonetheless progressed under trastuzumab, and other forms of therapy were studied for next line treatments, including tyrosine kinase inhibitors.  Lapatinib, a reversible inhibitor of tyrosine kinase activity in ErbB1 and ErbB2, and afatinib, an irreversible inhibitor of all 4 ErbB forms were shown to have activity in trastuzumab-progressed HER2 MBC.  Interestingly trastuzumab itself also turned out to remain effective in treatment of trastuzumab-progressed HER2 MBC.  The LUX-Breast 1 trial compared a TKI-based treatment (afatinib) to a trastuzumab-based treatment of trastuzumab-progressed HER2 MBC, and the LUX-Breast 3 trial addressed TKI application in the context of HER2 MBC with difficult to treat brain metastases.  In neither of these cases was the TKI more effective, making successful future replacement of trastuzumab-based therapy with a TKI in trastuzumab-progressed HER2 MBC seem unlikely.  Instead, a potential role for TKIs in this disease context is revealed in preclinical work suggesting synergism between TKI and trastuzumab action, and clinical trials with lapatinib or afatinib combined with trastuzumab indicate that dual HER2 blockade may be an effective therapy.  Dual antibody HER2 blockade with pertuzumab instead of TKI in HER2 MBC has also recently shown strong results in the CLEOPATRA trial. HER2 overexpression is targeted in neoadjuvant breast cancer treatment, and has also been successfully targeted in gastric cancer.",20,variant,123,transcript_amplification,Transcript Amplification,SO:0001889,A feature amplification of a region containing a transcript.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001889,17,37856333,37884915,,,ENST00000269571.5,,,,,75,GRCh37,,,,,,
307,ALK,238,EML4-ALK L1152R,,1,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,2,29445270,29445270,A,C,ENST00000389048.3,,,,,75,GRCh37,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886
308,ALK,238,EML4-ALK G1269A,The EML4-ALK G1269A mutation has been identified in non-small cell lung cancer patients resistant to crizotinib. Cell line data from multiple groups have shown this mutation enhances resistance to crizotinib treatment in vitro.,1,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,2,29432682,29432682,C,G,ENST00000389048.3,,,,,75,GRCh37,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886
309,EGFR,1956,AUTOCRINE ACTIVATION,,19,variant,,,,,,,7,55086794,55279321,,,ENST00000275493.2,,,,,75,GRCh37,,,,,,
310,ERBB4,2066,MUTATION,"ERBB4 mutations have been identified in melanoma, lung adenocarcinoma and medulloblastoma. In-vitro studies suggest that melanoma cell lines harboring an ERBB4 mutation are sensitive to ERBB4 inhibition with lapatinib.",1734,variant,42,transcript_variant,Transcript Variant,SO:0001576,A sequence variant that changes the structure of the transcript.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001576,2,212295697,212578308,,,ENST00000342788.4,,,,,75,GRCh37,160,gain_of_function_variant,Gain Of Function Variant,SO:0002053,A sequence variant whereby new or enhanced function is conferred on the gene product.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002053
311,PIK3CA,5290,MUTATION,"PIK3CA mutations are observed in many cancers among the most prevalent are breast cancer,  colorectal cancer, and head and neck squamous cell carcinoma. These mutations have been observed in up to 40%, 20%, and 21% respectively for each of these cancer types with mutations commonly occurring within the helical exon 9 and kinase domain of exon 20. In breast cancer PIK3CA mutations have been associated with better prognosis, and a greater survival outcome, however the PI3K pathway is also associated with increased drug resistance ( trastuzumab/lapatinib). PIK3CA mutations in both HNSCC and CRC have been associated with resistance to anti-EGFR therapeutic agents and are associated with a poorer prognosis in CRC. Interestingly PIK3CA mutations in HNSCC have been observed to be absent from a number of ethnic groups including greek, german, and vietnamese populations.",37,variant,42,transcript_variant,Transcript Variant,SO:0001576,A sequence variant that changes the structure of the transcript.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001576,3,178866311,178957881,,,ENST00000263967.3,,,,,75,GRCh37,160,gain_of_function_variant,Gain Of Function Variant,SO:0002053,A sequence variant whereby new or enhanced function is conferred on the gene product.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002053
312,EGFR,1956,VIII,"The EGFRvIII variant is an oncogenic mutation that has been reported in several cancers including glioblastoma multiforme, breast, lung, head and neck, ovarian and prostate. In high-grade gliomas, EGFRvIII has been reported in about 30% of cases with EGFR amplification. The EGFRvIII mutation leads to deletion of the receptor ectodomain exons 2-7. The presence of this variant has been linked with clinical response to EGFR TKI. (Arteaga and Engelmann, 2014)",19,variant,111,disruptive_inframe_deletion,Disruptive Inframe Deletion,SO:0001826,An inframe decrease in cds length that deletes bases from the coding sequence starting within an existing codon.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001826,7,55087058,55223523,,,ENST00000275493.2,,,,,75,GRCh37,,,,,,
313,PTEN,5728,EXPRESSION,,41,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,10,89622870,89731687,,,ENST00000371953.3,,,,,75,GRCh37,,,,,,
314,NRG1,3084,EXPRESSION,,2593,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,8,31497942,32622294,,,ENST00000523534.1,,,,,75,GRCh37,,,,,,
315,AREG,374,EXPRESSION,,389,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,4,75310851,75320726,,,ENST00000395748.3,,,,,75,GRCh37,,,,,,
316,TGFA,7039,EXPRESSION,,5742,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,2,70674412,70781147,,,ENST00000295400.6,,,,,75,GRCh37,,,,,,
317,EGFR,1956,G724S,,19,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,7,55241722,55241722,G,A,ENST00000275493.2,,,,,75,GRCh37,,,,,,
318,EREG,2069,EXPRESSION,,1737,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,4,75230860,75254468,,,ENST00000244869.2,,,,,75,GRCh37,,,,,,
319,EFNA2,1943,EXPRESSION,,1627,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,19,1286153,1301430,,,ENST00000215368.2,,,,,75,GRCh37,,,,,,
320,MAPK1,5594,E322K,,4532,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,22,22127164,22127164,C,T,ENST00000215832.6,,,,,75,GRCh37,160,gain_of_function_variant,Gain Of Function Variant,SO:0002053,A sequence variant whereby new or enhanced function is conferred on the gene product.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002053
321,MAPK1,5594,AMPLIFICATION,,4532,variant,123,transcript_amplification,Transcript Amplification,SO:0001889,A feature amplification of a region containing a transcript.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001889,22,22108789,22221919,,,ENST00000215832.6,,,,,75,GRCh37,,,,,,
322,KRAS,3845,A146V,,30,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,12,25378561,25378561,G,A,ENST00000256078.4,,,,,75,GRCh37,,,,,,
323,MET,4233,MUTATION,,52,variant,15,transcription_variant,Transcription Variant,SO:0001549,A variant that changes alters the transcription of a transcript with respect to a reference sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001549,7,116312459,116436396,,,ENST00000318493.6,,,,,75,GRCh37,160,gain_of_function_variant,Gain Of Function Variant,SO:0002053,A sequence variant whereby new or enhanced function is conferred on the gene product.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002053
324,MET,4233,EXON 14 SKIPPING MUTATION,"Exon 14 mutations have been observed in ~3% of patients with NSCLC (28/933 reported by Awad et al J Clin Onc 2016), confirmed to cause exon skipping when available, and associated with concurrent MET amplification. Responses to the c-MET inhibitor crizotinib have been reported in preclinical models and in individual case reports as well as a small-scale clinical trial (17 patients treated, Drilon et al., 2016 (suppl; abstr 108; ASCO ID 167889-176)). Larger studies are needed but enrollment of patients with MET exon 14 skipping mutation in trials with MET inhibitors or off-label treatment is encouraged (Paik et al., 2015 (suppl; abstr 8021)).",52,variant,38,exon_loss_variant,Exon Loss Variant,SO:0001572,A sequence variant whereby an exon is lost from the transcript.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001572,7,116411903,116412043,,,ENST00000318493.6,,,,,75,GRCh37,,,,,,
325,FGFR3,2261,EXPRESSION,,23,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,4,1795039,1810599,,,ENST00000440486.2,,,,,75,GRCh37,,,,,,
326,CBLC,23624,EXPRESSION,,9705,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,19,45281126,45303891,,,ENST00000270279.3,,,,,75,GRCh37,,,,,,
327,PTPRD,5789,MUTATION,,4692,variant,42,transcript_variant,Transcript Variant,SO:0001576,A sequence variant that changes the structure of the transcript.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001576,9,8314246,10033790,,,ENST00000381196.4,,,,,75,GRCh37,161,loss_of_function_variant,Loss Of Function Variant,SO:0002054,A sequence variant whereby the gene product has diminished or abolished function.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002054
328,DEFA1,1667,EXPRESSION,,1428,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,8,6835172,6837602,,,ENST00000382692.2,,,,,75,GRCh37,,,,,,
329,ERCC1,2067,EXPRESSION,,1735,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,19,45916692,45926824,,,ENST00000013807.5,,,,,75,GRCh37,,,,,,
330,NOTCH1,4851,AMPLIFICATION,,50,variant,123,transcript_amplification,Transcript Amplification,SO:0001889,A feature amplification of a region containing a transcript.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001889,9,139388896,139440314,,,ENST00000277541.6,,,,,75,GRCh37,,,,,,
331,WEE1,7465,POLYMORPHISM,,6104,variant,85,intron_variant,Intron Variant,SO:0001627,A transcript variant occurring within an intron.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001627,,,,,,,,,,,,,970,polymorphic_sequence_variant,Polymorphic Sequence Variant,SO:0001025,A sequence variant that is segregating in one or more natural populations of a species.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001025
332,FNTB,2342,RS11623866,,1950,variant,32,regulatory_region_variant,Regulatory Region Variant,SO:0001566,A sequence variant located within a regulatory region.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001566,14,65453063,65453063,G,C,ENST00000246166.2,,,,,75,GRCh37,,,,,,
333,PTPRT,11122,PROMOTER HYPERMETHYLATION,,8878,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,,,,,,,,,,,,,,,,,,
334,VEGFA,7422,UNDEREXPRESSION,,6071,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,6,43738444,43752346,,,ENST00000372055.4,,,,,75,GRCh37,,,,,,
335,DNMT1,1786,EXPRESSION,,1510,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,19,10244022,10305811,,,ENST00000340748.4,,,,,75,GRCh37,,,,,,
336,KRAS,3845,MUTATION,,30,variant,103,protein_altering_variant,Protein Altering Variant,SO:0001818,A sequence_variant which is predicted to change the protein encoded in the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001818,12,25362365,25403737,,,ENST00000256078.4,,,,,75,GRCh37,,,,,,
337,PDCD4,27250,EXPRESSION,"A new study, a retrospective analysis of 77 patients, has implicated PDCD4 expression in the sensitivity to paclitaxel. However, this finding came from a large proteome screen and has not yet been replicated in independent patient sets.",10573,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,10,112631596,112659763,,,ENST00000393104.2,,,,,75,GRCh37,,,,,,
338,MGMT,4255,RS16906252,,34,variant,104,synonymous_variant,Synonymous Variant,SO:0001819,A sequence variant where there is no resulting change to the encoded amino acid.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001819,10,131265545,131265545,C,T,ENST00000306010.7,,,,,75,GRCh37,,,,,,
339,TFF3,7033,EXPRESSION,,5737,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,21,43731777,43735761,,,ENST00000518498.1,,,,,75,GRCh37,,,,,,
340,DKK1,22943,NUCLEAR EXPRESSION,,9171,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,10,54074056,54077417,,,ENST00000373970.3,,,,,75,GRCh37,,,,,,
341,CD44,960,ISOFORM EXPRESSION,,855,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,11,35160728,35251574,,,ENST00000428726.2,,,,,75,GRCh37,,,,,,
342,EGF,1950,EXPRESSION,,1634,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,4,110834047,110933422,,,ENST00000265171.5,,,,,75,GRCh37,,,,,,
343,MDM2,4193,EXPRESSION,,3465,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,12,69201956,69239214,,,ENST00000462284.1,,,,,75,GRCh37,,,,,,
344,HMOX1,3162,EXPRESSION,,2657,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,22,35776828,35790207,,,ENST00000216117.8,,,,,75,GRCh37,,,,,,
345,SPHK1,8877,OVEREXPRESSION,,7041,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,17,74380731,74383936,,,ENST00000323374.4,,,,,75,GRCh37,,,,,,
346,CASP8,841,EXPRESSION,,761,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,2,202122759,202152434,,,ENST00000358485.4,,,,,75,GRCh37,,,,,,
347,TYMS,7298,EXPRESSION,,5971,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,18,657604,673578,,,ENST00000323274.10,,,,,75,GRCh37,,,,,,
348,PBK,55872,OVEREXPRESSION,,13276,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,8,27667137,27695612,,,ENST00000301905.4,,,,,75,GRCh37,,,,,,
349,SMARCA4,6597,UNDEREXPRESSION,,78,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,19,11071598,11172958,,,ENST00000358026.2,,,,,75,GRCh37,,,,,,
350,SETBP1,26040,EXON 4 MUTATION,,10024,variant,99,exon_variant,Exon Variant,SO:0001791,A sequence variant that changes exon sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001791,18,42531877,42531918,,,ENST00000282030.5,,,,,75,GRCh37,,,,,,
351,SETBP1,26040,G870S,,10024,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,18,42531913,42531913,G,A,ENST00000282030.5,,,,,75,GRCh37,,,,,,
352,ALK,238,EML4-ALK C1156YL1198F,EML4-ALK C1156Y alone is resistant to crizotinib in non-small cell lung cancer (NSCLC) which has been shown to be modulated (both increased sensitivity and resistance) by additional ALK mutations. A case report showed that an NSCLC harboring EML4-ALK C1156YL1198F was resistant to lorlatinib but this second mutation re-sensitized this tumor to crizotinib.,1,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,2,29443625,29445258,,,ENST00000389048.3,,,,,75,GRCh37,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886
354,EGFR,1956,EXPRESSION,,19,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,7,55086794,55279321,,,ENST00000275493.2,,,,,75,GRCh37,,,,,,
355,CDKN1A,1026,EXPRESSION,,913,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,6,36646487,36655108,,,ENST00000405375.1,,,,,75,GRCh37,,,,,,
356,ALCAM,214,EXPRESSION,,259,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,3,105085753,105295744,,,ENST00000306107.5,,,,,75,GRCh37,,,,,,
357,STMN1,3925,EXPRESSION,,3255,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,1,26211931,26232957,,,ENST00000426559.2,,,,,75,GRCh37,,,,,,
358,RSF1,51773,AMPLIFICATION,,12121,variant,123,transcript_amplification,Transcript Amplification,SO:0001889,A feature amplification of a region containing a transcript.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001889,11,77371041,77532063,,,ENST00000308488.6,,,,,75,GRCh37,,,,,,
359,AR,367,OVEREXPRESSION,,67,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,X,66764465,66950461,,,ENST00000374690.3,,,,,75,GRCh37,,,,,,
360,CDKN1B,1027,CYTOPLASMIC MISLOCALIZATION,,914,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,12,12870058,12875305,,,ENST00000228872.4,,,,,75,GRCh37,,,,,,
361,ERBB3,2065,EXPRESSION,,1733,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,12,56473645,56497289,,,ENST00000267101.3,,,,,75,GRCh37,,,,,,
362,AR,367,SPLICE VARIANT 7,,67,variant,,,,,,,X,66764662,66915917,,,ENST00000504326.1,,,,,75,GRCh37,,,,,,
363,UGT1A,7361,EXPRESSION,,6023,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,2,234526291,234681956,,,ENST00000373450.4,,,,,75,GRCh37,,,,,,
364,ERBB4,2066,NUCLEAR TRANSLOCATION,,1734,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,2,212240446,213403565,,,ENST00000342788.4,,,,,75,GRCh37,,,,,,
365,ERBB4,2066,EXPRESSION,,1734,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,2,212240446,213403565,,,ENST00000342788.4,,,,,75,GRCh37,,,,,,
366,SLFN11,91607,EXPRESSION,,16872,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,17,33677324,33700639,,,ENST00000394566.1,,,,,75,GRCh37,,,,,,
367,RAC1,5879,P29S,,4753,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,7,6426892,6426892,C,T,ENST00000356142.4,,,,,75,GRCh37,,,,,,
368,BIRC5,332,NUCLEAR EXPRESSION,,355,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,17,76210267,76221717,,,ENST00000301633.4,,,,,75,GRCh37,,,,,,
369,TP53,7157,WILD TYPE,,45,variant,826,wild_type,Wild Type,SO:0000817,An attribute describing sequence with the genotype found in nature and/or standard laboratory stock.,http://www.sequenceontology.org/browser/current_svn/term/SO:0000817,17,7571720,7590856,,,ENST00000269305.4,,,,,75,GRCh37,,,,,,
370,MRE11,4361,LOSS,,3586,variant,161,loss_of_function_variant,Loss Of Function Variant,SO:0002054,A sequence variant whereby the gene product has diminished or abolished function.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002054,11,94152895,94227074,,,ENST00000323929.3,,,,,75,GRCh37,,,,,,
371,TOP1,7150,AMPLIFICATION,,5845,variant,123,transcript_amplification,Transcript Amplification,SO:0001889,A feature amplification of a region containing a transcript.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001889,20,39657458,39753127,,,ENST00000361337.2,,,,,75,GRCh37,,,,,,
372,CDKN1B,1027,EXPRESSION,,914,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,12,12870058,12875305,,,ENST00000228872.4,,,,,75,GRCh37,,,,,,
373,AGR2,10551,EXPRESSION,,8407,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,7,16831435,16844704,,,ENST00000419304.2,,,,,75,GRCh37,,,,,,
374,NAPRT,93100,PROMOTER HYPERMETHYLATION,,17016,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,,,,,,,,,,,,,,,,,,
375,EGFR,1956,EXON 18 OVEREXPRESSION,,19,variant,99,exon_variant,Exon Variant,SO:0001791,A sequence variant that changes exon sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001791,7,55237999,55238735,,,ENST00000344576.2,,,,,75,GRCh37,,,,,,
376,ZEB1,6935,EXPRESSION,,5649,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,10,31608101,31818741,,,ENST00000361642.5,,,,,75,GRCh37,,,,,,
377,TIMP1,7076,OVEREXPRESSION,,5777,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,X,47441712,47446188,,,ENST00000218388.4,,,,,75,GRCh37,,,,,,
378,PTP4A3,11156,OVEREXPRESSION,,8908,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,8,142402093,142441394,,,ENST00000521578.1,,,,,75,GRCh37,,,,,,
379,TYMS,7298,AMPLIFICATION,,5971,variant,123,transcript_amplification,Transcript Amplification,SO:0001889,A feature amplification of a region containing a transcript.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001889,18,657604,673578,,,ENST00000323274.10,,,,,75,GRCh37,,,,,,
380,IGF1R,3480,EXPRESSION,,2899,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,15,99192200,99507759,,,ENST00000268035.6,,,,,75,GRCh37,,,,,,
381,EPHB4,2050,EXPRESSION,,1721,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,7,100400187,100425121,,,ENST00000358173.3,,,,,75,GRCh37,,,,,,
382,TYMS,7298,UNDEREXPRESSION,,5971,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,18,657604,673578,,,ENST00000323274.10,,,,,75,GRCh37,,,,,,
383,TOP2A,7153,EXPRESSION,,5848,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,17,38544768,38574202,,,ENST00000423485.1,,,,,75,GRCh37,,,,,,
384,TOP1,7150,EXPRESSION,,5845,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,20,39657458,39753127,,,ENST00000361337.2,,,,,75,GRCh37,,,,,,
385,PRKAA2,5563,T172 PHOSPHORYLATION,,4503,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,1,57159476,57159478,,,ENST00000371244.4,,,,,75,GRCh37,,,,,,
386,HSPA5,3309,EXPRESSION,,2778,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,9,127997132,128003609,,,ENST00000324460.6,,,,,75,GRCh37,,,,,,
387,EIF4EBP1,1978,PHOSPHORYLATION,,1655,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,8,37888200,37914663,,,ENST00000338825.4,,,,,75,GRCh37,,,,,,
388,KIT,3815,MUTATION,,29,variant,42,transcript_variant,Transcript Variant,SO:0001576,A sequence variant that changes the structure of the transcript.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001576,4,55524085,55606881,,,ENST00000288135.5,,,,,75,GRCh37,160,gain_of_function_variant,Gain Of Function Variant,SO:0002053,A sequence variant whereby new or enhanced function is conferred on the gene product.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002053
389,TUBB3,10381,EXPRESSION,,8262,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,16,89989687,90002505,,,ENST00000315491.7,,,,,75,GRCh37,,,,,,
390,EGFR,1956,Y1092 PHOSPHORYLATION,"Although referred to as Y1068 in the literature, based on the recognition peptide described, this tyrosine occurs at Y1039 (ENST00000454757.2 v75) or Y1092 (ENST00000275493.2 v75).",19,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,7,55272951,55272953,,,ENST00000275493.2,,,,,75,GRCh37,,,,,,
391,IGF1R,3480,NUCLEAR EXPRESSION,,2899,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,15,99192200,99507759,,,ENST00000268035.6,,,,,75,GRCh37,,,,,,
392,CFLAR,8837,EXPRESSION,,7009,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,2,201980827,202041410,,,ENST00000309955.3,,,,,75,GRCh37,,,,,,
393,PROM1,8842,EXPRESSION,,7014,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,4,15969857,16085324,,,ENST00000510224.1,,,,,75,GRCh37,,,,,,
394,FOXP3,50943,EXPRESSION,,11587,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,X,49106897,49121288,,,ENST00000376207.4,,,,,75,GRCh37,,,,,,
395,RPS6,6194,PHOSPHORYLATION,,5013,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,9,19376309,19376323,,,ENST00000380394.4,,,,,75,GRCh37,,,,,,
396,JAK1,3716,OVEREXPRESSION,,3090,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,1,65298912,65432187,,,ENST00000342505.4,,,,,75,GRCh37,,,,,,
397,BRCA1,672,EXPRESSION,,6,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,17,41196312,41277387,,,ENST00000357654.3,,,,,75,GRCh37,,,,,,
398,DUSP6,1848,EXPRESSION,,1567,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,12,89741009,89747048,,,ENST00000279488.7,,,,,75,GRCh37,,,,,,
399,BRAF,673,MUTATION,,5,variant,30,gene_variant,Gene Variant,SO:0001564,A sequence variant where the structure of the gene is changed.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001564,7,140453136,140481403,,,ENST00000288602.6,,,,,75,GRCh37,160,gain_of_function_variant,Gain Of Function Variant,SO:0002053,A sequence variant whereby new or enhanced function is conferred on the gene product.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002053
400,HSPB1,3315,EXPRESSION,,2784,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,7,75931861,75933612,,,ENST00000248553.6,,,,,75,GRCh37,,,,,,
401,NQO1,1728,EXPRESSION,,1463,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,16,69743304,69760854,,,ENST00000320623.5,,,,,75,GRCh37,,,,,,
402,NQO1,1728,P187S,,1463,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,16,69745145,69745145,G,A,ENST00000320623.5,,,,,75,GRCh37,,,,,,
403,BRCA1,672,UNDEREXPRESSION,,6,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,17,41196312,41277387,,,ENST00000357654.3,,,,,75,GRCh37,,,,,,
404,ABCB1,5243,EXPRESSION,,4244,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,7,87133175,87342564,,,ENST00000265724.3,,,,,75,GRCh37,,,,,,
405,CXCR4,7852,EXPRESSION,,6329,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,2,136871919,136873813,,,ENST00000409817.1,,,,,75,GRCh37,,,,,,
406,MAGEH1,28986,EXPRESSION,,11261,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,X,55478538,55479998,,,ENST00000342972.1,,,,,75,GRCh37,,,,,,
407,ABCC3,8714,AMPLIFICATION,,6906,variant,123,transcript_amplification,Transcript Amplification,SO:0001889,A feature amplification of a region containing a transcript.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001889,17,48712218,48769613,,,ENST00000285238.8,,,,,75,GRCh37,,,,,,
408,ABCC10,89845,EXPRESSION,,16656,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,6,43395292,43418168,,,ENST00000372530.4,,,,,75,GRCh37,,,,,,
409,ASNS,440,AMPLIFICATION,,446,variant,123,transcript_amplification,Transcript Amplification,SO:0001889,A feature amplification of a region containing a transcript.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001889,7,97481430,97501854,,,ENST00000175506.4,,,,,75,GRCh37,,,,,,
410,CDX2,1045,EXPRESSION,,927,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,13,28536274,28545276,,,ENST00000381020.7,,,,,75,GRCh37,,,,,,
411,STAT3,6774,SH2 DOMAIN MUTATION,,5516,variant,103,protein_altering_variant,Protein Altering Variant,SO:0001818,A sequence_variant which is predicted to change the protein encoded in the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001818,17,40465342,40475372,,,ENST00000264657.5,,,,,75,GRCh37,,,,,,
412,POU5F1,5460,EXPRESSION,,4419,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,6,31132120,31138470,,,ENST00000259915.8,,,,,75,GRCh37,,,,,,
413,ERBB2,2064,KINASE DOMAIN MUTATION,,20,variant,103,protein_altering_variant,Protein Altering Variant,SO:0001818,A sequence_variant which is predicted to change the protein encoded in the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001818,17,37879863,37882870,,,ENST00000269571.5,,,,,75,GRCh37,,,,,,
414,ERBB2,2064,M774INSAYVM,"Mutations in the HER2 kinase domain occur at a 2-4% frequency in lung adenocarcinomas, the majority of which are in exon 20 as in-frame duplications or insertions in a small 8 codon region (774-781 or 775-782). These are analogous to the exon 20 alterations found in EGFR TK domain. The M774 insertion, M774insAYVM, represents 62.5% of all HER2 kinase domain mutations identified (when combined with the A775insYVMA mutations as they translate to the identical amino acid sequence changes). As demonstrated in mouse models (Perrera et al., PNAS 2009) and subsequent clinical trials in human lung adenocarcinoma with these insertions, HER2 YVMA mutants predict response to several targeted HER2 agonists such as afatinib, trastuzumab, neratinib and TDM-1 (trastuzumab emtansine) as monotherapy or combined with specific chemotherapies.",20,variant,106,inframe_insertion,Inframe Insertion,SO:0001821,An inframe non synonymous variant that inserts bases into in the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001821,17,37880993,37880994,,GCTTACGTGATG,ENST00000269571.5,,,,,75,GRCh37,,,,,,
415,EGFR,1956,C797S,,19,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,7,55249091,55249091,T,A,ENST00000275493.2,,,,,75,GRCh37,,,,,,
416,ERBB2,2064,SERUM LEVELS,,20,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,17,37856333,37884915,,,ENST00000269571.5,,,,,75,GRCh37,,,,,,
417,THBS2,7058,UNDEREXPRESSION,,5761,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,6,169615875,169654139,,,ENST00000366787.3,,,,,75,GRCh37,,,,,,
419,NTRK1,4914,NTRK1 FUSIONS,,3983,variant,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886,1,156844175,156851434,,,ENST00000524377.1,,,,,75,GRCh37,,,,,,
420,IDH1,3417,R132H,"IDH1 R132 mutations have been observed in a number of cancer types, and appear to behave quite differently in different environments. In myelodysplastic syndromes and acute myeloid leukemia (AML), IDH1 R132 mutations have been shown to be associated with worse outcome and shorter overall survival. They have also been linked to cytogenetically normal AML, an intermediate risk subtype of the disease. However, in glioblastoma and astrocytoma, patients with IDH1 mutations have shown better overall survival than patients with wild-type IDH1. Also in contrast to AML, in glioblastoma, IDH1 mutations have been associated with the specific cytogenetic abnormalities, 1p and 19q deletions.",26,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,2,209113112,209113112,C,T,ENST00000415913.1,,,,,75,GRCh37,,,,,,
421,TERT,7015,RS2736100,,79,variant,138,coding_transcript_intron_variant,Coding Transcript Intron Variant,SO:0001969,A transcript variant occurring within an intron of a coding transcript.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001969,5,1286516,1286516,C,A,ENST00000310581.5,,,,,75,GRCh37,970,polymorphic_sequence_variant,Polymorphic Sequence Variant,SO:0001025,A sequence variant that is segregating in one or more natural populations of a species.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001025
422,STAG2,10735,UNDEREXPRESSION,,8553,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,X,123095568,123236506,,,ENST00000371157.3,,,,,75,GRCh37,,,,,,
423,HLA-DRA,3122,EXPRESSION,,2622,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,6,32407619,32412823,,,ENST00000395388.2,,,,,75,GRCh37,,,,,,
424,MYD88,4615,L265P,,3742,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,3,38182641,38182641,T,C,ENST00000396334.3,,,,,75,GRCh37,160,gain_of_function_variant,Gain Of Function Variant,SO:0002053,A sequence variant whereby new or enhanced function is conferred on the gene product.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002053
425,KRAS,3845,G12V,KRAS mutations are the most common mutations in pancreatic cancer occurring in > 90% of cases. Of these the G12D activating mutation is the most prevalent and results in a loss of GTPase activity which in turn leads to a constitutively active form of KRAS. This is enough to cause pre-cancerous pancreatic intraepithelial lesions,30,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,12,25398284,25398284,C,A,ENST00000256078.4,,,,,75,GRCh37,,,,,,
426,BRAF,673,WILD TYPE,,5,variant,826,wild_type,Wild Type,SO:0000817,An attribute describing sequence with the genotype found in nature and/or standard laboratory stock.,http://www.sequenceontology.org/browser/current_svn/term/SO:0000817,7,140434279,140624564,,,ENST00000288602.6,,,,,75,GRCh37,,,,,,
427,NRAS,4893,Q61K,,36,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,1,115256530,115256530,G,T,ENST00000369535.4,,,,,75,GRCh37,,,,,,
428,MRE11,4361,FRAMESHIFT MUTATION,,3586,variant,51,frameshift_variant,Frameshift Variant,SO:0001589,"A sequence variant which causes a disruption of the translational reading frame, because the number of nucleotides inserted or deleted is not a multiple of three.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001589,11,94152895,94227074,,,ENST00000323929.3,,,,,75,GRCh37,,,,,,
429,KIT,3815,EXPRESSION,,29,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,4,55524085,55606881,,,ENST00000288135.5,,,,,75,GRCh37,,,,,,
431,CBFB,865,CBFB-MYH11,"CBFB-MYH11 is the result of inv(16)(p13q22) or t(16;16)(p13;q22) and is sufficient for the diagnosis of acute myeloid leukemia (in the correct setting) according to WHO criteria, even when blast counts are <20% (Vardiman et al, Blood 2008). This fusion is typically associated with favorable prognosis relative to other AML subtypes (including cytogenetically normal); however, the impact of additional mutations in the context of this fusion is incompletely understood. AMLs with this fusion are often grouped with other rearrangements affecting genes encoding core binding factor subunits, referred to as CBF AMLs.",776,variant,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886,16,67063148,67116211,,,ENST00000412916.2,16,15797029,15820911,ENST00000396324.3,75,GRCh37,,,,,,
432,KMT2A,4297,MLL-MLLT3,,3537,variant,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886,,,,,,,,,,,,,,,,,,
433,HIF1A,3091,3' UTR Polymorphism,,2596,variant,83,3_prime_UTR_variant,3 Prime UTR Variant,SO:0001624,A UTR variant of the 3' UTR.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001624,14,62213848,62213848,T,C,ENST00000394997.1,,,,,75,GRCh37,738,SNP,Snp,SO:0000694,"SNPs are single base pair positions in genomic DNA at which different sequence alternatives exist in normal individuals in some population(s), wherein the least frequent variant has an abundance of 1% or greater.",http://www.sequenceontology.org/browser/current_svn/term/SO:0000694
434,HIF1A,3091,OVEREXPRESSION,,2596,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,14,62162258,62214976,,,ENST00000394997.1,,,,,75,GRCh37,,,,,,
435,EPAS1,2034,OVEREXPRESSION,,1705,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,2,46524541,46613836,,,ENST00000263734.3,,,,,75,GRCh37,,,,,,
436,VHL,7428,LOSS,,58,variant,161,loss_of_function_variant,Loss Of Function Variant,SO:0002054,A sequence variant whereby the gene product has diminished or abolished function.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002054,3,10182692,10193904,,,ENST00000256474.2,,,,,75,GRCh37,,,,,,
437,FLT3,2322,D835,,24,variant,103,protein_altering_variant,Protein Altering Variant,SO:0001818,A sequence_variant which is predicted to change the protein encoded in the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001818,13,28592642,28592642,C,A,ENST00000241453.7,,,,,75,GRCh37,,,,,,
438,PSMB8,5696,NUCLEAR EXPRESSION,,4616,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,6,32808494,32812480,,,ENST00000374881.2,,,,,75,GRCh37,,,,,,
439,PBK,55872,NUCLEAR EXPRESSION,,13276,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,8,27667137,27695612,,,ENST00000301905.4,,,,,75,GRCh37,,,,,,
440,PTTG1,9232,OVEREXPRESSION,,7297,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,5,159848829,159855748,,,ENST00000352433.5,,,,,75,GRCh37,,,,,,
441,LEPR,3953,UNDEREXPRESSION,,3274,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,1,65886335,66107242,,,ENST00000349533.6,,,,,75,GRCh37,,,,,,
442,EGFR,1956,MUTATION,,19,variant,95,inframe_variant,Inframe Variant,SO:0001650,A sequence variant which does not cause a disruption of the translational reading frame.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001650,7,55086794,55279321,,,ENST00000275493.2,,,,,75,GRCh37,,,,,,
443,EGFR,1956,G465R,,19,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,7,55227926,55227926,G,A,ENST00000275493.2,,,,,75,GRCh37,,,,,,
444,NEDD9,4739,EXPRESSION,,3852,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,6,11185051,11382581,,,ENST00000504387.1,,,,,75,GRCh37,,,,,,
445,ETS2,2114,RS461155,,1763,variant,104,synonymous_variant,Synonymous Variant,SO:0001819,A sequence variant where there is no resulting change to the encoded amino acid.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001819,21,40191638,40191638,A,G,ENST00000360214.3,,,,,75,GRCh37,,,,,,
446,KRT18,3875,UNDEREXPRESSION,,3215,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,12,53342655,53346684,,,ENST00000388837.2,,,,,75,GRCh37,,,,,,
447,FGF13,2258,CYTOPLASMIC EXPRESSION,,1883,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,X,137715011,138286269,,,ENST00000370603.3,,,,,75,GRCh37,,,,,,
448,SSX1,6756,SS18-SSX1,,5500,variant,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886,,,,,,,,,,,,,,,,,,
449,SSX2,6757,SS18-SSX2,,5501,variant,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886,,,,,,,,,,,,,,,,,,
450,SSX4,6759,SS18-SSX4,,5503,variant,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886,18,23612363,23670589,,,ENST00000415083.2,X,48261524,48265521,ENST00000376884.2,75,GRCh37,,,,,,
451,ABCB1,5243,S893A/T,"Refer to 
https://www.pharmgkb.org/rsid/rs2032582 
for more information.",4244,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,7,87160618,87160618,A,C,ENST00000265724.3,,,,,75,GRCh37,,,,,,
453,EGFR,1956,S492R,,19,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,7,55228009,55228009,C,A,ENST00000275493.2,,,,,75,GRCh37,,,,,,
454,EGFR,1956,R451C,,19,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,7,55227884,55227884,C,T,ENST00000275493.2,,,,,75,GRCh37,,,,,,
455,EGFR,1956,K467T,,19,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,7,55227933,55227933,A,C,ENST00000275493.2,,,,,75,GRCh37,,,,,,
456,FCGR2A,2212,H167R,,1842,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,1,161479745,161479745,A,G,ENST00000271450.6,,,,,75,GRCh37,,,,,,
457,FCGR3A,2214,F212V,,1844,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,1,161514542,161514542,A,C,ENST00000367969.3,,,,,75,GRCh37,,,,,,
458,FCGR2B,2213,I232T,,1843,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,1,161643798,161643798,T,C,ENST00000358671.5,,,,,75,GRCh37,,,,,,
460,EGFR,1956,P753S,,19,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,7,55242487,55242487,C,T,ENST00000275493.2,,,,,75,GRCh37,,,,,,
461,PML,5371,B2 DOMAIN MUTATION,The B2 domain in PML is the binding site for ATRA. Point mutations in this region have been associated with ATRA resistance in patients with APL.,39,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,15,74315213,74315219,,,ENST00000268058.3,,,,,75,GRCh37,,,,,,
462,PML,5371,PML-RARA A216V,A216V in the B2 domain of PML is one of the variants found in a patient with ATRA-resistant APL.,39,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,15,74315213,74315213,C,T,ENST00000268058.3,,,,,75,GRCh37,,,,,,
463,PML,5371,PML-RARA L218P,L218P in the B2 domain of PML is one of the variants found in a patient with ATRA-resistant APL.,39,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,15,74315219,74315219,T,C,ENST00000268058.3,,,,,75,GRCh37,,,,,,
464,MET,4233,EXON 14 MUTATION + AMPLIFICATION,,52,variant,38,exon_loss_variant,Exon Loss Variant,SO:0001572,A sequence variant whereby an exon is lost from the transcript.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001572,7,116312459,116436396,,,ENST00000318493.6,,,,,75,GRCh37,123,transcript_amplification,Transcript Amplification,SO:0001889,A feature amplification of a region containing a transcript.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001889
465,ROS1,6098,CD74-ROS1 G2032R,"The G2032R missense mutation has been observed in patients with crizotinib-resistant non-small cell lung cancer harboring CD74-ROS1 rearrangement. Independent in vitro studies have confirmed that this mutation confers marked resistance to crizotinib cells over CD74-ROS1 alone. Multiple groups have indicated CD74-ROS1 G2032R expressing cell lines are sensitive to both cabozantinib and foretinib individually administered in vitro. One group additionally showed this mutation conferred relative resistance to alectinib, brigatinib, ceritinib, and AZD3463 in vitro.",4941,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,6,117638347,117638347,C,T,ENST00000368508.3,,,,,75,GRCh37,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886
466,FGFR1,2260,ZNF198-FGFR1,,1885,variant,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886,,,,,,,,,,,,,,,,,,
467,KDR,3791,A1065T,,3153,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,4,55955969,55955969,C,T,ENST00000263923.4,,,,,75,GRCh37,,,,,,
468,KDR,3791,D717V,,3153,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,4,55968180,55968180,T,A,ENST00000263923.4,,,,,75,GRCh37,,,,,,
469,TSC2,7249,Q1178*,,47,variant,50,stop_gained,Stop Gained,SO:0001587,"A sequence variant whereby at least one base of a codon is changed, resulting in a premature stop codon, leading to a shortened polypeptide.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001587,16,2130300,2130300,C,T,ENST00000219476.3,,,,,75,GRCh37,,,,,,
470,MTOR,2475,F2108L,,2073,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,1,11187094,11187094,G,T,ENST00000361445.4,,,,,75,GRCh37,,,,,,
471,RAD51D,5892,R186*,,4765,variant,50,stop_gained,Stop Gained,SO:0001587,"A sequence variant whereby at least one base of a codon is changed, resulting in a premature stop codon, leading to a shortened polypeptide.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001587,17,33433425,33433425,G,A,ENST00000345365.6,,,,,75,GRCh37,,,,,,
472,ALDH1A2,8854,EXPRESSION,,7024,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,15,58245622,58358616,,,ENST00000249750.4,,,,,75,GRCh37,,,,,,
473,ALDH1A2,8854,UNDEREXPRESSION,,7024,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,15,58245622,58358616,,,ENST00000249750.4,,,,,75,GRCh37,,,,,,
474,KIAA1524,57650,EXPRESSION,,13948,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,3,108268716,108308299,,,ENST00000295746.8,,,,,75,GRCh37,,,,,,
475,KIAA1524,57650,UNDEREXPRESSION,,13948,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,3,108268716,108308299,,,ENST00000295746.8,,,,,75,GRCh37,,,,,,
476,MIR218-1,407000,EXPRESSION,,24938,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,4,20529898,20530007,,,ENST00000384999.1,,,,,75,GRCh37,,,,,,
477,BRCA1,672,P968FS,,6,variant,134,frameshift_truncation,Frameshift Truncation,SO:0001910,A frameshift variant that causes the translational reading frame to be shortened relative to the reference feature.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001910,17,41244645,41244646,,GA,ENST00000471181.2,,,,,75,GRCh37,,,,,,
479,KRAS,3845,Q22*,,30,variant,50,stop_gained,Stop Gained,SO:0001587,"A sequence variant whereby at least one base of a codon is changed, resulting in a premature stop codon, leading to a shortened polypeptide.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001587,12,25398255,25398255,G,A,ENST00000256078.4,,,,,75,GRCh37,,,,,,
480,DNMT3A,1788,P904L,,18,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,2,25457176,25457176,G,A,ENST00000264709.3,,,,,75,GRCh37,,,,,,
481,DDX43,55510,OVEREXPRESSION,,13005,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,6,74104471,74127292,,,ENST00000370336.4,,,,,75,GRCh37,,,,,,
482,KIT,3815,RS3733542,,29,variant,104,synonymous_variant,Synonymous Variant,SO:0001819,A sequence variant where there is no resulting change to the encoded amino acid.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001819,4,55602765,55602765,G,C,ENST00000288135.5,,,,,75,GRCh37,,,,,,
483,TBK1,29110,OVEREXPRESSION,,11322,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,12,64845660,64895888,,,ENST00000331710.5,,,,,75,GRCh37,,,,,,
485,STK11,6794,LOSS,,5534,variant,161,loss_of_function_variant,Loss Of Function Variant,SO:0002054,A sequence variant whereby the gene product has diminished or abolished function.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002054,19,1205740,1228428,,,ENST00000326873.7,,,,,75,GRCh37,,,,,,
486,HAVCR2,84868,OVEREXPRESSION,,16394,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,5,156512843,156536725,,,ENST00000307851.4,,,,,75,GRCh37,,,,,,
487,MMP2,4313,SERUM LEVELS,,3549,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,16,55512883,55540603,,,ENST00000219070.4,,,,,75,GRCh37,,,,,,
488,MMP9,4318,SERUM LEVELS,,3553,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,20,44637547,44645200,,,ENST00000372330.3,,,,,75,GRCh37,,,,,,
490,HSPH1,10808,NUCLEAR EXPRESSION,,8614,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,13,31710765,31736064,,,ENST00000320027.5,,,,,75,GRCh37,,,,,,
491,HSPH1,10808,T17 DELETION,,8614,variant,1742,short_tandem_repeat_variation,Short Tandem Repeat Variation,SO:0002096,A kind of sequence variant whereby a tandem repeat is expanded or contracted with regard to a reference.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002096,13,31722621,31722637,,,ENST00000320027.5,,,,,75,GRCh37,,,,,,
492,ECSCR,641700,EXPRESSION,,26599,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,,,,,,,,,,,,,,,,,,
493,ROBO4,54538,EXPRESSION,,12367,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,11,124753587,124768177,,,ENST00000306534.3,,,,,75,GRCh37,,,,,,
494,PIM1,5292,NUCLEAR EXPRESSION,,4286,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,6,37137979,37143202,,,ENST00000373509.5,,,,,75,GRCh37,,,,,,
495,MDM2,4193,SNP309,,3465,variant,138,coding_transcript_intron_variant,Coding Transcript Intron Variant,SO:0001969,A transcript variant occurring within an intron of a coding transcript.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001969,12,69202580,69202580,T,G,ENST00000462284.1,,,,,75,GRCh37,,,,,,
496,ERBB2,2064,L866M,This mutation was shown to be an activating mutation and conferred sensitivity to a combination of trastuzumab with neratinib or lapatinib in colorectal cancer patient-derived xenografts.,20,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,17,37881404,37881404,C,A,ENST00000269571.5,,,,,75,GRCh37,,,,,,
497,ERBB2,2064,S310F/Y,"ERBB2 S310F/Y was one of the first ERBB2 variants to be functionally classified (Greulich et al. 2012). This mutation was shown to be an activating mutation (through hyperphosphorylation) in an in vitro assay. In the same paper, this mutation (along with other ERBB2 activating mutations) in murine Ba/F3 cells have been shown to be sensitive to the ERBB2 inhibitors (afatinib, lapatinib and neratinib). More recent evidence may show that HER2 acitivating mutations confer sensitivity to a host of tyrosine kinase inhibitors, which is the topic of current clinical trials and research.",20,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,17,37868208,37868208,,,ENST00000269571.5,,,,,75,GRCh37,,,,,,
498,MIR218-1,407000,UNDEREXPRESSION,,24938,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,4,20529898,20530007,,,ENST00000384999.1,,,,,75,GRCh37,,,,,,
499,ALK,238,ALK FUSIONS,"Following the initial discovery and characterization of NPM-ALK fusion mutation in anaplastic large cell lymphoma (ALCL), EML4-ALK fusions were found to be driver mutations in a subset of lung adenocarcinomas. ALK fusions bring the C-terminal ALK kinase domain together with the N terminal region of the fusion partner, and have since been found in a range of cancers including inflammatory myofibroblastic tumor, renal cell carcinoma, diffuse large B cell lymphoma and colorectal cancer. 

In a Phase I trial for crizotinib, a 92% response rate was seen in the subset of patients with a specific EML4-ALK variant, which was higher than the 57% rate in the overall ALK-rearranged population, but the subpopulation numbers were insufficient to correlate variant type with patient response. 

Due to restricted wild-type ALK expression, and also mild phenotypes seen in ALK knockout mice, ALK fusions are desirable targets.  ALK inhibitor TAE684 was used in initial characterizations of ALK fusion cancer drivers, and crizotinib  a small molecule ATP-competitor RTK inhibitor which is highly selective for ALK and MET - has been approved as first line therapy in ALK-rearranged NSCLC.   

ALK-rearrangement defines an NSCLC subtype that makes up 3-5% of NSCLC cases, and is characterized by higher proportions of younger patients and never smokers. EML4-ALK variant 1 is the most common ALK fusion in NSCLC and was the first to be discovered and demonstrate cancer driver properties in vitro and in mouse models. A Phase I study of crizotinib in ALK-rearranged NSCLC demonstrated an increase in overall survival when compared to standard chemotherapy. These and other initial results prompted accelerated approval for crizotinib in NSCLC.  Continued clinical work demonstrated benefit with crizotinib over chemotherapy in multi-armed studies, and as first line therapy. Crizotinib was also found to remain beneficial to NSCLC patients who had progressed on crizotinib. Additionally, crizotinib was shown to increase intracranial disease control in brain metastasis occurring from ALK-rearranged NSCLC.",1,variant,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886,2,29415640,29446394,,,ENST00000389048.3,,,,,75,GRCh37,,,,,,
500,ALK,238,EML4-ALK E20;A20,"EML4-ALK variant 2 consists of a fusion of the ALK kinase domain (exons 20-29) with EML4 exons 1-20. Variant 2 has cytoplasmic distribution and makes up ~10% of EML4-ALK fusions found in NSCLC,. Although the specific variant is not consistently reported, single cases demonstrating response to crizotinib treatment in NSCLC and a differentiated malignant neoplasm of unknown origin have been reported. In vitro, this variant has shown greater sensitivity to ALK inhibition with TAE684 and crizotinib than the EML4-ALK variants 1 (E13;A20), 3a (E6;A20) and 3b (E6ins33;A20). The variant was reported to be less stable in cells than other variants, and may be a client protein of Hsp90. Along these lines the variant has shown preclinical sensitivity to Hsp90 inhibition.",1,variant,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886,2,42396490,42552694,,,ENST00000318522.5,2,29415640,29446394,ENST00000389048.3,75,GRCh37,,,,,,
501,ALK,238,EML4-ALK E2;A20,,1,variant,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886,2,42396490,42472827,,,ENST00000318522.5,2,29415640,29446394,ENST00000389048.3,75,GRCh37,,,,,,
502,KDR,3791,R961W,,3153,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,4,55961059,55961059,G,A,ENST00000263923.4,,,,,75,GRCh37,,,,,,
503,ALK,238,EML4-ALK E6;A20,"The EML4-ALK variant 3a consists of the ALK kinase domain fused to EML4 exons 1-6, while the 3b variant has an additional 33bp of intronic EML4 sequence between EML4 and ALK regions. The two variants were found to originate from a single genomic rearrangement, and 3a/3b is found in ~ 30% of EML4-ALK positive NSCLC. Variant 3a has cytoplasmic and nuclear distribution. In vitro, these variants have shown sensitivity to ALK inhibitors TAE684 and crizotinib but less sensitive than other EML4-ALK variants. The H2228 cell line contains 3a and 3b variants and is described as having cyctostatic response to ALK inhibition as opposed to apoptotic. In a study of 31 NSCLC patients with EML4-ALK rearrangements, 4/5 patients with the 3a variant showed a partial response while 1 showed progressive disease (the only PD observed). In cells the 3a variant was reported to be more stable than other variants, less sensitive to crizotinib and not to respond to Hsp90 inhibition.",1,variant,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886,2,42396490,42491871,,,ENST00000318522.5,2,29415640,29446394,ENST00000389048.3,75,GRCh37,,,,,,
504,TP53,7157,P47S,,45,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,17,7579548,7579548,G,A,ENST00000269305.4,,,,,75,GRCh37,,,,,,
505,GNAQ,2776,MUTATION,,2317,variant,,,,,,,9,80331003,80646374,,,ENST00000286548.4,,,,,75,GRCh37,,,,,,
506,GNA11,2767,MUTATION,,2308,variant,,,,,,,19,3094408,3124002,,,ENST00000078429.4,,,,,75,GRCh37,,,,,,
507,GNAQ,2776,Q209,,2317,variant,103,protein_altering_variant,Protein Altering Variant,SO:0001818,A sequence_variant which is predicted to change the protein encoded in the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001818,9,80409487,80409489,,,ENST00000286548.4,,,,,75,GRCh37,,,,,,
508,PMS2,5395,K706FS*19,,4371,variant,54,minus_1_frameshift_variant,Minus 1 Frameshift Variant,SO:0001592,"A sequence variant which causes a disruption of the translational reading frame, by shifting one base ahead.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001592,7,6022512,6022512,,,ENST00000265849.7,,,,,75,GRCh37,,,,,,
509,KIT,3815,EXON 9 MUTATION,"In patients with gastrointestinal stromal tumors (GIST), imatinib has improved outcomes for patients with KIT mutations. However, acquired resistance to imatinib is common. Patients harboring exon 9 KIT mutations may benefit from higher imatinib doses (800mg/daily). Similarly, imatinib-refractory tumors showed sensitivity to sunitinib treatment. Improved responses to either treatment were not observed in patients with exon 11 mutations.",29,variant,99,exon_variant,Exon Variant,SO:0001791,A sequence variant that changes exon sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001791,4,55592023,55592216,,,ENST00000288135.5,,,,,75,GRCh37,,,,,,
510,PTEN,5728,MUTATION,,41,variant,103,protein_altering_variant,Protein Altering Variant,SO:0001818,A sequence_variant which is predicted to change the protein encoded in the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001818,10,89622870,89731687,,,ENST00000371953.3,,,,,75,GRCh37,,,,,,
511,FGFR2,2263,MUTATION,,22,variant,42,transcript_variant,Transcript Variant,SO:0001576,A sequence variant that changes the structure of the transcript.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001576,10,123239371,123357917,,,ENST00000457416.2,,,,,75,GRCh37,160,gain_of_function_variant,Gain Of Function Variant,SO:0002053,A sequence variant whereby new or enhanced function is conferred on the gene product.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002053
512,ALK,238,MUTATION,,1,variant,30,gene_variant,Gene Variant,SO:0001564,A sequence variant where the structure of the gene is changed.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001564,2,29415640,30144432,,,ENST00000389048.3,,,,,75,GRCh37,160,gain_of_function_variant,Gain Of Function Variant,SO:0002053,A sequence variant whereby new or enhanced function is conferred on the gene product.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002053
513,ALK,238,NPM-ALK,,1,variant,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886,5,170814120,170818803,,,ENST00000517671.1,2,29415640,29446394,ENST00000389048.3,75,GRCh37,,,,,,
514,ALK,238,RANBP2-ALK,,1,variant,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886,2,109335937,109375004,,,ENST00000283195.6,2,29415640,29446394,ENST00000389048.3,75,GRCh37,,,,,,
515,FGFR1,2260,N546K,,1885,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,8,38274849,38274849,G,T,ENST00000341462.5,,,,,75,GRCh37,,,,,,
516,ROS1,6098,CD74-ROS1 L2026M,"The L2026M mutation is considered a gatekeeper mutation located in the inhibitor binding pocket of ROS1 and corresponding to L1196M in ALK and T790M in EGFR. This mutation has not been reportedly observed in a patient but inferred as a variant likely to emerge in crizotinib-resistant tumors. In vitro kinase activity, structural predictions and growth inhibition assays indicate the L2026M mutation in the CD74-ROS1 fusion provides crizotinib resistance. Additional preclinical assays have indicated that crizotinib resistant cells harboring this mutation are sensitive to PF-06463922 and foretinib.",4941,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,6,117638365,117638365,G,T,ENST00000368508.3,,,,,75,GRCh37,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886
517,ROS1,6098,CD74-ROS1 L2155S,,4941,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,6,117630062,117630062,A,G,ENST00000368508.3,,,,,75,GRCh37,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886
518,ROS1,6098,CD74-ROS1 G2101A,,4941,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,6,117631376,117631376,C,G,ENST00000368508.3,,,,,75,GRCh37,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886
519,FLT3,2322,MUTATION,,24,variant,42,transcript_variant,Transcript Variant,SO:0001576,A sequence variant that changes the structure of the transcript.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001576,13,28577411,28674729,,,ENST00000241453.7,,,,,75,GRCh37,160,gain_of_function_variant,Gain Of Function Variant,SO:0002053,A sequence variant whereby new or enhanced function is conferred on the gene product.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002053
520,ALK,238,CLTC-ALK,"The t(2;17)(p23;q23) translocation results in the CLTC-ALK fusion protein, the most common ALK fusion observed in diffuse large B cell lymphoma (DLBCL). ALK-rearranged DLBCL is less responsive to CHOP chemotherapy. Preclinical work indicates that CLTC-ALK DLBCL is responsive to ALK inhibition in cell lines and mouse models, and two case studies show short response followed by progression when heavily pretreated and advanced ALK-positive DLBCL is treated with crizotinib (one case CLTC-ALK, one case an unknown ALK fusion).",1,variant,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886,17,57697219,57768072,,,ENST00000269122.3,2,29415640,29446394,ENST00000389048.3,75,GRCh37,,,,,,
521,U2AF1,7307,MUTATION,,48,variant,103,protein_altering_variant,Protein Altering Variant,SO:0001818,A sequence_variant which is predicted to change the protein encoded in the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001818,21,44513066,44527697,,,ENST00000291552.4,,,,,75,GRCh37,,,,,,
522,BRAF,673,DEL 485-490,,5,variant,107,inframe_deletion,Inframe Deletion,SO:0001822,An inframe non synonymous variant that deletes bases from the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001822,7,140477838,140477855,AGGTGCTGTCACATTCAA,,ENST00000288602.6,,,,,75,GRCh37,,,,,,
524,DUX4,100288687,DUX4 FUSIONS,,34321,variant,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886,,,,,,,,,,,,,,,,,,
525,B4GALT1,2683,EXPRESSION,,2239,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,9,33110635,33167354,,,ENST00000379731.4,,,,,75,GRCh37,,,,,,
526,BCL2L11,10018,DELETION POLYMORPHISM,,7953,variant,970,polymorphic_sequence_variant,Polymorphic Sequence Variant,SO:0001025,A sequence variant that is segregating in one or more natural populations of a species.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001025,2,111883195,111886097,,,ENST00000393256.3,,,,,75,GRCh37,,,,,,
527,ALK,238,ALK FUSION I1171,Multiple case reports indicate that the I1171T missense mutation in ALK-rearranged non-small cell lung cancer (NSCLC) confers resistance to crizotinib and alectinib but is sensitive to ceritinib treatment. These results have been validated in vitro. In vitro evidence indicates this mutation interferes with alectinib binding the active site of ALK and may explain the sensitivity to the structurally distinct ALK inhibitor ceritinib.,1,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,2,29445213,29445213,A,G,ENST00000389048.3,,,,,75,GRCh37,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886
528,ALK,238,EML4-ALK  V1180L,"The V1180L missense mutation was identified in a mutagenesis screen to find mutations that conferred resistance to alectinib in a non-small cell lung cancer cell line. This mutation shows resistance to crizotinib and alectinib but sensitivity to TAE684, ceritinib and more mild sensitivity to brigatinib. Similar to I1171T, it resides in the ATP pocket of ALK and likely interferes with alectinib and crizotinib binding as a mechanism of resistance.",1,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,2,29443679,29443679,C,G,ENST00000389048.3,,,,,75,GRCh37,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886
529,SIRT1,23411,OVEREXPRESSION,,9538,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,10,69644427,69678147,,,ENST00000212015.6,,,,,75,GRCh37,,,,,,
530,KRAS,3845,G12R,,30,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,12,25398285,25398285,C,G,ENST00000256078.4,,,,,75,GRCh37,,,,,,
531,TP53,7157,P72R,"This polymorphism is relatively widely studied across cancer types, but meta-analyses in breast, lung and cervical cancer cohorts have so far been inconclusive as to the significance of a patient's genotype at this locus as it relates to cancer susceptibility and prognosis.",45,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,17,7579472,7579472,G,C,ENST00000269305.4,,,,,75,GRCh37,,,,,,
532,PALB2,79728,BIALLELIC INACTIVATION,,15013,variant,161,loss_of_function_variant,Loss Of Function Variant,SO:0002054,A sequence variant whereby the gene product has diminished or abolished function.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002054,16,23614491,23652631,,,ENST00000261584.4,,,,,75,GRCh37,,,,,,
533,SMAD4,4089,EXPRESSION,,77,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,18,48556583,48611409,,,ENST00000342988.3,,,,,75,GRCh37,,,,,,
534,FANCC,2176,LOSS-OF-FUNCTION,,1811,variant,161,loss_of_function_variant,Loss Of Function Variant,SO:0002054,A sequence variant whereby the gene product has diminished or abolished function.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002054,9,97861336,98079984,,,ENST00000289081.3,,,,,75,GRCh37,,,,,,
535,PDGFRB,5159,EBF1-PDGFRB,EBF1-PDGFRB fusions are associated with Ph-like acute lymphoblastic leukemia lacking the BCR-ABL fusion. Case reports have shown positive responses to imatinib treatment.,4176,variant,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886,,,,,,,,,,,,,,,,,,
536,SULT1E1,6783,SNP,,5525,variant,,,,,,,,,,,,,,,,,,,,,,,,
537,RB1,5925,EXPRESSION,,4795,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,13,48877911,49056122,,,ENST00000267163.4,,,,,75,GRCh37,,,,,,
538,MLH1,4292,METHYLATION,,3532,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,,,,,,,,,,,,,,,,,,
539,PTPN11,5781,EXPRESSION,,4685,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,12,112856718,112947717,,,ENST00000351677.2,,,,,75,GRCh37,,,,,,
540,FLT3,2322,T227M,"FLT3 T227M (rs1933437) is a common polymorphism with a GMAF around .60 based on the Exome Aggregation Consortium (ExAC) data. Its role in cancer predisposition is still unknown, however it may be associated with the development of leukopenia in patients treated with sunitinib.",24,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,13,28624294,28624294,G,A,ENST00000241453.7,,,,,75,GRCh37,738,SNP,Snp,SO:0000694,"SNPs are single base pair positions in genomic DNA at which different sequence alternatives exist in normal individuals in some population(s), wherein the least frequent variant has an abundance of 1% or greater.",http://www.sequenceontology.org/browser/current_svn/term/SO:0000694
541,PALB2,79728,L531FS*30,,15013,variant,54,minus_1_frameshift_variant,Minus 1 Frameshift Variant,SO:0001592,"A sequence variant which causes a disruption of the translational reading frame, by shifting one base ahead.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001592,16,23646276,23646276,,,ENST00000261584.4,,,,,75,GRCh37,738,SNP,Snp,SO:0000694,"SNPs are single base pair positions in genomic DNA at which different sequence alternatives exist in normal individuals in some population(s), wherein the least frequent variant has an abundance of 1% or greater.",http://www.sequenceontology.org/browser/current_svn/term/SO:0000694
542,MTOR,2475,S2215Y,,2073,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,1,11184573,11184573,G,T,ENST00000361445.4,,,,,75,GRCh37,,,,,,
543,MTOR,2475,C1483Y,,2073,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,1,11217230,11217230,C,T,ENST00000361445.4,,,,,75,GRCh37,,,,,,
544,MTOR,2475,E1799K,,2073,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,1,11190804,11190804,C,T,ENST00000361445.4,,,,,75,GRCh37,,,,,,
545,FGFR2,2263,N550K,,22,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,10,123258034,123258034,A,T,ENST00000457416.2,,,,,75,GRCh37,160,gain_of_function_variant,Gain Of Function Variant,SO:0002053,A sequence variant whereby new or enhanced function is conferred on the gene product.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002053
546,ACTA1,58,EXPRESSION,,128,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,1,229566992,229569841,,,ENST00000366684.3,,,,,75,GRCh37,,,,,,
547,RB1,5925,OVEREXPRESSION,,4795,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,13,48877911,49056122,,,ENST00000267163.4,,,,,75,GRCh37,,,,,,
548,PPP1R15A,23645,RS557806,,9722,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,19,49377242,49377242,G,C,ENST00000200453.5,,,,,75,GRCh37,970,polymorphic_sequence_variant,Polymorphic Sequence Variant,SO:0001025,A sequence variant that is segregating in one or more natural populations of a species.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001025
549,ALK,238,F1245C,,1,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,2,29436859,29436859,A,C,ENST00000389048.3,,,,,75,GRCh37,,,,,,
550,ALK,238,DEL4-11,,1,variant,107,inframe_deletion,Inframe Deletion,SO:0001822,An inframe non synonymous variant that deletes bases from the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001822,2,29497965,29754982,,,ENST00000389048.3,,,,,75,GRCh37,,,,,,
551,ALK,238,ALK FUSION F1245C,"In neuroblastoma, F1245 is one of three hotspot ALK mutations found at a high frequency. In a case study, a pretreated non-small cell lung cancer (NSCLC) patient with EML4-ALK F1245C mutation responded well to ceritinib after slow disease progression during crizotinib treatment. Crizotinib resistance was attributed to the F1245C mutation, although the ALK-rearrangement was not sequenced prior to crizotinib treatment. The patient's slow onset of disease progression during crizotinib treatment mirrors preclinical findings that indicate ALK-fusion with F1245C has moderate resistance to crizotinib compared to the fusion alone.",1,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,2,29436859,29436859,A,C,ENST00000389048.3,,,,,75,GRCh37,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886
552,ALK,238,ALK FUSION G1269A,,1,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,2,29432682,29432682,C,G,ENST00000389048.3,,,,,75,GRCh37,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886
553,CDK4,1019,AMPLIFICATION,,13,variant,123,transcript_amplification,Transcript Amplification,SO:0001889,A feature amplification of a region containing a transcript.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001889,12,58141510,58146304,,,ENST00000257904.6,,,,,75,GRCh37,,,,,,
554,CDKN2A,1029,LOSS,,14,variant,161,loss_of_function_variant,Loss Of Function Variant,SO:0002054,A sequence variant whereby the gene product has diminished or abolished function.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002054,9,21967752,21994623,,,ENST00000579755.1,,,,,75,GRCh37,,,,,,
555,CDKN2B,1030,LOSS,,916,variant,127,transcript_ablation,Transcript Ablation,SO:0001893,A feature ablation whereby the deleted region includes a transcript feature.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001893,9,22002902,22009362,,,ENST00000276925.6,,,,,75,GRCh37,,,,,,
556,CDK4,1019,R24C,,13,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,12,58145431,58145431,G,A,ENST00000257904.6,,,,,75,GRCh37,,,,,,
557,ASXL1,171023,EXON 12 MUTATION,,68,variant,99,exon_variant,Exon Variant,SO:0001791,A sequence variant that changes exon sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001791,20,31021087,31021720,,,ENST00000375687.4,,,,,75,GRCh37,,,,,,
558,GNA11,2767,Q209,,2308,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,19,3118942,3118942,,,ENST00000078429.4,,,,,75,GRCh37,,,,,,
559,CALR,811,EXON 9 FRAMESHIFT,"Exon 9 insertions and deletions have become part of the WHO diagnostic criteria for essential thrombocythemia (ET) and primary myelofibrosis (PMF) (Arber et al, 2016). These mutations are typically heterozygous and in the absence of JAK2 and MPL mutations. Approximately 80% of observed mutations are type 1 (p.L367fs*46), the result of a 52bp deletion, or type 2 (p.K385fs*47), the result of a 5-bp TTGTC insertion, and studies have suggested phenotypic and prognostic differences between them. In PMF patients, CALR exon 9 mutations have been associated with improved median survival.",732,variant,99,exon_variant,Exon Variant,SO:0001791,A sequence variant that changes exon sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001791,19,13054527,13054727,,,ENST00000316448.5,,,,,75,GRCh37,,,,,,
560,CSF3R,1441,MUTATION,,1239,variant,103,protein_altering_variant,Protein Altering Variant,SO:0001818,A sequence_variant which is predicted to change the protein encoded in the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001818,1,36932096,36933444,,,ENST00000373106.1,,,,,75,GRCh37,,,,,,
562,EGFR,1956,S768I,,19,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,7,55249005,55249005,G,T,ENST00000275493.2,,,,,75,GRCh37,,,,,,
563,BRAF,673,V600K,,5,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,7,140453136,140453137,AC,TT,ENST00000288602.6,,,,,75,GRCh37,,,,,,
564,SMAD4,4089,LOSS,,77,variant,161,loss_of_function_variant,Loss Of Function Variant,SO:0002054,A sequence variant whereby the gene product has diminished or abolished function.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002054,18,48556583,48611409,,,ENST00000342988.3,,,,,75,GRCh37,,,,,,
565,SF3B1,23451,K700E,,44,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,2,198266834,198266834,T,C,ENST00000335508.6,,,,,75,GRCh37,,,,,,
566,MAP2K7,5609,E116K,,4546,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,19,7975157,7975157,G,A,ENST00000397979.3,,,,,75,GRCh37,,,,,,
567,PDGFRA,5156,PDGFRA FUSIONS,,38,variant,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886,,,,,,,,,,,,,,,,,,
568,PDGFRB,5159,PDGFRB FUSIONS,,4176,variant,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886,,,,,,,,,,,,,,,,,,
569,FGFR1,2260,FGFR1 FUSIONS,,1885,variant,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886,8,38268656,38325363,,,ENST00000425967.3,,,,,75,GRCh37,,,,,,
570,IDH2,3418,MUTATION,,27,variant,103,protein_altering_variant,Protein Altering Variant,SO:0001818,A sequence_variant which is predicted to change the protein encoded in the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001818,15,90626277,90645736,,,ENST00000330062.3,,,,,75,GRCh37,,,,,,
571,JAK2,3717,PCM1-JAK2,,28,variant,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886,,,,,,,,,,,,GRCh37,,,,,,
572,MTOR,2475,E2014K + E2419K,,2073,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,1,11174420,11187857,,,ENST00000361445.4,,,,,75,GRCh37,,,,,,
573,RICTOR,253260,AMPLIFICATION,,20480,variant,123,transcript_amplification,Transcript Amplification,SO:0001889,A feature amplification of a region containing a transcript.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001889,5,38938021,39074510,,,ENST00000357387.3,,,,,75,GRCh37,,,,,,
574,PDGFRA,5156,FIP1L1-PDGFRA,"Prospective trials of patients with hypereosinophilic syndrome harboring the FIP1L1-PDGFRA fusion identified marked response to imatinib treatment (Gotlib and Cool, Leukemia 2008). Imatinib is FDA approved for the treatment of &quot;adult patients with hypereosinophilic syndrome (HES) and/or chronic eosinophilic leukemia (CEL) who have the FIP1L1-PDGFR fusion kinase&quot; (NDA021588).",38,variant,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886,4,54243812,54294350,,,ENST00000337488.6,4,55141008,55164414,ENST00000257290.5,75,GRCh37,,,,,,
576,ROS1,6098,TFG-ROS1,,4941,variant,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886,3,100428269,100447702,,,ENST00000240851.4,6,117609463,117642557,ENST00000368508.3,75,GRCh37,,,,,,
577,PDGFRA,5156,FIP1L1-PDGFRA T674I,A case study of relapsed myeloproliferative hypereosinophilic syndrome suggests that a T674I mutation in the PDGFRA split kinase domain of FIP1L1-PDGFRA fusions may confer resistance to imatinib.,38,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,4,55144547,55144547,C,T,ENST00000257290.5,,,,,75,GRCh37,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886
578,BIRC5,332,OVEREXPRESSION,,355,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,17,76210267,76221717,,,ENST00000301633.4,,,,,75,GRCh37,,,,,,
579,BRAF,673,D594A,,5,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,7,140453154,140453154,T,G,ENST00000288602.6,,,,,75,GRCh37,,,,,,
580,BRAF,673,D594V,,5,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,7,140453154,140453154,T,A,ENST00000288602.6,,,,,75,GRCh37,,,,,,
581,BRAF,673,K483M,The K483M variant is a kinase dead loss-of-function variant in the catalytic site of BRAF. This engineered variant is often used as a control when evaluating other BRAF variants.,5,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,7,140477859,140477860,TT,CA,ENST00000288602.6,,,,,75,GRCh37,161,loss_of_function_variant,Loss Of Function Variant,SO:0002054,A sequence variant whereby the gene product has diminished or abolished function.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002054
582,BRAF,673,L597S,,5,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,7,140453145,140453146,AG,GA,ENST00000288602.6,,,,,75,GRCh37,,,,,,
583,BRAF,673,L597Q,,5,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,7,140453145,140453145,A,T,ENST00000288602.6,,,,,75,GRCh37,,,,,,
584,BRAF,673,K601E,,5,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,7,140453134,140453134,T,C,ENST00000288602.6,,,,,75,GRCh37,,,,,,
585,BRAF,673,L597V,,5,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,7,140453146,140453146,G,C,ENST00000288602.6,,,,,75,GRCh37,,,,,,
586,KIT,3815,AMPLIFICATION,,29,variant,123,transcript_amplification,Transcript Amplification,SO:0001889,A feature amplification of a region containing a transcript.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001889,4,55524085,55606881,,,ENST00000288135.5,,,,,75,GRCh37,,,,,,
587,NF1,4763,MUTATION,,3867,variant,103,protein_altering_variant,Protein Altering Variant,SO:0001818,A sequence_variant which is predicted to change the protein encoded in the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001818,17,29421945,29704695,,,ENST00000358273.4,,,,,75,GRCh37,161,loss_of_function_variant,Loss Of Function Variant,SO:0002054,A sequence variant whereby the gene product has diminished or abolished function.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002054
588,ALK,238,HIP1-ALK I1171N,,1,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,2,29445213,29445213,A,T,ENST00000389048.3,,,,,75,GRCh37,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886
589,ALK,238,EML4-ALK I1171S,,1,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,2,29445213,29445213,A,C,ENST00000389048.3,,,,,75,GRCh37,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886
590,BIRC3,330,TRUNCATING MUTATION,,353,variant,51,frameshift_variant,Frameshift Variant,SO:0001589,"A sequence variant which causes a disruption of the translational reading frame, because the number of nucleotides inserted or deleted is not a multiple of three.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001589,11,102201730,102207833,,,ENST00000263464.3,,,,,75,GRCh37,,,,,,
591,RAF1,5894,AMPLIFICATION,,4767,variant,123,transcript_amplification,Transcript Amplification,SO:0001889,A feature amplification of a region containing a transcript.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001889,3,12625100,12705725,,,ENST00000251849.4,,,,,75,GRCh37,,,,,,
592,KRAS,3845,AMPLIFICATION,,30,variant,123,transcript_amplification,Transcript Amplification,SO:0001889,A feature amplification of a region containing a transcript.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001889,12,25362365,25403737,,,ENST00000256078.4,,,,,75,GRCh37,,,,,,
594,CEBPA,1050,BIALLELIC INACTIVATION,,15,variant,161,loss_of_function_variant,Loss Of Function Variant,SO:0002054,A sequence variant whereby the gene product has diminished or abolished function.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002054,19,33790840,33793470,,,ENST00000498907.2,,,,,75,GRCh37,,,,,,
595,SRSF2,6427,MUTATION,,5210,variant,30,gene_variant,Gene Variant,SO:0001564,A sequence variant where the structure of the gene is changed.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001564,17,74732402,74733113,,,ENST00000392485.2,,,,,75,GRCh37,,,,,,
596,NRAS,4893,G12/G13,,36,variant,103,protein_altering_variant,Protein Altering Variant,SO:0001818,A sequence_variant which is predicted to change the protein encoded in the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001818,1,115258744,115258748,,,ENST00000369535.4,,,,,75,GRCh37,,,,,,
597,RET,5979,OVEREXPRESSION,,42,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,10,43572475,43625799,,,ENST00000355710.3,,,,,75,GRCh37,,,,,,
599,CTLA4,1493,CTLA4-CD28,"A survey of 115 T-cell lymphoma samples of diverse subtypes identified this fusion in 26 of 45 cases of angioimmunoblastic T-cell lymphomas (58%), nine of 39 peripheral T-cell lymphomas, not otherwise specified (23%), and nine of 31 extranodal NK/T cell lymphomas (29%).",1285,variant,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886,2,204732509,204736210,,,ENST00000302823.3,2,204599507,204603635,ENST00000324106.8,75,GRCh37,,,,,,
600,AR,367,MUTATION,,67,variant,42,transcript_variant,Transcript Variant,SO:0001576,A sequence variant that changes the structure of the transcript.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001576,X,66764465,66950461,,,ENST00000374690.3,,,,,75,GRCh37,,,,,,
601,NOTCH1,4851,LOSS-OF-FUNCTION,,50,variant,161,loss_of_function_variant,Loss Of Function Variant,SO:0002054,A sequence variant whereby the gene product has diminished or abolished function.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002054,9,139388896,139440314,,,ENST00000277541.6,,,,,75,GRCh37,,,,,,
602,CDK6,1021,OVEREXPRESSION,,12,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,7,92234235,92463231,,,ENST00000265734.4,,,,,75,GRCh37,,,,,,
603,FLT3,2322,OVEREXPRESSION,,24,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,13,28577411,28674729,,,ENST00000241453.7,,,,,75,GRCh37,,,,,,
604,GNAQ,2776,Q209P,,2317,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,9,80409488,80409488,T,G,ENST00000286548.4,,,,,75,GRCh37,,,,,,
605,PTEN,5728,V317FS,,41,variant,51,frameshift_variant,Frameshift Variant,SO:0001589,"A sequence variant which causes a disruption of the translational reading frame, because the number of nucleotides inserted or deleted is not a multiple of three.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001589,10,89720799,89720802,TACT,,ENST00000371953.3,,,,,75,GRCh37,,,,,,
606,RB1,5925,LOSS-OF-FUNCTION,,4795,variant,161,loss_of_function_variant,Loss Of Function Variant,SO:0002054,A sequence variant whereby the gene product has diminished or abolished function.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002054,13,48877911,49056122,,,ENST00000267163.4,,,,,75,GRCh37,,,,,,
607,ESR1,2099,OVEREXPRESSION,,21,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,6,152128686,152424406,,,ENST00000206249.3,,,,,75,GRCh37,,,,,,
608,ALK,238,EML4-ALK C1156YL1196M,,1,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,2,29443631,29445258,,,ENST00000389048.3,,,,,75,GRCh37,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886
609,MTOR,2475,M2327I,,2073,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,1,11177096,11177096,C,A,ENST00000361445.4,,,,,75,GRCh37,,,,,,
610,MTOR,2475,A2034V,,2073,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,1,11187796,11187796,G,A,ENST00000361445.4,,,,,75,GRCh37,,,,,,
611,BRAF,673,D594G,,5,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,7,140453154,140453154,T,C,ENST00000288602.6,,,,,75,GRCh37,,,,,,
612,FLT3,2322,D835H,,24,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,13,28592642,28592642,C,G,ENST00000241453.7,,,,,75,GRCh37,,,,,,
613,FLT3,2322,D835H/Y,,24,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,13,28592642,28592642,C,G/A,ENST00000241453.7,,,,,75,GRCh37,,,,,,
614,JAK1,3716,Q503*,,3090,variant,50,stop_gained,Stop Gained,SO:0001587,"A sequence variant whereby at least one base of a codon is changed, resulting in a premature stop codon, leading to a shortened polypeptide.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001587,1,65321333,65321333,G,A,ENST00000342505.4,,,,,75,GRCh37,,,,,,
615,JAK2,3717,Exon 12 splice site insertion,,28,variant,,,,,,,9,5070053,5070054,,G,ENST00000381652.3,,,,,75,GRCh37,,,,,,
616,B2M,567,S14FS,,537,variant,134,frameshift_truncation,Frameshift Truncation,SO:0001910,A frameshift variant that causes the translational reading frame to be shortened relative to the reference feature.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001910,15,45003786,45003789,TCTT,,ENST00000558401.1,,,,,75,GRCh37,,,,,,
617,BRAF,673,PPFIBP2-BRAF,,5,variant,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886,11,7535001,7586998,,,ENST00000299492.4,7,140434279,140481493,ENST00000288602.6,75,GRCh37,,,,,,
618,BRAF,673,KIAA1549-BRAF,,5,variant,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886,7,138545885,138666064,,,ENST00000440172.1,7,140434279,140487384,ENST00000288602.6,75,GRCh37,,,,,,
619,PTGS2,5743,OVEREXPRESSION,,4659,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,1,186640923,186649559,,,ENST00000367468.5,,,,,75,GRCh37,,,,,,
621,MET,4233,OVEREXPRESSION,,52,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,7,116312459,116436396,,,ENST00000318493.6,,,,,75,GRCh37,,,,,,
623,POT1,25913,MUTATION,,9935,variant,103,protein_altering_variant,Protein Altering Variant,SO:0001818,A sequence_variant which is predicted to change the protein encoded in the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001818,7,124462440,124570035,,,ENST00000357628.3,,,,,75,GRCh37,161,loss_of_function_variant,Loss Of Function Variant,SO:0002054,A sequence variant whereby the gene product has diminished or abolished function.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002054
624,MKI67,4288,EXPRESSION,,3529,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,10,129894923,129924649,,,ENST00000368654.3,,,,,75,GRCh37,,,,,,
625,RAD23B,5887,EXPRESSION,,4760,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,9,110045560,110094475,,,ENST00000358015.3,,,,,75,GRCh37,,,,,,
626,RET,5979,CCDC6-RET,,42,variant,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886,,,,,,,,,,,,,,,,,,
627,MAP2K1,5604,C121S,,31,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,15,66729154,66729154,G,C,ENST00000307102.5,,,,,75,GRCh37,,,,,,
628,FGFR3,2261,S249C,,23,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,4,1803568,1803568,C,G,ENST00000340107.4,,,,,75,GRCh37,,,,,,
629,FGFR2,2263,AMPLIFICATION,,22,variant,123,transcript_amplification,Transcript Amplification,SO:0001889,A feature amplification of a region containing a transcript.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001889,10,123239371,123357917,,,ENST00000457416.2,,,,,75,GRCh37,,,,,,
630,FGF3,2248,AMPLIFICATION,,1873,variant,123,transcript_amplification,Transcript Amplification,SO:0001889,A feature amplification of a region containing a transcript.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001889,11,69624992,69633792,,,ENST00000334134.2,,,,,75,GRCh37,,,,,,
631,VHL,7428,R200W (c.598C>T),,58,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,3,10191605,10191605,C,T,ENST00000256474.2,,,,,75,GRCh37,,,,,,
632,RB1,5925,PHOSPHORYLATION,,4795,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,13,48877911,49056122,,,ENST00000267163.4,,,,,75,GRCh37,,,,,,
633,PIK3R1,5295,MUTATION,,4289,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,5,67511548,67597649,,,ENST00000521381.1,,,,,75,GRCh37,160,gain_of_function_variant,Gain Of Function Variant,SO:0002053,A sequence variant whereby new or enhanced function is conferred on the gene product.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002053
634,STK11,6794,D194E,,5534,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,19,1220489,1220489,C,A,ENST00000326873.7,,,,,75,GRCh37,97,loss_of_heterozygosity,Loss Of Heterozygosity,SO:0001786,A functional variant whereby the sequence alteration causes a loss of function of one allele of a gene.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001786
635,AKT2,208,AMPLIFICATION,,254,variant,123,transcript_amplification,Transcript Amplification,SO:0001889,A feature amplification of a region containing a transcript.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001889,19,40736224,40791302,,,ENST00000392038.2,,,,,75,GRCh37,,,,,,
636,PTEN,5728,R130*,,41,variant,50,stop_gained,Stop Gained,SO:0001587,"A sequence variant whereby at least one base of a codon is changed, resulting in a premature stop codon, leading to a shortened polypeptide.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001587,10,89692904,89692904,C,T,ENST00000371953.3,,,,,75,GRCh37,,,,,,
637,FBXW7,55294,LOSS-OF-FUNCTION,,12903,variant,161,loss_of_function_variant,Loss Of Function Variant,SO:0002054,A sequence variant whereby the gene product has diminished or abolished function.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002054,4,153242410,153457253,,,ENST00000281708.4,,,,,75,GRCh37,,,,,,
638,RB1,5925,M695FS*26,,4795,variant,134,frameshift_truncation,Frameshift Truncation,SO:0001910,A frameshift variant that causes the translational reading frame to be shortened relative to the reference feature.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001910,13,49033946,49033947,,A,ENST00000267163.4,,,,,75,GRCh37,,,,,,
639,JUN,3725,OVEREXPRESSION,,3094,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,1,59246465,59249785,,,ENST00000371222.2,,,,,75,GRCh37,,,,,,
640,FOS,2353,OVEREXPRESSION,,1955,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,14,75745477,75748933,,,ENST00000303562.4,,,,,75,GRCh37,,,,,,
641,CDKN2A,1029,RS3814960,,14,variant,180,5_prime_UTR_exon_variant,5 Prime UTR Exon Variant,SO:0002092,A UTR variant of exonic sequence of the 5' UTR.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002092,9,21975017,21975017,C,T,ENST00000498124.1,,,,,75,GRCh37,,,,,,
642,MDM2,4193,RS34886328,,3465,variant,154,3_prime_UTR_truncation,3 Prime UTR Truncation,SO:0002015,A sequence variant that causes the reduction of a the 3' UTR  with regard to the reference sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002015,12,69234988,69234988,,,ENST00000462284.1,,,,,75,GRCh37,,,,,,
643,CBLB,868,RS2305035,,779,variant,104,synonymous_variant,Synonymous Variant,SO:0001819,A sequence variant where there is no resulting change to the encoded amino acid.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001819,3,105439026,105439026,G,A,ENST00000264122.4,,,,,75,GRCh37,970,polymorphic_sequence_variant,Polymorphic Sequence Variant,SO:0001025,A sequence variant that is segregating in one or more natural populations of a species.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001025
644,PRDM1,639,MUTATION,,593,variant,42,transcript_variant,Transcript Variant,SO:0001576,A sequence variant that changes the structure of the transcript.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001576,6,106534195,106557813,,,ENST00000369096.4,,,,,75,GRCh37,161,loss_of_function_variant,Loss Of Function Variant,SO:0002054,A sequence variant whereby the gene product has diminished or abolished function.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002054
645,IDH1,3417,MUTATION,,26,variant,42,transcript_variant,Transcript Variant,SO:0001576,A sequence variant that changes the structure of the transcript.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001576,2,209101803,209116275,,,ENST00000415913.1,,,,,75,GRCh37,,,,,,
646,SMAD4,4089,DELETION,,77,variant,127,transcript_ablation,Transcript Ablation,SO:0001893,A feature ablation whereby the deleted region includes a transcript feature.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001893,18,48556583,48611409,,,ENST00000342988.3,,,,,75,GRCh37,,,,,,
647,LRP1B,53353,DELETION,,12146,variant,127,transcript_ablation,Transcript Ablation,SO:0001893,A feature ablation whereby the deleted region includes a transcript feature.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001893,2,140988992,142889270,,,ENST00000389484.3,,,,,75,GRCh37,,,,,,
648,ATRX,546,UNDEREXPRESSION,,525,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,X,76760356,77041702,,,ENST00000373344.5,,,,,75,GRCh37,,,,,,
649,MET,4233,D1228N,,52,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,7,116423407,116423407,G,A,ENST00000397752.3,,,,,75,GRCh37,,,,,,
650,CASP8,841,D302H,,761,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,2,202149589,202149589,G,C,ENST00000264275.5,,,,,75,GRCh37,970,polymorphic_sequence_variant,Polymorphic Sequence Variant,SO:0001025,A sequence variant that is segregating in one or more natural populations of a species.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001025
651,AXL,558,EXPRESSION,,533,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,19,41725108,41767671,,,ENST00000301178.4,,,,,75,GRCh37,,,,,,
652,GAS6,2621,EXPRESSION,,2186,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,13,114523524,114567046,,,ENST00000357389.3,,,,,75,GRCh37,,,,,,
653,ETV4,2118,OVEREXPRESSION,,1767,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,17,41605212,41623800,,,ENST00000319349.5,,,,,75,GRCh37,,,,,,
654,STAG3,10734,UNDEREXPRESSION,,8552,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,7,99775186,99812003,,,ENST00000426455.1,,,,,75,GRCh37,,,,,,
655,MAP2K1,5604,Q56_V60del,,31,variant,107,inframe_deletion,Inframe Deletion,SO:0001822,An inframe non synonymous variant that deletes bases from the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001822,15,66727449,66727463,CCAGAAGCAGAAGGT,,ENST00000307102.5,,,,,75,GRCh37,,,,,,
656,BRAF,673,BRAF-CUL1,,5,variant,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886,7,140434279,140487384,,,ENST00000288602.6,7,148395737,148457588,ENST00000602748.1,75,GRCh37,,,,,,
657,BRAF,673,ZKSCAN1-BRAF,,5,variant,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886,7,99613222,99627575,,,ENST00000426572.1,7,140434279,140482957,ENST00000288602.6,75,GRCh37,,,,,,
658,BRAF,673,L505H,,5,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,7,140477794,140477794,A,T,ENST00000288602.6,,,,,75,GRCh37,,,,,,
659,NF2,4771,MUTATION,,3870,variant,42,transcript_variant,Transcript Variant,SO:0001576,A sequence variant that changes the structure of the transcript.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001576,22,29999547,30094587,,,ENST00000338641.4,,,,,75,GRCh37,,,,,,
660,HIF1A,3091,EXPRESSION,,2596,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,14,62164340,62214489,,,ENST00000539097.1,,,,,75,GRCh37,,,,,,
661,BRCA2,675,D3095E,,7,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,13,32968854,32968854,C,A,ENST00000544455.1,,,,,75,GRCh37,,,,,,
662,MLH1,4292,EXPRESSION,,3532,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,3,37034823,37092409,,,ENST00000231790.2,,,,,75,GRCh37,,,,,,
663,BCOR,54880,MUTATION,,12555,variant,42,transcript_variant,Transcript Variant,SO:0001576,A sequence variant that changes the structure of the transcript.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001576,X,39910501,40036582,,,ENST00000342274.4,,,,,75,GRCh37,,,,,,
664,CDH1,999,MUTATION,,888,variant,15,transcription_variant,Transcription Variant,SO:0001549,A variant that changes alters the transcription of a transcript with respect to a reference sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001549,16,68771128,68869451,,,ENST00000261769.5,,,,,75,GRCh37,,,,,,
665,RHOA,387,MUTATION,,399,variant,15,transcription_variant,Transcription Variant,SO:0001549,A variant that changes alters the transcription of a transcript with respect to a reference sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001549,3,49412898,49405977,,,ENST00000418115.1,,,,,75,GRCh37,160,gain_of_function_variant,Gain Of Function Variant,SO:0002053,A sequence variant whereby new or enhanced function is conferred on the gene product.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002053
666,ERBB2,2064,MUTATION,,20,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,17,37868196,37881332,,,ENST00000269571.5,,,,,75,GRCh37,,,,,,
667,MEN1,4221,FRAMESHIFT TRUNCATION,,3485,variant,134,frameshift_truncation,Frameshift Truncation,SO:0001910,A frameshift variant that causes the translational reading frame to be shortened relative to the reference feature.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001910,11,64572092,64572092,C,,ENST00000337652.1,,,,,75,GRCh37,,,,,,
668,KMT2C,58508,MUTATION,,14089,variant,15,transcription_variant,Transcription Variant,SO:0001549,A variant that changes alters the transcription of a transcript with respect to a reference sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001549,7,151832010,152133090,,,ENST00000262189.6,,,,,75,GRCh37,161,loss_of_function_variant,Loss Of Function Variant,SO:0002054,A sequence variant whereby the gene product has diminished or abolished function.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002054
669,STAG2,10735,MUTATION,,8553,variant,103,protein_altering_variant,Protein Altering Variant,SO:0001818,A sequence_variant which is predicted to change the protein encoded in the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001818,X,123176418,123217308,,,ENST00000218089.9,,,,,75,GRCh37,,,,,,
670,MYCL,4610,EXPRESSION,,3738,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,1,40361098,40367685,,,ENST00000397332.2,,,,,75,GRCh37,,,,,,
671,HGF,3082,EXPRESSION,,2591,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,7,81328322,81399514,,,ENST00000222390.5,,,,,75,GRCh37,,,,,,
672,SOX10,6663,LOSS,,5418,variant,161,loss_of_function_variant,Loss Of Function Variant,SO:0002054,A sequence variant whereby the gene product has diminished or abolished function.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002054,22,38368307,38380544,,,ENST00000396884.2,,,,,75,GRCh37,,,,,,
673,FGF2,2247,EXPRESSION,,1872,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,4,123747863,123819391,,,ENST00000264498.3,,,,,75,GRCh37,,,,,,
674,EIF1AX,1964,MUTATION,,1646,variant,42,transcript_variant,Transcript Variant,SO:0001576,A sequence variant that changes the structure of the transcript.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001576,X,20156713,20159754,,,ENST00000379607.5,,,,,75,GRCh37,,,,,,
683,PAX8,7849,EXPRESSION,,75,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,2,113973574,114036527,,,ENST00000429538.3,,,,,75,GRCh37,,,,,,
691,ERRFI1,54206,E384*,,12271,variant,50,stop_gained,Stop Gained,SO:0001587,"A sequence variant whereby at least one base of a codon is changed, resulting in a premature stop codon, leading to a shortened polypeptide.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001587,1,8073509,8073509,C,A,ENST00000377482.5,,,,,75,GRCh37,161,loss_of_function_variant,Loss Of Function Variant,SO:0002054,A sequence variant whereby the gene product has diminished or abolished function.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002054
692,ESR1,2099,S463P,,21,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,6,152415537,152415537,T,C,ENST00000440973.1,,,,,75,GRCh37,,,,,,
693,SGK1,6446,OVEREXPRESSION,,5225,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,6,134490384,134639196,,,ENST00000367858.5,,,,,75,GRCh37,,,,,,
694,BRAF,673,G596C,,5,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,7,140453149,140453149,C,A,ENST00000288602.6,,,,,75,GRCh37,,,,,,
695,SMARCB1,6598,UNDEREXPRESSION,,5356,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,22,24129150,24176703,,,ENST00000344921.6,,,,,75,GRCh37,,,,,,
696,SMARCB1,6598,DELETION,,5356,variant,127,transcript_ablation,Transcript Ablation,SO:0001893,A feature ablation whereby the deleted region includes a transcript feature.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001893,22,24129150,24176703,,,ENST00000344921.6,,,,,75,GRCh37,,,,,,
697,NF2,4771,LOSS,,3870,variant,161,loss_of_function_variant,Loss Of Function Variant,SO:0002054,A sequence variant whereby the gene product has diminished or abolished function.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002054,22,29999547,30094587,,,ENST00000338641.4,,,,,75,GRCh37,,,,,,
698,NF1,4763,LOSS,,3867,variant,161,loss_of_function_variant,Loss Of Function Variant,SO:0002054,A sequence variant whereby the gene product has diminished or abolished function.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002054,17,29421945,29704695,,,ENST00000358273.4,,,,,75,GRCh37,,,,,,
699,SH2B3,10019,RS3184504,,7954,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,12,111884608,111884608,T,C,ENST00000341259.2,,,,,75,GRCh37,970,polymorphic_sequence_variant,Polymorphic Sequence Variant,SO:0001025,A sequence variant that is segregating in one or more natural populations of a species.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001025
700,KIF23,9493,EXPRESSION,,7502,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,15,69706688,69740756,,,ENST00000260363.4,,,,,75,GRCh37,,,,,,
701,ERBB3,2065,V104M,,1733,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,12,56478854,56478854,G,A,ENST00000267101.3,,,,,75,GRCh37,,,,,,
702,ERBB3,2065,R103G,,1733,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,12,56478851,56478851,C,G,ENST00000267101.3,,,,,75,GRCh37,,,,,,
703,ERBB3,2065,G284R,,1733,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,12,56481922,56481922,G,A,ENST00000267101.3,,,,,75,GRCh37,,,,,,
705,GADD45A,1647,rs681673,,1411,variant,138,coding_transcript_intron_variant,Coding Transcript Intron Variant,SO:0001969,A transcript variant occurring within an intron of a coding transcript.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001969,1,68152388,68152388,T,C,ENST00000370986.4,,,,,75,GRCh37,,,,,,
706,EWSR1,2130,EWSR1-FLI1,"In approximately 90% of Ewing sarcoma/primitive neuroectodermal tumor (ES/PNET) a translocation t(11;22)(q24; q12) is identified, fusing the 5 exons (containing the transactivatin domain, at least exon 1-7) of EWSR1, with the 3 exons (from exon 9, coding the DNA binding domain) of FLI1.",54,variant,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886,22,29664307,29688158,,,ENST00000414183.2,11,128638013,128683162,ENST00000527786.2,75,GRCh37,,,,,,
707,TMPRSS2,7113,TMPRSS2-ERG,,5813,variant,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886,21,42879877,42879992,,,ENST00000398585.3,21,39751949,39817544,ENST00000398910.1,75,GRCh37,,,,,,
708,BRCA2,675,TRUNCATING MUTATION,,7,variant,130,feature_truncation,Feature Truncation,SO:0001906,"A sequence variant that causes the reduction of a genomic feature, with regard to the reference sequence.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001906,,,,,,,,,,,,,,,,,,
709,BRCA1,672,Alu insertion,,6,variant,,,,,,,,,,,,,,,,,,,,,,,,
711,KLLN,100144748,PROMOTER METHYLATION,,32083,variant,274,gene_silenced_by_DNA_methylation,Gene Silenced By Dna Methylation,SO:0000129,A gene that is silenced by DNA methylation.,http://www.sequenceontology.org/browser/current_svn/term/SO:0000129,,,,,,,,,,,,,,,,,,
712,EGFR,1956,D761Y,,19,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,7,55242511,55242511,G,T,ENST00000275493.2,,,,,75,GRCh37,,,,,,
713,CRBN,51185,MUTATION,,11761,variant,,,,,,,3,3191695,3221394,,,ENST00000231948.4,,,,,75,GRCh37,,,,,,
714,TSC1,7248,R1062W,,46,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,9,135771933,135771933,G,A,ENST00000298552.3,,,,,75,GRCh37,,,,,,
715,STK11,6794,MUTATION,,5534,variant,30,gene_variant,Gene Variant,SO:0001564,A sequence variant where the structure of the gene is changed.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001564,19,1205740,1223074,,,ENST00000326873.7,,,,,75,GRCh37,,,,,,
716,PDGFRA,5156,AMPLIFICATION,,38,variant,123,transcript_amplification,Transcript Amplification,SO:0001889,A feature amplification of a region containing a transcript.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001889,4,55095264,55164414,,,ENST00000257290.5,,,,,75,GRCh37,,,,,,
717,DDIT3,1649,EWSR1-DDIT3,,1413,variant,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886,22,29664307,29687588,,,ENST00000414183.2,12,57910376,57911536,ENST00000346473.3,75,GRCh37,,,,,,
718,EGFR,1956,G719,,19,variant,103,protein_altering_variant,Protein Altering Variant,SO:0001818,A sequence_variant which is predicted to change the protein encoded in the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001818,7,55241707,55241708,,,ENST00000275493.2,,,,,75,GRCh37,,,,,,
719,BRD4,23476,BRD4-NUTM1,,9588,variant,,,,,,,,,,,,,,,,,,,,,,,,
720,EGFR,1956,S720,,19,variant,103,protein_altering_variant,Protein Altering Variant,SO:0001818,A sequence_variant which is predicted to change the protein encoded in the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001818,7,55241710,55241711,,,ENST00000275493.2,,,,,75,GRCh37,,,,,,
721,CYP2D6,1565,LOSS-OF-FUNCTION,,1342,variant,161,loss_of_function_variant,Loss Of Function Variant,SO:0002054,A sequence variant whereby the gene product has diminished or abolished function.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002054,22,42522501,42526908,,,ENST00000360608.5,,,,,75,GRCh37,,,,,,
722,DDIT3,1649,FUS-DDIT3,,1413,variant,31,gene_fusion,Gene Fusion,SO:0001565,A sequence variant whereby a two genes have become joined.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001565,,,,,,,,,,,,,,,,,,
723,EGFR,1956,K757R,,19,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,7,55242500,55242500,A,G,ENST00000275493.2,,,,,75,GRCh37,,,,,,
724,EGFR,1956,E746G,,19,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,7,55242467,55242467,A,G,ENST00000275493.2,,,,,75,GRCh37,,,,,,
725,MLH1,4292,E13FS*3,,3532,variant,134,frameshift_truncation,Frameshift Truncation,SO:0001910,A frameshift variant that causes the translational reading frame to be shortened relative to the reference feature.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001910,3,37035075,37035075,G,,ENST00000231790.2,,,,,75,GRCh37,,,,,,
726,EGFR,1956,EXON 20 INSERTION,,19,variant,106,inframe_insertion,Inframe Insertion,SO:0001821,An inframe non synonymous variant that inserts bases into in the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001821,7,55248991,55249022,,,ENST00000275493.2,,,,,75,GRCh37,,,,,,
727,MSH2,4436,R383*,,3628,variant,50,stop_gained,Stop Gained,SO:0001587,"A sequence variant whereby at least one base of a codon is changed, resulting in a premature stop codon, leading to a shortened polypeptide.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001587,2,47656951,47656951,C,T,ENST00000233146.2,,,,,75,GRCh37,,,,,,
728,MLH1,4292,V534R,,3532,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,3,37081718,37081719,GT,AG,ENST00000231790.2,,,,,75,GRCh37,,,,,,
729,UGT1A1,54658,UGT1A1*28,,12422,variant,419,microsatellite,Microsatellite,SO:0000289,A repeat_region containing repeat_units of 2 to 10 bp repeated in tandem.,http://www.sequenceontology.org/browser/current_svn/term/SO:0000289,2,234668881,234668882,,TATATATATATATA,ENST00000305208.5,,,,,75,GRCh37,,,,,,
730,MLH1,4292,G606FS*2,,3532,variant,134,frameshift_truncation,Frameshift Truncation,SO:0001910,A frameshift variant that causes the translational reading frame to be shortened relative to the reference feature.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001910,3,37089094,37089095,GG,,ENST00000231790.2,,,,,75,GRCh37,,,,,,
731,MLH1,4292,C.790+1G>A,,3532,variant,41,splice_donor_variant,Splice Donor Variant,SO:0001575,A splice variant that changes the 2 base pair region at the 5' end of an intron.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001575,3,37056036,37056036,G,A,ENST0000023170.2,,,,,75,GRCh37,,,,,,
732,UGT1A1,54658,UGT1A1*60,,12422,variant,419,microsatellite,Microsatellite,SO:0000289,A repeat_region containing repeat_units of 2 to 10 bp repeated in tandem.,http://www.sequenceontology.org/browser/current_svn/term/SO:0000289,,,,,,,,,,,,,,,,,,
733,MLH1,4292,K618DEL,,3532,variant,107,inframe_deletion,Inframe Deletion,SO:0001822,An inframe non synonymous variant that deletes bases from the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001822,3,37089130,37089132,AAG,,ENST00000231790.2,,,,,75,GRCh37,,,,,,
734,MLH1,4292,P138T,,3532,variant,,,,,,,,,,,,,,,,,,,,,,,,
735,MLH1,4292,R687FS,,3532,variant,51,frameshift_variant,Frameshift Variant,SO:0001589,"A sequence variant which causes a disruption of the translational reading frame, because the number of nucleotides inserted or deleted is not a multiple of three.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001589,3,37090464,37090464,C,,ENST00000231790.2,,,,,75,GRCh37,,,,,,
736,EGFR,1956,V769_770insASV,,19,variant,716,insertion,Insertion,SO:0000667,The sequence of one or more nucleotides added between two adjacent nucleotides in the sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0000667,7,55249009,55249010,,,ENST00000275493.2,,,,,75,GRCh37,,,,,,
737,DPYD,1806,DPYD*2A HOMOZYGOSITY,,1526,variant,41,splice_donor_variant,Splice Donor Variant,SO:0001575,A splice variant that changes the 2 base pair region at the 5' end of an intron.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001575,1,97915614,97915614,C,T,ENST00000370192.3,,,,,75,GRCh37,,,,,,
738,DPYD,1806,DPYD*13 HOMOZYGOSITY,,1526,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,1,97981343,97981343,A,C,ENST00000370192.3,,,,,75,GRCh37,,,,,,
739,FOS,2353,TRUNCATING FUSION,,1955,variant,50,stop_gained,Stop Gained,SO:0001587,"A sequence variant whereby at least one base of a codon is changed, resulting in a premature stop codon, leading to a shortened polypeptide.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001587,14,75745477,75748127,,,ENST00000303562.4,,,,,75,GRCh37,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886
740,DPYD,1806,RS67376798 HOMOZYGOSITY,,1526,variant,970,polymorphic_sequence_variant,Polymorphic Sequence Variant,SO:0001025,A sequence variant that is segregating in one or more natural populations of a species.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001025,,,,,,,,,,,,,,,,,,
741,MLH1,4292,R100*,,3532,variant,50,stop_gained,Stop Gained,SO:0001587,"A sequence variant whereby at least one base of a codon is changed, resulting in a premature stop codon, leading to a shortened polypeptide.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001587,3,37042536,37042536,C,T,ENST00000231790.2,,,,,75,GRCh37,,,,,,
742,WWTR1,25937,WWTR1-CAMTA1,,9952,variant,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886,3,149235022,149290787,,,ENST00000465804.1,1,7721786,7829766,ENST00000303635.7,75,GRCh37,,,,,,
743,MLH1,4292,T117M,,3532,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,3,37045935,37045935,C,T,ENST00000231790.2,,,,,75,GRCh37,,,,,,
744,MLH1,4292,Q426FS,,3532,variant,134,frameshift_truncation,Frameshift Truncation,SO:0001910,A frameshift variant that causes the translational reading frame to be shortened relative to the reference feature.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001910,3,37067365,37067365,C,,ENST00000231790.2,,,,,75,GRCh37,,,,,,
745,MLH1,4292,V49A,,3532,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,3,37038139,37038139,T,C,ENST00000231790.2,,,,,75,GRCh37,,,,,,
746,MLH1,4292,D667FS,,3532,variant,134,frameshift_truncation,Frameshift Truncation,SO:0001910,A frameshift variant that causes the translational reading frame to be shortened relative to the reference feature.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001910,3,37090406,37090406,C,,ENST00000231790.2,,,,,75,GRCh37,,,,,,
747,MLH1,4292,M1L,,3532,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,3,37035039,37035039,A,T,ENST00000231790.2,,,,,75,GRCh37,,,,,,
748,MLH1,4292,*757L,,3532,variant,44,stop_lost,Stop Lost,SO:0001578,"A sequence variant where at least one base of the terminator codon (stop) is changed, resulting in an elongated transcript.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001578,3,37092143,37092143,A,T,ENST00000231790.2,,,,,75,GRCh37,,,,,,
749,MLH1,4292,R265G,,3532,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,3,37058999,37058999,C,G,ENST00000231790.2,,,,,75,GRCh37,,,,,,
750,MLH1,4292,V213FS,,3532,variant,134,frameshift_truncation,Frameshift Truncation,SO:0001910,A frameshift variant that causes the translational reading frame to be shortened relative to the reference feature.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001910,3,37053551,37053551,T,,ENST00000231790.2,,,,,75,GRCh37,,,,,,
751,MLH1,4292,N551T,,3532,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,3,37081770,37081770,A,C,ENST00000231790.2,,,,,75,GRCh37,,,,,,
752,MLH1,4292,A424T,,3532,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,3,37067359,37067359,G,A,ENST00000231790.2,,,,,75,GRCh37,,,,,,
753,MLH1,4292,Q149*,,3532,variant,50,stop_gained,Stop Gained,SO:0001587,"A sequence variant whereby at least one base of a codon is changed, resulting in a premature stop codon, leading to a shortened polypeptide.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001587,3,37048546,37048546,C,T,ENST00000231790.2,,,,,75,GRCh37,,,,,,
754,MLH1,4292,R226*,,3532,variant,50,stop_gained,Stop Gained,SO:0001587,"A sequence variant whereby at least one base of a codon is changed, resulting in a premature stop codon, leading to a shortened polypeptide.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001587,3,37053589,37053589,C,T,ENST00000231790.2,,,,,75,GRCh37,,,,,,
755,MSH6,2956,I972F,,2478,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,2,48028036,48028036,A,T,ENST00000234420.5,,,,,75,GRCh37,,,,,,
756,MLH1,4292,P536FS,,3532,variant,134,frameshift_truncation,Frameshift Truncation,SO:0001910,A frameshift variant that causes the translational reading frame to be shortened relative to the reference feature.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001910,3,37081726,37081726,T,,ENST00000231790.2,,,,,75,GRCh37,,,,,,
757,MLH1,4292,G67R,,3532,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,3,37038192,37038192,G,A,ENST00000231790.2,,,,,75,GRCh37,,,,,,
758,MLH1,4292,I68S,,3532,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,3,37038196,37038196,T,G,ENST00000231790.2,,,,,75,GRCh37,,,,,,
759,MLH1,4292,G65D,,3532,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,3,37038187,37038187,G,A,ENST00000231790.2,,,,,75,GRCh37,,,,,,
760,MLH1,4292,A681V,,3532,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,3,37090447,37090447,C,T,ENST00000231790.2,,,,,75,GRCh37,,,,,,
761,MSH6,2956,P138T,,2478,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,2,48018217,48018217,C,A,ENST00000234420.5,,,,,75,GRCh37,,,,,,
762,MSH2,4436,V273FS,,3628,variant,51,frameshift_variant,Frameshift Variant,SO:0001589,"A sequence variant which causes a disruption of the translational reading frame, because the number of nucleotides inserted or deleted is not a multiple of three.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001589,2,47641433,47641433,T,,ENST00000233146.2,,,,,75,GRCh37,,,,,,
763,MSH2,4436,E28FS,,3628,variant,133,frameshift_elongation,Frameshift Elongation,SO:0001909,A frameshift variant that causes the translational reading frame to be extended relative to the reference feature.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001909,2,47630413,47630414,,G,ENST00000233146.2,,,,,75,GRCh37,,,,,,
764,VHL,7428,E55FS (c.163_164delGA),,58,variant,134,frameshift_truncation,Frameshift Truncation,SO:0001910,A frameshift variant that causes the translational reading frame to be shortened relative to the reference feature.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001910,3,10183694,10183695,GA,,ENST00000256474.2,,,,,75,GRCh37,,,,,,
765,MSH6,2956,I891FS,,2478,variant,134,frameshift_truncation,Frameshift Truncation,SO:0001910,A frameshift variant that causes the translational reading frame to be shortened relative to the reference feature.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001910,2,48027794,48027795,TC,,ENST00000234420.5,,,,,75,GRCh37,,,,,,
766,VHL,7428,E55RfsTer11 (c.163delG),,58,variant,134,frameshift_truncation,Frameshift Truncation,SO:0001910,A frameshift variant that causes the translational reading frame to be shortened relative to the reference feature.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001910,3,10183694,10183694,G,,ENST00000256474.2,,,,,75,GRCh37,,,,,,
767,MSH6,2956,R1242H,,2478,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,2,48033421,48033421,G,A,ENST00000234420.5,,,,,75,GRCh37,,,,,,
768,PMS2,5395,R315*,,4371,variant,50,stop_gained,Stop Gained,SO:0001587,"A sequence variant whereby at least one base of a codon is changed, resulting in a premature stop codon, leading to a shortened polypeptide.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001587,7,6031649,6031649,G,A,ENST00000265849.7,,,,,75,GRCh37,,,,,,
769,MLH1,4292,M490T,,3532,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,3,37070334,37070334,T,C,ENST00000231790.2,,,,,75,GRCh37,,,,,,
770,MSH2,4436,K172*,,3628,variant,50,stop_gained,Stop Gained,SO:0001587,"A sequence variant whereby at least one base of a codon is changed, resulting in a premature stop codon, leading to a shortened polypeptide.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001587,2,47637380,47637380,A,T,ENST00000233146.2,,,,,75,GRCh37,,,,,,
771,VHL,7428,A56FS (c.164_165insG),,58,variant,134,frameshift_truncation,Frameshift Truncation,SO:0001910,A frameshift variant that causes the translational reading frame to be shortened relative to the reference feature.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001910,3,10183695,10183696,,G,ENST00000256474.2,,,,,75,GRCh37,,,,,,
772,HOXB13,10481,G84E,,8351,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,17,46805705,46805705,C,T,ENST00000290295.7,,,,,75,GRCh37,,,,,,
773,MSH2,4436,E483G,,3628,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,2,47690231,47690231,A,G,ENST00000233146.2,,,,,75,GRCh37,,,,,,
774,PDGFRA,5156,TNKS2-PDGFRA,,38,variant,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886,10,93558069,93619405,,,ENST00000371627.4,4,55141008,55164414,ENST00000257290.5,75,GRCh37,,,,,,
775,MSH6,2956,V352I,,2478,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,2,48026176,48026176,G,A,ENST00000234420.5,,,,,75,GRCh37,,,,,,
776,MSH6,2956,R1242C,,2478,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,2,48033420,48033420,C,T,ENST00000234420.5,,,,,75,GRCh37,,,,,,
777,SLCO1B1,10599,RS4149056,,8450,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,12,21331549,21331549,T,C,ENST00000256958.2,,,,,75,GRCh37,970,polymorphic_sequence_variant,Polymorphic Sequence Variant,SO:0001025,A sequence variant that is segregating in one or more natural populations of a species.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001025
778,SLCO1B1,10599,N130D,,8450,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,12,21329738,21329738,A,G,ENST00000256958.2,,,,,75,GRCh37,,,,,,
779,TYMS,7298,RS34743033,,5971,variant,,,,,,,18,657646,657646,C,T,ENST00000323274.10,,,,,75,,,,,,,
780,GLI1,2735,ACTB-GLI1,"Fusion of the hedgehog pathway component gene GLI1 to the -actin gene (ACTB)  has been described as a mechanism of GLI1,and by extension hedgehog pathway, activation. These fusions have been described in histologically distinctive soft tissue tumours showing a pericytic phenotype.  Gene fusions retain the DNA-binding zinc finger domains of GLI1 and it is likely that the replacement of the promoter region of GLI1with that of the ubiquitously expressed ACTB gene leads to deregulation of GLI expression and its downstream target genes.",2279,variant,31,gene_fusion,Gene Fusion,SO:0001565,A sequence variant whereby a two genes have become joined.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001565,,,,,,,,,,,,,,,,,,
781,ERBB3,2065,V855A,,1733,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,12,56491672,56491672,T,C,ENST000000267101.3,,,,,75,GRCh37,,,,,,
782,FGFR2,2263,FGFR2-BICC1,,22,variant,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886,10,123239371,123357917,,,ENST00000457416.2,10,60461834,60591195,ENST00000373886.3,75,GRCh37,,,,,,
783,FGFR2,2263,FGFR2-AHCYL1,,22,variant,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886,10,123239371,123357917,,,ENST00000457416.2,1,110554984,110566357,ENST00000369799.5,75,GRCh37,,,,,,
784,CDKN2B,1030,METHYLATION,,916,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,9,22009121,22009172,,,ENST00000276925.6,,,,,75,GRCh37,,,,,,
785,CHEK2,11200,1100DELC,,8950,variant,134,frameshift_truncation,Frameshift Truncation,SO:0001910,A frameshift variant that causes the translational reading frame to be shortened relative to the reference feature.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001910,22,29091857,29091857,G,,ENST00000328354.6,,,,,75,GRCh37,,,,,,
787,CHEK2,11200,I157T,,8950,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,22,29121087,29121087,A,G,ENST00000328354.6,,,,,75,GRCh37,,,,,,
788,CHEK2,11200,IVS2+1G>A,,8950,variant,,,,,,,,,,,,,,,,,,,,,,,,
792,PTPRD,5789,V253I,,4692,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,9,8521481,8521481,C,T,ENST00000381196.4,,,,,75,GRCh37,,,,,,
793,VHL,7428,A56FS (c.164_165insA),,58,variant,134,frameshift_truncation,Frameshift Truncation,SO:0001910,A frameshift variant that causes the translational reading frame to be shortened relative to the reference feature.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001910,3,10183695,10183696,,A,ENST00000256474.2,,,,,75,GRCh37,,,,,,
794,VHL,7428,E55E (c.165G>A),,58,variant,1,silent_mutation,Silent Mutation,SO:0001017,"A sequence variant that does not affect protein function. Silent mutations may occur in genic ( CDS, UTR, intron etc) and intergenic regions. Silent mutations may have affects on processes such as splicing and regulation.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001017,3,10183696,10183696,G,A,ENST00000256474.2,,,,,75,GRCh37,,,,,,
795,RRM1,6240,OVEREXPRESSION,,5051,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,11,4116039,4160106,,,ENST00000300738.5,,,,,75,GRCh37,,,,,,
796,RRM2,6241,OVEREXPRESSION,,5052,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,2,10262455,10271545,,,ENST00000360566.2,,,,,75,GRCh37,,,,,,
797,POLE,5426,MUTATION,,4386,variant,30,gene_variant,Gene Variant,SO:0001564,A sequence variant where the structure of the gene is changed.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001564,12,133202900,133256623,,,ENST00000320574.5,,,,,75,GRCh37,,,,,,
798,MET,4233,D1228V,,52,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,7,116423408,116423408,A,T,ENST00000397752.3,,,,,75,GRCh37,,,,,,
799,RB1,5925,MUTATION,,4795,variant,30,gene_variant,Gene Variant,SO:0001564,A sequence variant where the structure of the gene is changed.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001564,13,48877911,49056122,,,ENST00000267163.4,,,,,75,GRCh37,,,,,,
800,NTRK1,4914,SQSTM1-NTRK1,,3983,variant,,,,,,,,,,,,,,,,,,,,,,,,
801,NTRK3,4916,ETV6-NTRK3,,3985,variant,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886,12,11802788,12022903,,,ENST00000396373.4,15,88483984,88418230,ENST00000394480.2,75,GRCh37,,,,,,
802,RUNX1,861,K83E,,43,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,21,36259163,36259163,T,C,ENST00000344691.4,,,,,75,GRCh37,,,,,,
803,RUNX1,861,Y260*,,43,variant,50,stop_gained,Stop Gained,SO:0001587,"A sequence variant whereby at least one base of a codon is changed, resulting in a premature stop codon, leading to a shortened polypeptide.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001587,21,36171704,36171704,G,T,ENST00000344691.4,,,,,75,GRCh37,,,,,,
804,RUNX1,861,R135FSX177,,43,variant,,,,,,,,,,,,,,,,,,,,,,,,
805,NTRK3,4916,ETV6-NTRK3 G623R,,3985,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,15,88476265,88476265,C,T,ENST00000394480.2,,,,,75,GRCh37,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886
806,RUNX1,861,D198Y,"D198Y was observed in a pedigree with a history of Familial platelet disorder with predisposition to acute myeloid leukemia. It occurs within the Runt domain of RUNX1, known to be associated with the disease.",43,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,21,36231792,36231792,C,A,ENST00000300305.3,,,,,75,GRCh37,161,loss_of_function_variant,Loss Of Function Variant,SO:0002054,A sequence variant whereby the gene product has diminished or abolished function.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002054
807,RUNX1,861,A107P,,43,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,21,36252962,36252962,C,G,ENST00000344691.4,,,,,75,GRCh37,,,,,,
808,MSH2,4436,LOSS,,3628,variant,161,loss_of_function_variant,Loss Of Function Variant,SO:0002054,A sequence variant whereby the gene product has diminished or abolished function.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002054,2,47630108,47710367,,,ENST00000233146.2,,,,,75,GRCh37,,,,,,
809,MSH6,2956,LOSS,,2478,variant,161,loss_of_function_variant,Loss Of Function Variant,SO:0002054,A sequence variant whereby the gene product has diminished or abolished function.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002054,2,48010221,48037240,,,ENST00000234420.5,,,,,75,GRCh37,,,,,,
810,RUNX1,861,T148HFSX9,,43,variant,134,frameshift_truncation,Frameshift Truncation,SO:0001910,A frameshift variant that causes the translational reading frame to be shortened relative to the reference feature.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001910,21,36252913,36252920,GCTGCGGT,,ENST00000300305.3,,,,,75,GRCh37,,,,,,
811,ETV6,2120,R399C,,1769,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,12,12038902,12038902,C,T,ENST00000396373.4,,,,,75,GRCh37,,,,,,
812,ETV6,2120,R369Q,,1769,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,12,12037475,12037475,G,A,ENST00000396373.4,,,,,75,GRCh37,,,,,,
813,ETV6,2120,P214L,,1769,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,12,12022535,12022535,C,T,ENST00000396373.4,,,,,75,GRCh37,,,,,,
814,DDX41,51428,R164W,,11932,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,5,176942767,176942767,G,A,ENST00000507955.1,,,,,75,GRCh37,,,,,,
815,ERBB2,2064,Y772_A775DUP,,20,variant,106,inframe_insertion,Inframe Insertion,SO:0001821,An inframe non synonymous variant that inserts bases into in the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001821,17,37880996,37880997,,,ENST00000269571.5,,,,,75,GRCh37,,,,,,
816,ERBB2,2064,G776L,,20,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,17,37880997,37880998,GG,CT,ENST00000269571.5,,,,,75,GRCh37,,,,,,
817,ERBB2,2064,G778_P780DUP,,20,variant,,,,,,,17,37881011,37881012,,,ENST00000269571.5,,,,,75,GRCh37,,,,,,
818,ERBB2,2064,M774DELINSWLV,,20,variant,105,inframe_indel,Inframe Indel,SO:0001820,A coding sequence variant where the change does not alter the frame of the transcript.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001820,17,37880991,37880991,A,TGGCTGG,ENST00000269571.5,,,,,75,GRCh37,,,,,,
819,PTPRB,5787,LOSS-OF-FUNCTION,,4690,variant,161,loss_of_function_variant,Loss Of Function Variant,SO:0002054,A sequence variant whereby the gene product has diminished or abolished function.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002054,12,70910630,71031220,,,ENST00000334414.6,,,,,75,GRCh37,,,,,,
820,VHL,7428,A149S (c.445G>T),,58,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,3,10188302,10188302,G,T,ENST00000256474.2,,,,,75,GRCh37,,,,,,
821,HLA-C,3107,COPY-NEUTRAL LOSS OF HETEROZYGOSITY,,2608,variant,,,,,,,,,,,,,,,,,,,,,,,,
822,JAK1,3716,S703I,,3090,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,1,65311203,65311203,C,A,ENST00000342505.4,,,,,75,GRCh37,,,,,,
823,EPCAM,4072,3' EXON DELETION,,3364,variant,111,disruptive_inframe_deletion,Disruptive Inframe Deletion,SO:0001826,An inframe decrease in cds length that deletes bases from the coding sequence starting within an existing codon.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001826,2,47612305,47614173,,,ENST00000263735,,,,,75,GRCh37,,,,,,
824,MAP2K1,5604,K57T,,31,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,15,66727454,66727454,A,C,ENST00000307102.5,,,,,75,GRCh37,,,,,,
825,ARAF,369,S490T,,3,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,X,47429340,47429340,T,A,ENST00000377045.4,,,,,75,GRCh37,,,,,,
826,GNAS,2778,R201C,,2319,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,20,57484420,57484420,C,T,ENST00000371085.3,,,,,75,GRCh37,,,,,,
827,FGFR3,2261,MUTATION,,23,variant,,,,,,,,,,,,,,,,,,,,,,,,
828,FGFR2,2263,FUSION,,22,variant,,,,,,,,,,,,,,,,,,,,,,,,
829,VHL,7428,M54IFS (c.162_166delGGAGG),,58,variant,134,frameshift_truncation,Frameshift Truncation,SO:0001910,A frameshift variant that causes the translational reading frame to be shortened relative to the reference feature.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001910,3,10183693,10183697,GGAGG,,ENST00000256474.2,,,,,75,GRCh37,,,,,,
830,FGFR3,2261,FGFR3-TACC3,,23,variant,,,,,,,,,,,,,,,,,,,,,,,,
837,SMO,6608,W535L,,5365,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,7,128850341,128850341,G,T,ENST00000249373.3,,,,,75,GRCh37,,,,,,
838,PTEN,5728,R173C,,41,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,10,89711899,89711899,C,T,ENST00000371953.3,,,,,75,GRCh37,,,,,,
839,ALK,238,ALTERNATIVE TRANSCRIPT (ATI),This novel ALK transcript (alternative isoform) initiates from a de novo alternative transcription initiation (ATI) site in ALK intron 19.,1,variant,,,,,,,,,,,,,,,,,,,,,,,,
840,BRAF,673,G469R,,5,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,7,140481403,140481403,C,G,ENST00000288602.6,,,,,75,GRCh37,,,,,,
841,BRAF,673,G469V,,5,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,7,140481402,140481402,C,A,ENST00000288602.6,,,,,75,GRCh37,,,,,,
842,BRAF,673,APC,,5,variant,,,,,,,,,,,,,,,,,,,,,,,,
843,VHL,7428,EXON 1-3 DELETION,,58,variant,38,exon_loss_variant,Exon Loss Variant,SO:0001572,A sequence variant whereby an exon is lost from the transcript.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001572,3,10183532,10191649,,,ENST00000256474.2,,,,,75,GRCh37,,,,,,
844,VHL,7428,EXON 1 DELETION,,58,variant,38,exon_loss_variant,Exon Loss Variant,SO:0001572,A sequence variant whereby an exon is lost from the transcript.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001572,3,10183532,10183871,,,ENST00000256474.2,,,,,75,GRCh37,,,,,,
845,VHL,7428,EXON 1-2 DELETION,,58,variant,38,exon_loss_variant,Exon Loss Variant,SO:0001572,A sequence variant whereby an exon is lost from the transcript.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001572,3,10183532,10188320,,,ENST00000256474.2,,,,,75,GRCh37,,,,,,
846,VHL,7428,M1FS (c.1_17del17),,58,variant,151,start_lost,Start Lost,SO:0002012,A codon variant that changes at least one base of the canonical start codon.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002012,3,10183532,10183548,ATGCCCCGGAGGGCGGA,,ENST00000256474.2,,,,,75,GRCh37,,,,,,
847,VHL,7428,M1? (c.1-1_20del21),,58,variant,151,start_lost,Start Lost,SO:0002012,A codon variant that changes at least one base of the canonical start codon.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002012,3,10183531,10183551,AATGCCCCGGAGGGCGGAGAA,,ENST00000256474.2,,,,,75,GRCh37,,,,,,
848,VHL,7428,M1? (c.3G>A),,58,variant,151,start_lost,Start Lost,SO:0002012,A codon variant that changes at least one base of the canonical start codon.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002012,3,10183534,10183534,G,A,ENST00000256474.2,,,,,75,GRCh37,,,,,,
849,VHL,7428,N7D (c.19A>G),,58,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,3,10183550,10183550,A,G,ENST00000256474.2,,,,,75,GRCh37,,,,,,
850,VHL,7428,P25L (c.74C>T),,58,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,3,10183605,10183605,C,T,ENST00000256474.2,,,,,75,GRCh37,,,,,,
851,VHL,7428,P59fs (c.173_174insC),,58,variant,134,frameshift_truncation,Frameshift Truncation,SO:0001910,A frameshift variant that causes the translational reading frame to be shortened relative to the reference feature.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001910,3,10183704,10183705,,C,ENST00000256474.2,,,,,75,GRCh37,,,,,,
852,VHL,7428,Y98FS (c.291_310DEL20),,58,variant,134,frameshift_truncation,Frameshift Truncation,SO:0001910,A frameshift variant that causes the translational reading frame to be shortened relative to the reference feature.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001910,3,10183822,10183841,CTACCCAACGCTGCCGCCTG,,ENST00000256474.2,,,,,75,GRCh37,,,,,,
853,NBN,4683,LOSS,,3801,variant,161,loss_of_function_variant,Loss Of Function Variant,SO:0002054,A sequence variant whereby the gene product has diminished or abolished function.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002054,8,90945564,90996944,,,ENST00000265433.3,,,,,75,GRCh37,,,,,,
854,HRAS,3265,Q61L,,2747,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,11,533874,533874,T,A,ENST00000451590.1,,,,,75,GRCh37,,,,,,
855,KIT,3815,EXON 8 MUTATION,,29,variant,,,,,,,,,,,,,,,,,,,,,,,,
856,CREBBP,1387,DELETION,,1193,variant,,,,,,,,,,,,,,,,,,,,,,,,
857,NTRK3,4916,EXPRESSION,,3985,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,15,88418230,88799978,,,ENST00000394480.2,,,,,75,GRCh37,,,,,,
858,CSF1,1435,OVEREXPRESSION,,1234,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,1,110453255,110473614,,,ENST00000329608.6,,,,,75,GRCh37,,,,,,
859,ROS1,6098,OVEREXPRESSION,,4941,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,6,117609463,117747018,,,ENST00000368508.3,,,,,75,GRCh37,,,,,,
860,NTRK1,4914,EXPRESSION,,3983,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,1,156830686,156851434,,,ENST00000524377.1,,,,,75,GRCh37,,,,,,
861,EGFR,1956,T725M,,19,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,7,55241726,55241726,C,T,ENST00000275493.2,,,,,75,GRCh37,,,,,,
862,PDGFRA,5156,P577S,,38,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,4,55141083,55141083,C,T,ENST00000257290.5,,,,,75,GRCh37,,,,,,
863,PDGFRA,5156,R841K,,38,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,4,55152090,55152090,G,A,ENST00000257290.5,,,,,75,GRCh37,,,,,,
864,PDGFRA,5156,H845Y,,38,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,4,55152101,55152101,C,T,ENST00000257290.5,,,,,75,GRCh37,,,,,,
865,PDGFRA,5156,G853D,,38,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,4,55152126,55152126,G,A,ENST00000257290.5,,,,,75,GRCh37,,,,,,
866,MITF,4286,OVEREXPRESSION,,3527,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,3,69788586,70017487,,,ENST00000352241.4,,,,,75,GRCh37,,,,,,
867,MTAP,4507,DELETION,,3659,variant,,,,,,,,,,,,,,,,,,,,,,,,
868,VPS37A,137492,UNDEREXPRESSION,,18353,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,8,17104080,17155533,,,ENST00000324849.4,,,,,75,GRCh37,,,,,,
869,YAP1,10413,OVEREXPRESSION,,8292,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,11,101981192,102104154,,,ENST00000282441.5,,,,,75,GRCh37,,,,,,
870,BTK,695,T316A,,65,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,X,100613633,100613633,T,C,ENST00000308731.7,,,,,75,GRCh37,,,,,,
871,ERBB2,2064,T862A,,20,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,17,37881392,37881392,A,G,ENST00000269571.5,,,,,75,GRCh37,,,,,,
872,ERBB2,2064,V773A,,20,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,17,37880989,37880989,T,C,ENST00000269571.5,,,,,75,GRCh37,,,,,,
873,ERBB2,2064,N857S,,20,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,17,37881378,37881378,A,G,ENST00000269571.5,,,,,75,GRCh37,,,,,,
874,ERBB2,2064,H878Y,,20,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,17,37881440,37881440,C,T,ENST00000269571.5,,,,,75,GRCh37,,,,,,
875,ERBB2,2064,OVEREXPRESSION,,20,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,,,,,,,,,,,,,,,,,,
876,GNAS,2778,MUTATION,,2319,variant,,,,,,,,,,,,,,,,,,,,,,,,
877,GNAS,2778,T393C,,2319,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,20,57428713,57428713,T,C,ENST00000371100,,,,,75,GRCh37,,,,,,
878,NRAS,4893,G12D,,36,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,1,115258747,115258747,C,T,ENST00000369535.4,,,,,75,GRCh37,,,,,,
879,TP53,7157,G245S,,45,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
880,IDH1,3417,R132L,,26,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,2,209113112,209113112,C,A,ENST00000415913.1,,,,,75,GRCh37,,,,,,
881,PIK3CA,5290,E545Q,,37,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,3,178936091,178936091,G,C,ENST00000263967.3,,,,,75,GRCh37,,,,,,
882,PIK3CA,5290,E545A,,37,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,3,178936092,178936092,A,C,ENST00000263967.3,,,,,75,GRCh37,,,,,,
883,PIK3CA,5290,E545G,,37,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,3,178936092,178936092,A,G,ENST00000263967.3,,,,,75,GRCh37,,,,,,
884,PIK3CA,5290,E545V,,37,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,3,178936092,178936092,A,T,ENST00000263967.3,,,,,75,GRCh37,,,,,,
885,PIK3CA,5290,Q546K,,37,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,3,178936094,178936094,C,A,ENST00000263967.3,,,,,75,GRCh37,,,,,,
886,PIK3CA,5290,Q546E,,37,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,3,178936094,178936094,C,G,ENST00000263967.3,,,,,75,GRCh37,,,,,,
890,EGFR,1956,L747_S752del,,19,variant,,,,,,,7,55242469,55242486,,,,,,,,,GRCh37,,,,,,
891,EGFR,1956,S752_I759delSPKANKEI,,19,variant,107,inframe_deletion,Inframe Deletion,SO:0001822,An inframe non synonymous variant that deletes bases from the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001822,,,,,,,,,,,,GRCh37,,,,,,
892,ABL1,25,F359V,,4,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,9,133748414,133748414,T,G,ENST00000318560.5,,,,,75,GRCh37,,,,,,
893,NRAS,4893,Q61H,,36,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,1,115256528,115256528,T,G,ENST00000369535.4,,,,,75,GRCh37,,,,,,
895,NRAS,4893,G13C,,36,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,1,115258745,115258745,C,A,ENST00000369535.4,,,,,75,GRCh37,,,,,,
896,NRAS,4893,G13R,,36,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,1,115258745,115258745,C,G,ENST00000369535.4,,,,,75,GRCh37,,,,,,
897,NRAS,4893,G12C,,36,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,1,115258748,115258748,C,A,ENST00000369535.4,,,,,75,GRCh37,,,,,,
898,NRAS,4893,G12S,,36,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,1,115258748,115258748,C,T,ENST00000369535.4,,,,,75,GRCh37,,,,,,
901,ATM,472,T2666A,,69,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,11,108204681,108204681,A,G,ENST00000278616.4,,,,,75,GRCh37,,,,,,
902,ATM,472,L2890V,,69,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,11,108218089,108218089,C,G,ENST00000278616.4,,,,,75,GRCh37,,,,,,
903,ATM,472,R3008C,,69,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,11,108236086,108236086,C,T,ENST00000278616.4,,,,,75,GRCh37,,,,,,
904,ATM,472,R3008H,,69,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,11,108236087,108236087,G,A,ENST00000278616.4,,,,,75,GRCh37,,,,,,
905,KRAS,3845,A146P,,30,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,12,25378562,25378562,C,G,ENST00000256078.4,,,,,75,GRCh37,,,,,,
906,KRAS,3845,A146T,,30,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,12,25378562,25378562,C,T,ENST00000256078.4,,,,,75,GRCh37,,,,,,
907,KRAS,3845,Q61H,,30,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,12,25380275,25380275,T,G,ENST00000256078.4,,,,,75,GRCh37,,,,,,
908,KRAS,3845,Q61L,,30,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,12,25380276,25380276,T,A,ENST00000256078.4,,,,,75,GRCh37,,,,,,
909,KRAS,3845,Q61R,,30,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,12,25380276,25380276,T,C,ENST00000256078.4,,,,,75,GRCh37,,,,,,
910,KRAS,3845,Q61K,,30,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,12,25380277,25380277,G,T,ENST00000256078.4,,,,,75,GRCh37,,,,,,
911,KRAS,3845,G13C,,30,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,12,25398282,25398282,C,A,ENST00000256078.4,,,,,75,GRCh37,,,,,,
913,KRAS,3845,G12S,,30,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,12,25398285,25398285,C,T,ENST00000256078.4,,,,,75,GRCh37,,,,,,
918,TP53,7157,R273L,,45,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,17,7577120,7577120,C,A,ENST00000269305.4,,,,,75,GRCh37,,,,,,
922,TP53,7157,Y220C,,45,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,17,7578190,7578190,T,C,ENST00000269305.4,,,,,75,GRCh37,,,,,,
925,STK11,6794,LKB1,,5534,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
927,IDH1,3417,R132G,,26,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,2,209113113,209113113,G,C,ENST00000415913.1,,,,,75,GRCh37,,,,,,
928,IDH1,3417,R132S,,26,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,2,209113113,209113113,G,T,ENST00000415913.1,,,,,75,GRCh37,,,,,,
930,PIK3CA,5290,N345K,,37,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,,,,,,,,,,,,GRCh37,,,,,,
931,PIK3CA,5290,C420R,,37,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,3,178927980,178927980,T,C,ENST00000263967.3,,,,,75,GRCh37,,,,,,
933,PIK3CA,5290,E542Q,,37,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,3,178936082,178936082,G,C,ENST00000263967.3,,,,,75,GRCh37,,,,,,
934,PIK3CA,5290,E545D,,37,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,3,178936093,178936093,G,C,ENST00000263967.3,,,,,75,GRCh37,,,,,,
935,PIK3CA,5290,Y1021C,,37,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,3,178952007,178952007,A,G,ENST00000263967.3,,,,,75,GRCh37,,,,,,
937,PIK3CA,5290,M1043I,,37,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,3,178952074,178952074,G,T,ENST00000263967.3,,,,,75,GRCh37,,,,,,
938,PIK3CA,5290,H1047Y,,37,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,3,178952084,178952084,C,T,ENST00000263967.3,,,,,75,GRCh37,,,,,,
939,PIK3CA,5290,G1049S,,37,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,3,178952090,178952090,G,A,ENST00000263967.3,,,,,75,GRCh37,,,,,,
940,PIK3CA,5290,G1049R,,37,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,3,178952090,178952090,G,C,ENST00000263967.3,,,,,75,GRCh37,,,,,,
941,PDGFRA,5156,V561D,,38,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
946,KIT,3815,Y503_F504insAY,,29,variant,,,,,,,4,55592185,55592186,,GCCTAT,ENST00000288135.5,,,,,75,GRCh37,,,,,,
948,KIT,3815,K550_W557del,,29,variant,,,,,,,4,55593582,55593605,AAACCCATGTATGAAGTACAGTGG,,,,,,,,GRCh37,,,,,,
949,KIT,3815,K550_K558DEL,,29,variant,107,inframe_deletion,Inframe Deletion,SO:0001822,An inframe non synonymous variant that deletes bases from the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001822,4,55593582,55593608,AAACCCATGTATGAAGTACAGTGGAAG,,ENST00000288135.5,,,,,75,GRCh37,,,,,,
950,KIT,3815,P551L,,29,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,4,55593586,55593586,C,T,ENST00000288135.5,,,,,75,GRCh37,,,,,,
951,KIT,3815,M552_W557DEL,,29,variant,107,inframe_deletion,Inframe Deletion,SO:0001822,An inframe non synonymous variant that deletes bases from the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001822,4,55593588,55593605,ATGTATGAAGTACAGTGG,,ENST00000288135.5,,,,,75,GRCh37,,,,,,
952,KIT,3815,Y553D,,29,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,4,55593591,55593591,T,G,ENST00000288135.5,,,,,75,GRCh37,,,,,,
953,KIT,3815,Y553_K558DEL,,29,variant,107,inframe_deletion,Inframe Deletion,SO:0001822,An inframe non synonymous variant that deletes bases from the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001822,4,55593591,55593608,,,,,,,,,GRCh37,,,,,,
954,KIT,3815,DEL 554-558,,29,variant,107,inframe_deletion,Inframe Deletion,SO:0001822,An inframe non synonymous variant that deletes bases from the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001822,4,55593594,55593608,GAAGTACAGTGGAAG,,ENST00000288135.5,,,,,75,GRCh37,,,,,,
955,KIT,3815,E554D,,29,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,4,55593596,55593596,A,C,ENST00000288135.5,,,,,75,GRCh37,,,,,,
956,KIT,3815,V555_Q556DEL,,29,variant,107,inframe_deletion,Inframe Deletion,SO:0001822,An inframe non synonymous variant that deletes bases from the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001822,4,55593597,55593602,GTACAG,,ENST00000288135.5,,,,,75,GRCh37,,,,,,
957,KIT,3815,V555-P573DELVQWKVVEEINGNNYVYIDP,,29,variant,107,inframe_deletion,Inframe Deletion,SO:0001822,An inframe non synonymous variant that deletes bases from the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001822,4,55593597,55593653,,,,,,,,,GRCh37,,,,,,
958,KIT,3815,W557R,,29,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,4,55593603,55593603,T,C,ENST00000288135.5,,,,,75,GRCh37,,,,,,
959,KIT,3815,W557G,,29,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,4,55593603,55593603,T,G,ENST00000288135.5,,,,,75,GRCh37,,,,,,
960,KIT,3815,W557T,,29,variant,,,,,,,4,55593603,55593604,TG,AC,ENST00000288135.5,,,,,75,GRCh37,,,,,,
961,KIT,3815,W557_K558DELWK,,29,variant,,,,,,,4,55593603,55593608,TGGAAG,,,,,,,,GRCh37,,,,,,
962,KIT,3815,W557_E561DEL,,29,variant,,,,,,,4,55593603,55593617,,,,,,,,,GRCh37,,,,,,
963,KIT,3815,K558Q,,29,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,4,55593606,55593606,A,C,ENST00000288135.5,,,,,75,GRCh37,,,,,,
964,KIT,3815,K558_V559DEL,,29,variant,,,,,,,4,55593606,55593611,AAGGTT,,ENST00000288135.5,,,,,75,GRCh37,,,,,,
965,KIT,3815,K558R,,29,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,4,55593607,55593607,A,G,ENST00000288135.5,,,,,75,GRCh37,,,,,,
966,KIT,3815,V559DEL,,29,variant,,,,,,,4,55593609,55593611,GTT,,ENST00000288135.5,,,,,75,GRCh37,,,,,,
967,KIT,3815,V559_V560DEL,,29,variant,,,,,,,4,55593609,55593614,GTTGTT,,ENST00000288135.5,,,,,75,GRCh37,,,,,,
968,KIT,3815,V559D,,29,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,4,55593610,55593610,T,A,,,,,,,GRCh37,,,,,,
969,KIT,3815,V559A,,29,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,4,55593610,55593610,T,C,ENST00000288135.5,,,,,75,GRCh37,,,,,,
970,KIT,3815,V559G,,29,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,4,55593610,55593610,T,G,ENST00000288135.5,,,,,75,GRCh37,,,,,,
971,KIT,3815,V560D,,29,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,4,55593613,55593613,T,A,ENST00000288135.5,,,,,75,GRCh37,,,,,,
972,KIT,3815,V560G,,29,variant,,,,,,,4,55593613,55593613,T,G,ENST00000288135.5,,,,,75,GRCh37,,,,,,
974,KIT,3815,T574A,,29,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,4,55593654,55593654,A,G,ENST00000288135.5,,,,,75,GRCh37,,,,,,
975,KIT,3815,Q575L,,29,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,4,55593658,55593658,A,T,ENST00000288135.5,,,,,75,GRCh37,,,,,,
976,KIT,3815,P577L,,29,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,4,55593664,55593664,C,T,ENST00000288135.5,,,,,75,GRCh37,,,,,,
977,KIT,3815,D579DEL,,29,variant,107,inframe_deletion,Inframe Deletion,SO:0001822,An inframe non synonymous variant that deletes bases from the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001822,4,55593669,55593671,GAT,,ENST00000288135.5,,,,,75,GRCh37,,,,,,
978,KIT,3815,K642E,,29,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,4,55594221,55594221,A,G,ENST00000288135.5,,,,,75,GRCh37,,,,,,
979,KIT,3815,T661I,,29,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,4,55594279,55594279,C,T,ENST00000288135.5,,,,,75,GRCh37,,,,,,
980,KIT,3815,S692L,,29,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,4,55595585,55595585,C,T,ENST00000288135.5,,,,,75,GRCh37,,,,,,
981,KIT,3815,Q694K,,29,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,4,55595590,55595590,C,A,ENST00000288135.5,,,,,75,GRCh37,,,,,,
983,KIT,3815,D816H,,29,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,4,55599320,55599320,G,C,ENST00000288135.5,,,,,75,GRCh37,,,,,,
984,KIT,3815,D816Y,,29,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
986,KIT,3815,D820Y,,29,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,4,55599332,55599332,G,T,ENST00000288135.5,,,,,75,GRCh37,,,,,,
989,KIT,3815,Y823D,,29,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,4,55599341,55599341,T,G,ENST00000288135.5,,,,,75,GRCh37,,,,,,
991,BRAF,673,V600R,,5,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
992,BRAF,673,G469A,,5,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,7,140481402,140481402,C,G,ENST00000288602.6,,,,,75,GRCh37,,,,,,
994,EGFR,1956,R108K,,19,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
995,EGFR,1956,T263P,,19,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
996,EGFR,1956,A289V,,19,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,7,55221822,55221822,C,T,ENST00000275493.2,,,,,75,GRCh37,,,,,,
999,EGFR,1956,G719A,,19,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,7,55241708,55241708,G,C,ENST00000275493.2,,,,,75,GRCh37,,,,,,
1001,EGFR,1956,V742A,,19,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1002,EGFR,1956,E746_A750delELREA,,19,variant,107,inframe_deletion,Inframe Deletion,SO:0001822,An inframe non synonymous variant that deletes bases from the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001822,7,55242465,55242479,,,,,,,,,GRCh37,,,,,,
1003,EGFR,1956,E746_T751>I,,19,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1004,EGFR,1956,E746_T751delinsA,,19,variant,,,,,,,7,55242467,55242481,AATTAAGAGAAGCAA,,ENST00000275493.2,,,,,75,GRCh37,,,,,,
1005,EGFR,1956,E746V,,19,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1006,EGFR,1956,L747_A750>P,,19,variant,,,,,,,7,55242468,55242478,,GC,,,,,,,GRCh37,,,,,,
1007,EGFR,1956,L747_T751delLREAT,,19,variant,,,,,,,7,55242468,55242482,,,,,,,,,GRCh37,,,,,,
1008,EGFR,1956,L747_T751>Q,,19,variant,,,,,,,7,55242468,55242482,,GCA,,,,,,,GRCh37,,,,,,
1009,EGFR,1956,E746_S752>D,,19,variant,107,inframe_deletion,Inframe Deletion,SO:0001822,An inframe non synonymous variant that deletes bases from the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001822,7,55242468,55242485,,,,,,,,,GRCh37,,,,,,
1010,EGFR,1956,L747_T751>P,,19,variant,,,,,,,7,55242469,55242481,,C,,,,,,,GRCh37,,,,,,
1011,EGFR,1956,L747_P753>Q,,19,variant,,,,,,,7,55242469,55242488,,CA,,,,,,,GRCh37,,,,,,
1012,EGFR,1956,L747_P753delinsS,,19,variant,107,inframe_deletion,Inframe Deletion,SO:0001822,An inframe non synonymous variant that deletes bases from the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001822,7,55242470,55242487,,,,,,,,,GRCh37,,,,,,
1013,EGFR,1956,D761N,,19,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1016,EGFR,1956,G810S,,19,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1017,EGFR,1956,R831H,,19,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,7,55259434,55259434,G,A,ENST00000275493.2,,,,,75,GRCh37,,,,,,
1018,EGFR,1956,L838V,,19,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1020,EGFR,1956,L861Q,,19,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1021,ABL1,25,M244V,,4,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,9,133738330,133738330,A,G,ENST00000318560.5,,,,,75,GRCh37,,,,,,
1022,ABL1,25,L248V,,4,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,9,133738342,133738342,C,G,ENST00000318560.5,,,,,75,GRCh37,,,,,,
1023,ABL1,25,G250E,,4,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,9,133738349,133738349,G,A,ENST00000318560.5,,,,,75,GRCh37,,,,,,
1024,ABL1,25,Q252H,,4,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,9,133738356,133738356,G,C,ENST00000318560.5,,,,,75,GRCh37,,,,,,
1025,ABL1,25,Y253H,,4,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,9,133738357,133738357,T,C,ENST00000318560.5,,,,,75,GRCh37,,,,,,
1026,ABL1,25,Y253F,,4,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,9,133738358,133738358,A,T,ENST00000318560.5,,,,,75,GRCh37,,,,,,
1027,ABL1,25,D276G,,4,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,9,133747520,133747520,A,G,ENST00000318560.5,,,,,75,GRCh37,,,,,,
1028,ABL1,25,F317L,,4,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,9,133748290,133748290,C,G,ENST00000318560.5,,,,,75,GRCh37,,,,,,
1029,ABL1,25,M351T,,4,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,9,133748391,133748391,T,C,ENST00000318560.5,,,,,75,GRCh37,,,,,,
1030,ABL1,25,H396R,,4,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,9,133750356,133750356,A,G,ENST00000318560.5,,,,,75,GRCh37,,,,,,
1031,NOTCH1,4851,L1600P,,50,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,9,139399344,139399344,A,G,ENST00000277541.6,,,,,75,GRCh37,,,,,,
1032,NOTCH1,4851,L1574P,,50,variant,,,,,,,9,139399422,139399422,A,G,ENST00000277541.6,,,,,75,GRCh37,,,,,,
1033,NOTCH1,4851,R1598P,,50,variant,,,,,,,9,139399350,139399350,C,G,ENST00000277541.6,,,,,75,GRCh37,,,,,,
1034,NOTCH1,4851,L1678P,,50,variant,,,,,,,9,139397768,139397768,A,G,ENST00000277541.6,,,,,75,GRCh37,,,,,,
1049,TP53,7157,P278S,,45,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1066,TP53,7157,M237I,,45,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1068,TP53,7157,Y234C,,45,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,17,7577580,7577580,T,C,ENST00000269305.4,,,,,75,GRCh37,,,,,,
1092,TP53,7157,V157F,,45,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1103,KRAS,3845,Q61P,,30,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,12,25380276,25380276,T,G,ENST00000256078.4,,,,,75,GRCh37,,,,,,
1104,KRAS,3845,Q61E,,30,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,12,25380277,25380277,G,C,ENST00000256078.4,,,,,75,GRCh37,,,,,,
1105,KRAS,3845,Q61FS,,30,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1106,BRAF,673,G464V,,5,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,7,140481417,140481417,C,A,ENST00000288602.6,,,,,75,GRCh37,,,,,,
1107,BRAF,673,D594N,,5,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,7,140453155,140453155,C,T,ENST00000288602.6,,,,,75,GRCh37,,,,,,
1108,TP53,7157,R282L,,45,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,17,7577093,7577093,C,A,ENST00000269305.4,,,,,75,GRCh37,,,,,,
1109,TP53,7157,R213P,,45,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,17,7578211,7578211,C,G,ENST00000269305.4,,,,,75,GRCh37,,,,,,
1120,KRAS,3845,K117N,,30,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,12,25378647,25378647,T,A,ENST00000256078.4,,,,,75,GRCh37,,,,,,
1121,BRAF,673,F595L,,5,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,7,140453150,140453150,A,C,ENST00000288602.6,,,,,75,GRCh37,,,,,,
1127,NOTCH1,4851,F1592S,,50,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,9,139399368,139399368,A,G,ENST00000277541.6,,,,,75,GRCh37,,,,,,
1140,NOTCH1,4851,L1600Q,,50,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,9,139399344,139399344,A,T,ENST00000277541.6,,,,,75,GRCh37,,,,,,
1142,NOTCH1,4851,L1585R,,50,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,9,139399389,139399389,A,C,ENST00000277541.6,,,,,75,GRCh37,,,,,,
1143,NOTCH1,4851,V1577A,,50,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,9,139399413,139399413,A,G,ENST00000277541.6,,,,,75,GRCh37,,,,,,
1144,NOTCH1,4851,V1577E,,50,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,9,139399413,139399413,A,T,ENST00000277541.6,,,,,75,GRCh37,,,,,,
1145,NOTCH1,4851,L1574Q,,50,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,9,139399422,139399422,A,T,ENST00000277541.6,,,,,75,GRCh37,,,,,,
1151,PIK3CA,5290,H1047L,,37,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,3,178952085,178952085,A,T,ENST00000263967.3,,,,,75,GRCh37,,,,,,
1152,ABL1,25,BCR-ABL F486S,,4,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,9,133755488,133755488,T,C,ENST00000318560.5,,,,,75,GRCh37,,,,,,
1153,ATM,472,P292R,,69,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,11,108115727,108115727,C,G,ENST00000278616.4,,,,,75,GRCh37,,,,,,
1154,ATM,472,M1FS,,69,variant,51,frameshift_variant,Frameshift Variant,SO:0001589,"A sequence variant which causes a disruption of the translational reading frame, because the number of nucleotides inserted or deleted is not a multiple of three.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001589,,,,,,,,,,,,GRCh37,,,,,,
1155,ATM,472,K293*,,69,variant,50,stop_gained,Stop Gained,SO:0001587,"A sequence variant whereby at least one base of a codon is changed, resulting in a premature stop codon, leading to a shortened polypeptide.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001587,11,108115729,108115729,A,T,ENST00000278616.4,,,,,75,GRCh37,,,,,,
1156,ATM,472,R2459C,,69,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,11,108201008,108201008,C,T,,,,,,,GRCh37,,,,,,
1157,ATM,472,Q984E,,69,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,11,108142006,108142006,C,G,ENST00000278616.4,,,,,75,GRCh37,,,,,,
1158,ATM,472,F1025L,,69,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,11,108142131,108142131,T,G,ENST00000278616.4,,,,,75,GRCh37,,,,,,
1159,ATM,472,Q1084*,,69,variant,50,stop_gained,Stop Gained,SO:0001587,"A sequence variant whereby at least one base of a codon is changed, resulting in a premature stop codon, leading to a shortened polypeptide.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001587,11,108143545,108143545,C,T,ENST00000278616.4,,,,,75,GRCh37,,,,,,
1160,ATM,472,D1930V,,69,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,11,108180913,108180913,A,T,ENST00000278616.4,,,,,75,GRCh37,,,,,,
1161,ATM,472,R2034P,,69,variant,,,,,,,11,108186743,108186743,G,C,ENST00000278616.4,,,,,75,GRCh37,,,,,,
1162,ATM,472,E2187*,,69,variant,50,stop_gained,Stop Gained,SO:0001587,"A sequence variant whereby at least one base of a codon is changed, resulting in a premature stop codon, leading to a shortened polypeptide.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001587,11,108192134,108192134,G,T,ENST00000278616.4,,,,,75,GRCh37,,,,,,
1163,ATM,472,L2427P,,69,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,11,108199938,108199938,T,C,ENST00000278616.4,,,,,75,GRCh37,,,,,,
1164,ATM,472,F2732V,,69,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,11,108206614,108206614,T,G,ENST00000278616.4,,,,,75,GRCh37,,,,,,
1165,ATM,472,R777FS,,69,variant,51,frameshift_variant,Frameshift Variant,SO:0001589,"A sequence variant which causes a disruption of the translational reading frame, because the number of nucleotides inserted or deleted is not a multiple of three.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001589,11,108128286,108128289,AGAA,,,,,,,,GRCh37,,,,,,
1166,ATM,472,K468FS,,69,variant,51,frameshift_variant,Frameshift Variant,SO:0001589,"A sequence variant which causes a disruption of the translational reading frame, because the number of nucleotides inserted or deleted is not a multiple of three.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001589,11,108121594,108121595,AA,,ENST00000278616.4,,,,,75,GRCh37,,,,,,
1167,ATM,472,V1268FS,,69,variant,51,frameshift_variant,Frameshift Variant,SO:0001589,"A sequence variant which causes a disruption of the translational reading frame, because the number of nucleotides inserted or deleted is not a multiple of three.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001589,,,,,,,,,,,,GRCh37,,,,,,
1168,ATM,472,D1682H,,69,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,11,108170479,108170479,G,C,ENST00000278616.4,,,,,75,GRCh37,,,,,,
1169,ATM,472,A2062V,,69,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,11,108186827,108186827,C,T,ENST00000278616.4,,,,,75,GRCh37,,,,,,
1170,ATM,472,R1575H,,69,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,11,108164152,108164152,G,A,ENST00000278616.4,,,,,75,GRCh37,,,,,,
1171,ATM,472,A2274T,,69,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,11,108196797,108196797,G,A,ENST00000278616.4,,,,,75,GRCh37,,,,,,
1172,ATM,472,C2488Y,,69,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,11,108201096,108201096,G,A,ENST00000278616.4,,,,,75,GRCh37,,,,,,
1173,ABL1,25,E255V,,4,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,9,133738364,133738364,A,T,ENST00000318560.5,,,,,75,GRCh37,,,,,,
1174,NOTCH1,4851,F1592C,,50,variant,,,,,,,9,139399368,139399368,A,C,ENST00000277541.6,,,,,75,GRCh37,,,,,,
1175,NRAS,4893,G12V,,36,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1178,PIK3CA,5290,R93W,,37,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,3,178916890,178916890,C,T,ENST00000263967.3,,,,,75,GRCh37,,,,,,
1181,EGFR,1956,R776C,,19,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1182,EGFR,1956,S784F,,19,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1183,ABL1,25,E292V,,4,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,9,133747568,133747568,A,T,ENST00000318560.5,,,,,75,GRCh37,,,,,,
1184,ABL1,25,F359C,,4,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,9,133748415,133748415,T,G,ENST00000318560.5,,,,,75,GRCh37,,,,,,
1187,EGFR,1956,A864T,,19,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,7,55259532,55259532,G,A,ENST00000275493.2,,,,,75,GRCh37,,,,,,
1188,EGFR,1956,N826S,,19,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1196,BRAF,673,G466A,,5,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,7,140481411,140481411,C,G,ENST00000288602.6,,,,,75,GRCh37,,,,,,
1206,KIT,3815,S501_A502INSAY,,29,variant,106,inframe_insertion,Inframe Insertion,SO:0001821,An inframe non synonymous variant that inserts bases into in the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001821,4,55592179,55592180,,GCCTAT,,,,,,,GRCh37,,,,,,
1214,EGFR,1956,E746_T751delinsVA,,19,variant,107,inframe_deletion,Inframe Deletion,SO:0001822,An inframe non synonymous variant that deletes bases from the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001822,7,55242467,55242483,AATTAAGAGAAGCAACA,TTGCT,ENST00000275493.2,,,,,75,GRCh37,,,,,,
1227,AKT3,10000,E17K,,7936,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,1,243859016,243859016,C,T,ENST00000366539.1,,,,,75,GRCh37,,,,,,
1230,ABL1,25,L384M,,4,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,9,133750319,133750319,C,A,ENST00000318560.5,,,,,75,GRCh37,,,,,,
1231,ABL1,25,V299L,,4,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,9,133747588,133747588,G,C,ENST00000318560.5,,,,,75,GRCh37,,,,,,
1232,ABL1,25,L387F,,4,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,9,133750330,133750330,G,C,ENST00000318560.5,,,,,75,GRCh37,,,,,,
1233,ABL1,25,BCR-ABL G398R,,4,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,9,133750361,133750361,G,C,ENST00000318560.5,,,,,75,GRCh37,,,,,,
1234,PIK3CA,5290,K111N,,37,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,3,178916946,178916946,G,C,ENST00000263967.3,,,,,75,GRCh37,,,,,,
1235,PIK3CA,5290,I391M,,37,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,3,178927410,178927410,A,G,ENST00000263967.3,,,,,75,GRCh37,,,,,,
1236,BRCA1,672,M1V,,6,variant,151,start_lost,Start Lost,SO:0002012,A codon variant that changes at least one base of the canonical start codon.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002012,17,41276113,41276113,T,C,ENST00000471181.2,,,,,75,GRCh37,,,,,,
1237,BRCA1,672,M1I,,6,variant,151,start_lost,Start Lost,SO:0002012,A codon variant that changes at least one base of the canonical start codon.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002012,17,41276111,41276111,C,A,ENST00000471181.2,,,,,75,GRCh37,,,,,,
1238,BRCA1,672,C61G,,6,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,17,41258504,41258504,A,C,ENST00000471181.2,,,,,75,GRCh37,,,,,,
1239,BRCA1,672,C64Y,,6,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,17,41258494,41258494,C,T,ENST00000471181.2,,,,,75,GRCh37,,,,,,
1240,BRCA1,672,R71G,,6,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,17,41258474,41258474,T,C,ENST00000471181.2,,,,,75,GRCh37,,,,,,
1241,BRCA1,672,R71K,,6,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,17,41258473,41258473,C,T,ENST00000471181.2,,,,,75,GRCh37,,,,,,
1242,BRCA1,672,R1495M,,6,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,17,41228505,41228505,C,A,ENST00000357654.3,,,,,75,GRCh37,,,,,,
1243,BRCA1,672,E1559K,,6,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,17,41226348,41226348,C,T,ENST00000357654.3,,,,,75,GRCh37,,,,,,
1244,BRCA1,672,D1692N,,6,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,17,41219625,41219625,C,T,ENST00000357654.3,,,,,75,GRCh37,,,,,,
1245,BRCA1,672,R1443*,,6,variant,50,stop_gained,Stop Gained,SO:0001587,"A sequence variant whereby at least one base of a codon is changed, resulting in a premature stop codon, leading to a shortened polypeptide.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001587,17,41234451,41234451,G,A,ENST00000471181.2,,,,,75,GRCh37,,,,,,
1246,BRCA1,672,Q1467*,,6,variant,50,stop_gained,Stop Gained,SO:0001587,"A sequence variant whereby at least one base of a codon is changed, resulting in a premature stop codon, leading to a shortened polypeptide.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001587,17,41228590,41228590,G,A,ENST00000357654.3,,,,,75,GRCh37,,,,,,
1247,BRCA2,675,M1R,,7,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,13,32890599,32890599,T,G,ENST00000544455.1,,,,,,GRCh37,,,,,,
1248,BRCA2,675,M1I,,7,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,13,32890600,32890600,G,T,ENST00000544455.1,,,,,75,GRCh37,,,,,,
1249,BRCA2,675,V159M,,7,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,13,32900287,32900287,G,A,ENST00000544455.1,,,,,75,GRCh37,,,,,,
1250,BRCA2,675,V211L,,7,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,13,32900751,32900751,G,C,,,,,,,GRCh37,,,,,,
1251,BRCA2,675,V211I,,7,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,13,32900751,32900751,G,A,,,,,,,GRCh37,,,,,,
1252,BRCA2,675,R2336P,,7,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,13,32921033,32921033,G,C,ENST00000544455.1,,,,,75,GRCh37,,,,,,
1253,BRCA2,675,R2336H,,7,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,13,32921033,32921033,G,A,ENST00000544455.1,,,,,75,GRCh37,,,,,,
1254,TP53,7157,V143A,,45,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,17,7578502,7578502,A,G,ENST00000269305.4,,,,,75,GRCh37,,,,,,
1255,MGMT,4255,UNDEREXPRESSION,,34,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,10,131265448,131566271,,,ENST00000306010.7,,,,,75,GRCh37,,,,,,
1256,TERT,7015,OVEREXPRESSION,,79,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,5,1253282,1295162,,,ENST00000310581.5,,,,,75,GRCh37,,,,,,
1257,RRM1,6240,UNDEREXPRESSION,,5051,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,11,4116039,4160106,,,ENST00000300738.5,,,,,75,GRCh37,,,,,,
1258,PTPRF,5792,EXPRESSION,,4695,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,1,43996547,44089337,,,ENST00000359947.4,,,,,75,GRCh37,,,,,,
1259,AEBP1,165,OVEREXPRESSION,,221,variant,,,,,,,,,,,,,,,,,,,,,,,,
1260,RET,5979,C609Y,"There is some functional evidence that this variant leads to reduced RET activity (PMID: 9230192) and increased cell proliferation and resistance to apoptosis (PMID: 16715139). It has been widely reported in both familial and sporadic cases of multiple endocrine neoplasia type 2 with medullary thyroid cancers. Despite extensive WGS and Exome coverage for a combined total of ~150k alleles in the GNOMAD browser, this variant has never been observed.",42,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,10,43609070,43609070,G,A,ENST00000355710.3,,,,,75,GRCh37,,,,,,
1261,MDM2,4193,AMPLIFICATION,,3465,variant,,,,,,,,,,,,,,,,,,,,,,,,
1262,MDM4,4194,EXPRESSION,,3466,variant,,,,,,,,,,,,,,,,,,,,,,,,
1263,KIT,3815,N822K,,29,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,4,55599340,55599340,T,A,ENST00000288135.5,,,,,75,GRCh37,,,,,,
1264,KIT,3815,C809G,,29,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,4,55599299,55599299,T,G,ENST00000288135.5,,,,,75,GRCh37,,,,,,
1265,KIT,3815,D820A,,29,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,4,55599333,55599333,A,C,ENST00000288135.5,,,,,75,GRCh37,,,,,,
1266,KIT,3815,D820G,,29,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,4,55599333,55599333,A,G,ENST00000288135.5,,,,,75,GRCh37,,,,,,
1267,KIT,3815,T670I,,29,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,4,55595519,55595519,C,T,ENST00000288135.5,,,,,75,GRCh37,,,,,,
1268,MDM4,4194,AMPLIFICATION,,3466,variant,,,,,,,,,,,,,,,,,,,,,,,,
1269,BRAF,673,AMPLIFICATION,,5,variant,123,transcript_amplification,Transcript Amplification,SO:0001889,A feature amplification of a region containing a transcript.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001889,7,140434279,140624564,,,ENST00000288602.6,,,,,75,GRCh37,,,,,,
1270,MAP2K1,5604,F53L,,31,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,15,66727441,66727441,T,C,ENST00000307102.5,,,,,75,GRCh37,,,,,,
1271,ROS1,6098,G2032R,,4941,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,6,117638347,117638347,C,T,ENST00000368508.3,,,,,75,GRCh37,,,,,,
1272,MAP2K1,5604,K57N,,31,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,15,66727455,66727455,G,T,ENST00000307102.5,,,,,75,GRCh37,,,,,,
1273,CTAG1B,1485,OVEREXPRESSION,,1278,variant,,,,,,,,,,,,,,,,,,,,,,,,
1274,CTAG2,30848,OVEREXPRESSION,,11492,variant,,,,,,,,,,,,,,,,,,,,,,,,
1275,ALK,238,L1198F,,1,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,2,29443625,29443625,G,A,ENST00000389048.3,,,,,75,GRCh37,,,,,,
1276,SMO,6608,AMPLIFICATION,,5365,variant,,,,,,,,,,,,,,,,,,,,,,,,
1277,NTRK3,4916,FUSIONS,,3985,variant,,,,,,,,,,,,,,,,,,,,,,,,
1278,NTRK1,4914,LMNA-NTRK1,,3983,variant,120,transcript_fusion,Transcript Fusion,SO:0001886,A feature fusion where the deletion brings together transcript regions.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001886,1,156084498,156108548,,,ENST00000368300.4,1,156844363,156851434,ENST00000524377.1,75,GRCh37,,,,,,
1279,BRD4,23476,OVEREXPRESSION,,9588,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,19,15347647,15391262,,,ENST00000263377.2,,,,,75,GRCh37,,,,,,
1280,NTRK1,4914,AMPLIFICATION,,3983,variant,123,transcript_amplification,Transcript Amplification,SO:0001889,A feature amplification of a region containing a transcript.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001889,1,156830686,156851434,,,ENST00000524377.1,,,,,75,GRCh37,,,,,,
1281,NTRK3,4916,AMPLIFICATION,,3985,variant,123,transcript_amplification,Transcript Amplification,SO:0001889,A feature amplification of a region containing a transcript.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001889,15,88418230,88799978,,,ENST00000394480.2,,,,,75,GRCh37,,,,,,
1282,NTRK1,4914,LMNA-NTRK1 G595R AND G667C,,3983,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,1,156846342,156849107,,,ENST00000524377.1,,,,,75,GRCh37,,,,,,
1283,CDK2,1017,CYTOPLASMIC EXPRESSION,,906,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,12,56360553,56366568,,,ENST00000266970.4,,,,,75,GRCh37,,,,,,
1284,DCC,1630,EXPRESSION,,1396,variant,,,,,,,,,,,,,,,,,,,,,,,,
1285,CTNNB1,1499,T41A,,1290,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,3,41266124,41266124,A,G,ENST00000349496.5,,,,,75,GRCh37,,,,,,
1286,CTNNB1,1499,S45F,,1290,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,3,41266137,41266137,C,T,ENST00000349496.5,,,,,75,GRCh37,,,,,,
1287,CTNNB1,1499,S45P,,1290,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,3,41266136,41266136,T,C,ENST00000349496.5,,,,,75,GRCh37,,,,,,
1288,JAK3,3718,M511I,,3091,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,19,17949108,17949108,C,T,ENST00000458235.1,,,,,75,GRCh37,,,,,,
1289,JAK3,3718,V722I,,3091,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,19,17945696,17945696,C,T,ENST00000458235.1,,,,,75,GRCh37,,,,,,
1290,JAK3,3718,S61C,,3091,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,19,17955046,17955046,T,A,ENST00000458235.1,,,,,75,GRCh37,,,,,,
1291,JAK1,3716,P429S,,3090,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,1,65325837,65325837,G,A,ENST00000342505.4,,,,,75,GRCh37,,,,,,
1292,JAK1,3716,W690*,,3090,variant,50,stop_gained,Stop Gained,SO:0001587,"A sequence variant whereby at least one base of a codon is changed, resulting in a premature stop codon, leading to a shortened polypeptide.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001587,1,65311241,65311242,,,ENST00000342505.4,,,,,75,GRCh37,,,,,,
1293,ARID1A,8289,LOSS-OF-FUNCTION,,6559,variant,,,,,,,,,,,,,,,,,,,,,,,,
1294,VHL,7428,W8* (c.24G>A),,58,variant,50,stop_gained,Stop Gained,SO:0001587,"A sequence variant whereby at least one base of a codon is changed, resulting in a premature stop codon, leading to a shortened polypeptide.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001587,3,10183555,10183555,G,A,ENST00000256474.2,,,,,75,GRCh37,,,,,,
1295,ALK,238,F1245V,,1,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,2,29436860,29436860,A,C,ENST00000389048.3,,,,,75,GRCh37,,,,,,
1296,CTNNB1,1499,ACTIVATING MUTATION,,1290,variant,42,transcript_variant,Transcript Variant,SO:0001576,A sequence variant that changes the structure of the transcript.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001576,3,41240930,41281936,,,ENST00000349496.5,,,,,75,GRCh37,160,gain_of_function_variant,Gain Of Function Variant,SO:0002053,A sequence variant whereby new or enhanced function is conferred on the gene product.,http://www.sequenceontology.org/browser/current_svn/term/SO:0002053
1298,BRAF,673,599INST,,5,variant,,,,,,,,,,,,,,,,,,,,,,,,
1299,MERTK,10461,OVEREXPRESSION,,8331,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,2,112656056,112787138,,,ENST00000295408.4,,,,,75,GRCh37,,,,,,
1300,TP53,7157,CONSERVED DOMAIN MUT,,45,variant,,,,,,,,,,,,,,,,,,,,,,,,
1301,AKT3,10000,OVEREXPRESSION,,7936,variant,,,,,,,,,,,,,,,,,,,,,,,,
1302,FLT3,2322,D835V,,24,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,13,28592641,28592641,T,A,ENST00000241453.7,,,,,75,GRCh37,,,,,,
1303,MYC,4609,OVEREXPRESSION,,3737,variant,,,,,,,,,,,,,,,,,,,,,,,,
1304,ERBB2,2064,L755P,,20,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,17,37880219,37880220,TT,CC,ENST00000269571.5,,,,,75,GRCh37,,,,,,
1305,ERBB2,2064,T798M,,20,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,17,37881064,37881065,CA,TG,ENST00000269571.5,,,,,75,GRCh37,,,,,,
1306,TP53,7157,OVEREXPRESSION,,45,variant,,,,,,,17,7571720,7590856,,,ENST00000269305.4,,,,,75,GRCh37,,,,,,
1307,TP53,7157,ALTERATION,P53 ALTERATION is a bucket type variant used in studies which is constructed by combining all cases of p53 mutation together with p53 overexpression. This includes cases which have p53 mutation or overexpression alone or as well as cases where both occur in combination.,45,variant,,,,,,,,,,,,,,,,,,,,,,,,
1308,ERBB2,2064,L768S,,20,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,17,37880259,37880259,T,C,ENST00000269571.5,,,,,75,GRCh37,,,,,,
1309,ERBB2,2064,L638S,,20,variant,,,,,,,,,,,,,,,,,,,,,,,,
1310,ERBB2,2064,V773,,20,variant,,,,,,,,,,,,,,,,,,,,,,,,
1311,ERBB2,2064,V773L,,20,variant,,,,,,,,,,,,,,,,,,,,,,,,
1312,ERBB2,2064,K753E,,20,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,17,37880213,37880213,A,G,ENST00000269571.5,,,,,75,GRCh37,,,,,,
1313,ERBB2,2064,L753E,,20,variant,,,,,,,,,,,,,,,,,,,,,,,,
1314,ERBB2,2064,K755S,,20,variant,,,,,,,,,,,,,,,,,,,,,,,,
1316,KIT,3815,V559,,29,variant,,,,,,,,,,,,,,,,,,,,,,,,
1317,NRAS,4893,G13V,,36,variant,,,,,,,,,,,,,,,,,,,,,,,,
1318,TP53,7157,L3 Domain Mutation,,45,variant,,,,,,,,,,,,,,,,,,,,,,,,
1319,GNAS,2778,R201H,,2319,variant,,,,,,,,,,,,,,,,,,,,,,,,
1320,ERBB2,2064,NON-AMPLIFICATION,,20,variant,,,,,,,,,,,,,,,,,,,,,,,,
1387,HRAS,3265,G12D,,2747,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1390,EGFR,1956,E884K,,19,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1391,HRAS,3265,Q61R,,2747,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1392,HRAS,3265,Q61K,,2747,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1393,HRAS,3265,G13R,,2747,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1394,HRAS,3265,G12V,,2747,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1395,KRAS,3845,G13R,,30,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,12,25398282,25398282,C,G,ENST00000256078.4,,,,,75,GRCh37,,,,,,
1396,KRAS,3845,G13S,,30,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,12,25398282,25398282,C,T,ENST00000256078.4,,,,,75,GRCh37,,,,,,
1397,FLT3,2322,D835E,,24,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,13,28592640,28592640,A,T,,,,,,,GRCh37,,,,,,
1398,MAP2K2,5605,F57C,,4542,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,19,4117550,4117550,A,C,,,,,,,GRCh37,,,,,,
1399,PIK3CA,5290,D549N,,37,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,3,178936103,178936103,G,A,ENST00000263967.3,,,,,75,GRCh37,,,,,,
1400,FGFR3,2261,K650E,,23,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1402,KIT,3815,D816G,,29,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1420,EGFR,1956,G719D,,19,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1432,EGFR,1956,E746_T751delELREAT,,19,variant,107,inframe_deletion,Inframe Deletion,SO:0001822,An inframe non synonymous variant that deletes bases from the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001822,7,55242466,55242483,,,,,,,,,GRCh37,,,,,,
1433,EGFR,1956,E746_S752>A,,19,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1435,EGFR,1956,L747_T751>S,,19,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1443,EGFR,1956,S768N,,19,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1445,EGFR,1956,D770_N771insSVD,,19,variant,,,,,,,7,55249013,55249014,,GCGTGGACA,,,,,,,GRCh37,,,,,,
1446,EGFR,1956,H773_V774insH,,19,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1457,EGFR,1956,L838P,,19,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1463,EGFR,1956,T847I,,19,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1465,EGFR,1956,P848L,,19,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1466,EGFR,1956,V851I,,19,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1467,EGFR,1956,T854A,,19,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1474,EGFR,1956,A859T,,19,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,7,55259517,55259517,G,A,ENST00000275493.2,,,,,75,GRCh37,,,,,,
1477,EGFR,1956,L861R,,19,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1482,EGFR,1956,E868G,,19,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1487,ABL1,25,E355G,,4,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1488,ABL1,25,L387M,,4,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1489,HRAS,3265,G13V,,2747,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1491,KRAS,3845,A59T,,30,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,12,25380283,25380283,C,T,ENST00000256078.4,,,,,75,GRCh37,,,,,,
1492,ALK,238,F1174C,,1,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,2,29443696,29443696,A,C,ENST00000,,,,,75,GRCh37,,,,,,
1493,ALK,238,T1151M,,1,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,,,,,,ENST00000389048.3,,,,,75,GRCh37,,,,,,
1494,ABL1,25,T277A,,4,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1495,ABL1,25,S438C,,4,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,,,,,,ENST00000318560.5,,,,,75,GRCh37,,,,,,
1496,ABL1,25,E450G,,4,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1497,KIT,3815,P551_E554DELPMYE,,29,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1498,KIT,3815,W557_V559INSC,,29,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1499,PIK3CA,5290,S158L,,37,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,3,178917598,178917598,C,T,ENST00000263967.3,,,,,75,GRCh37,,,,,,
1500,PIK3CA,5290,E81K,,37,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,3,178916854,178916854,G,A,ENST00000263967.3,,,,,75,GRCh37,,,,,,
1501,PIK3CA,5290,G1049A,,37,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,3,178952091,178952091,G,C,ENST00000263967.3,,,,,75,GRCh37,,,,,,
1503,FBXW7,55294,R505C,,12903,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,,,,,,ENST00000281708.4,,,,,75,GRCh37,,,,,,
1504,FBXW7,55294,R505H,,12903,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1505,ALK,238,F1174V,,1,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,2,29443697,29443697,A,C,ENST00000389048.3,,,,,75,GRCh37,,,,,,
1506,ABL1,25,L298V,,4,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1507,ABL1,25,F311I,,4,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1508,ABL1,25,L364I,,4,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1509,ABL1,25,E453Q,,4,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1510,ARID1A,8289,Q456X,,6559,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1511,EGFR,1956,S768_D770dup,,19,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1513,EGFR,1956,H773_V774insNPH,,19,variant,106,inframe_insertion,Inframe Insertion,SO:0001821,An inframe non synonymous variant that inserts bases into in the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001821,7,55249012,55249013,,AACCCCCAC,,,,,,,GRCh37,,,,,,
1514,EGFR,1956,D770_N771insGL,,19,variant,106,inframe_insertion,Inframe Insertion,SO:0001821,An inframe non synonymous variant that inserts bases into in the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001821,7,55249012,55249013,,GGGTTA,ENST00000275493.2,,,,,,GRCh37,,,,,,
1515,EGFR,1956,A763_Y764insFQEA,,19,variant,106,inframe_insertion,Inframe Insertion,SO:0001821,An inframe non synonymous variant that inserts bases into in the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001821,7,55248992,55248993,,TCCAGGAAGCCT,ENST00000275493.2,,,,,,GRCh37,,,,,,
1517,KRAS,3845,G13V,,30,variant,,,,,,,12,25398280,25398281,GC,AA,,,,,,,GRCh37,,,,,,
1518,PDGFRA,5156,DIM842_844DEL,,38,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1519,EGFR,1956,L747FS*10,,19,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1520,MTOR,2475,Q2223K,,2073,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1521,CDKN2A,1029,W110*,,14,variant,50,stop_gained,Stop Gained,SO:0001587,"A sequence variant whereby at least one base of a codon is changed, resulting in a premature stop codon, leading to a shortened polypeptide.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001587,9,21971028,21971028,C,T,ENST00000498124.1,,,,,75,GRCh37,,,,,,
1522,CDKN2A,1029,A20P,,14,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,9,21974769,21974769,C,G,ENST00000498124.1,,,,,75,GRCh37,,,,,,
1523,ABL1,25,F359I,,4,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1524,ABL1,25,M343T,,4,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1525,ABL1,25,F317V,,4,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1526,ABL1,25,E279K,,4,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1527,ABL1,25,Q300R,,4,variant,,,,,,,,,,,,ENST00000318560.5,,,,,75,GRCh37,,,,,,
1528,ABL1,25,F311L,,4,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1529,ABL1,25,N331S,,4,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1530,ABL1,25,L364P,,4,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1531,ABL1,25,H396P,,4,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1532,ABL1,25,D421G,,4,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1533,ABL1,25,I432T,,4,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1534,ABL1,25,E450V,,4,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1535,ABL1,25,E453K,,4,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1536,ABL1,25,E453A,,4,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1537,ABL1,25,P480A,,4,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1538,ABL1,25,F486Y,,4,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1539,PDGFRA,5156,W559_R560DELWR,,38,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1540,PDGFRA,5156,L579M,,38,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1541,KIT,3815,Q556_I571DEL,,29,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1542,KIT,3815,Y553_W557DELYEVQW,,29,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1543,KIT,3815,V555_I571DEL,,29,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1544,FLT3,2322,E611_F612INS25,,24,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1545,KIT,3815,K550_W557DELKPMYEVQW,,29,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1546,KIT,3815,T417_D419DELTYDINSI,,29,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1547,KIT,3815,D579_H580INSIDPTQLPYD,,29,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1548,KIT,3815,Y570_L576DEL,,29,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1549,KIT,3815,K558NP,,29,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1550,KIT,3815,V560_L576DEL,,29,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1551,KIT,3815,V569_L576DEL,,29,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1552,MAPK1,5594,E278E,,4532,variant,104,synonymous_variant,Synonymous Variant,SO:0001819,A sequence variant where there is no resulting change to the encoded amino acid.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001819,22,22127162,22127162,C,T,ENST00000544786.1,,,,,75,GRCh37,,,,,,
1553,ALK,238,L1196Q,,1,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,2,29443630,29443630,A,T,ENST00000389048.3,,,,,75,GRCh37,,,,,,
1554,ALK,238,L1152P,,1,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,2,29445270,29445270,A,G,ENST00000389048.3,,,,,75,GRCh37,,,,,,
1555,BRCA1,672,W1815X,,6,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1556,ALK,238,L1198P,,1,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,2,29443624,29443624,A,G,ENST00000389048.3,,,,,75,GRCh37,,,,,,
1557,ERBB2,2064,ERBB2 G776INSV_G/C,,20,variant,106,inframe_insertion,Inframe Insertion,SO:0001821,An inframe non synonymous variant that inserts bases into in the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001821,17,37880999,37881000,,TGT,,,,,,,GRCh37,,,,,,
1558,KIT,3815,A502_Y503INSAY,,29,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1559,KIT,3815,D816E,,29,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1560,SMO,6608,D473G,,5365,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1561,SMO,6608,D473Y,,5365,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1562,SMO,6608,S278I,,5365,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1563,SMO,6608,W281C,,5365,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1564,SMO,6608,Q477E,,5365,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1566,EGFR,1956,D770_N771insGT,,19,variant,106,inframe_insertion,Inframe Insertion,SO:0001821,An inframe non synonymous variant that inserts bases into in the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001821,7,55249012,55249013,,GGCACA,ENST00000275493.2,,,,,,GRCh37,,,,,,
1567,EGFR,1956,V774_C775insHV,,19,variant,106,inframe_insertion,Inframe Insertion,SO:0001821,An inframe non synonymous variant that inserts bases into in the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001821,,,,,,,,,,,,GRCh37,,,,,,
1569,EGFR,1956,D770_N771insNPG,,19,variant,106,inframe_insertion,Inframe Insertion,SO:0001821,An inframe non synonymous variant that inserts bases into in the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001821,,,,,,,,,,,,GRCh37,,,,,,
1570,SMO,6608,L412F,,5365,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,7,128846398,128846398,C,T,ENST00000249373.3,,,,,75,GRCh37,,,,,,
1571,EGFR,1956,W731L,,19,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1572,EGFR,1956,E734Q,,19,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,,,,,,,,,,,,GRCh37,,,,,,
1573,EGFR,1956,T785A,,19,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1574,EGFR,1956,C797Y,,19,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,7,55249092,55249092,G,A,ENST00000275493.2,,,,,75,GRCh37,,,,,,
1575,EGFR,1956,Y801H,,19,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1576,SMO,6608,V321M,,5365,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1577,EGFR,1956,E709_T710>D,,19,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1578,EGFR,1956,V769A,,19,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1579,EGFR,1956,A767_V769dupASV,,19,variant,106,inframe_insertion,Inframe Insertion,SO:0001821,An inframe non synonymous variant that inserts bases into in the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001821,7,55249000,55249001,,GCCAGCGTG,ENST00000275493.2,,,,,,GRCh37,,,,,,
1580,EGFR,1956,L747_S752INSQ,,19,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1581,EGFR,1956,N771>GY,,19,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1582,EGFR,1956,P546S,,19,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1583,SMO,6608,W281L,,5365,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1584,SMO,6608,G497W,,5365,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1585,SMO,6608,I408V,,5365,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1586,SMO,6608,C469Y,,5365,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1587,SMO,6608,T241M,,5365,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1588,SMO,6608,A459V,,5365,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1589,SMO,6608,S533N,,5365,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1590,PTCH1,5727,W170X,,4645,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1591,PTCH1,5727,W712X,,4645,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1592,PTCH1,5727,Q787X,,4645,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1593,PTCH1,5727,Q17X,,4645,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1594,PIK3CA,5290,R1023Q,,37,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,3,178952013,178952013,G,A,ENST00000263967.3,,,,,75,GRCh37,,,,,,
1595,ABL1,25,H201L,,4,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1596,ABL1,25,Y232S,,4,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,9,133738295,133738295,A,C,ENST00000318560.5,,,,,75,GRCh37,,,,,,
1597,ABL1,25,M237V,,4,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1598,ABL1,25,I242T,,4,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1599,ABL1,25,G250V,,4,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1600,ABL1,25,Q252R,,4,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1601,ABL1,25,E258D,,4,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1602,ABL1,25,L273M,,4,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1603,ABL1,25,E281K,,4,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1604,ABL1,25,V289I,,4,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,9,133747558,133747558,G,A,ENST00000318560.5,,,,,75,GRCh37,,,,,,
1605,ABL1,25,Y342H,,4,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,9,133748363,133748363,T,C,ENST00000318560.5,,,,,75,GRCh37,,,,,,
1606,ABL1,25,D363Y,,4,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1607,ABL1,25,A365V,,4,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,,,,,,ENST00000318560.5,,,,,75,GRCh37,,,,,,
1608,ABL1,25,A366G,,4,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1609,ABL1,25,V379I,,4,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,9,133750304,133750304,G,A,ENST00000318560.5,,,,,75,GRCh37,,,,,,
1610,ABL1,25,M388L,,4,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1611,ABL1,25,Y393C,,4,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,9,133750347,133750347,A,G,ENST00000318560.5,,,,,75,GRCh37,,,,,,
1612,ABL1,25,A397P,,4,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1613,ABL1,25,S417Y,,4,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1614,ABL1,25,I418V,,4,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1615,ABL1,25,I418S,,4,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1616,ABL1,25,P441L,,4,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1617,ABL1,25,E450K,,4,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1618,ABL1,25,E450Q,,4,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1619,ABL1,25,E450A,,4,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1620,ABL1,25,E453V,,4,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1621,ABL1,25,E459G,,4,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1622,ABL1,25,M472I,,4,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1623,ABL1,25,P480L,,4,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1624,ABL1,25,G514S,,4,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1625,ABL1,25,F317I,,4,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1626,MAP2K1,5604,E203K,,31,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,15,66774131,66774131,G,A,ENST00000307102.5,,,,,75,GRCh37,,,,,,
1627,BRAF,673,G596R,,5,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,7,140453149,140453149,C,G,ENST00000288602.6,,,,,75,GRCh37,,,,,,
1628,NF1,4763,R163X,,3867,variant,50,stop_gained,Stop Gained,SO:0001587,"A sequence variant whereby at least one base of a codon is changed, resulting in a premature stop codon, leading to a shortened polypeptide.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001587,,,,,,,,,,,,GRCh37,,,,,,
1630,FLT3,2322,Y591_V592INSVDFREYE,,24,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1631,FLT3,2322,E588_Y589INSKYFYVDFRE,,24,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1632,FLT3,2322,V592_D593INSDFREY,,24,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1633,EGFR,1956,E746_S752>I,,19,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1634,EGFR,1956,E746_T751>V,,19,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1635,EGFR,1956,E746_A750>IP,,19,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1636,EGFR,1956,E746_T751>IP,,19,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1637,EGFR,1956,E746_P753>VS,,19,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1638,EGFR,1956,K745_E749delKELRE,,19,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1639,ABL1,25,C475V,,4,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1640,ABL1,25,N336S,,4,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1641,ROS1,6098,D2033N,,4941,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1642,POLD1,5424,Y956N,,4384,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1643,SCN8A,6334,Q225X,,5128,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1644,PXDNL,137902,P1460T,,18364,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1645,PAPPA2,60676,Y1520X,,14195,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1646,POLE4,56655,A59E,,13465,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1647,POLD1,5424,C284Y,,4384,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1648,POLD1,5424,E374K,,4384,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1649,MET,4233,D1010Y,,52,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1650,BRAF,673,G596V,,5,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,,,,,,,,,,,,GRCh37,,,,,,
1651,MET,4233,D1010N,,52,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1652,PIK3R2,5296,N561D,,4290,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1653,PIK3CA,5290,D350G,,37,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,3,178921567,178921567,A,G,ENST00000263967.3,,,,,75,GRCh37,,,,,,
1654,NRAS,4893,Q179X,,36,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1656,ABL1,25,R351W,,4,variant,,,,,,,,,,,,ENST00000372348.2,,,,,75,GRCh37,,,,,,
1657,ABL1,25,G340L; G321L,,4,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1658,BRAF,673,V600_K601DELINSD,,5,variant,107,inframe_deletion,Inframe Deletion,SO:0001822,An inframe non synonymous variant that deletes bases from the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001822,,,,,,,,,,,,GRCh37,,,,,,
1659,KIT,3815,S628N,,29,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1660,MET,4233,D1010H,,52,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1661,ALK,238,R1192P,,1,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,2,29443642,29443642,C,G,ENST00000389048.3,,,,,75,GRCh37,,,,,,
1662,EGFR,1956,N771DELinsVH,,19,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1663,BRAF,673,DELNVTAP,,5,variant,107,inframe_deletion,Inframe Deletion,SO:0001822,An inframe non synonymous variant that deletes bases from the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001822,,,,,,,,,,,,GRCh37,,,,,,
1664,EGFR,1956,M766_A767insAI,,19,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1665,EGFR,1956,Y764_V765insHH,,19,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1666,EGFR,1956,D770_N771insGY,,19,variant,106,inframe_insertion,Inframe Insertion,SO:0001821,An inframe non synonymous variant that inserts bases into in the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001821,,,,,,,,,,,,GRCh37,,,,,,
1667,EGFR,1956,P772_H773insYNP,,19,variant,106,inframe_insertion,Inframe Insertion,SO:0001821,An inframe non synonymous variant that inserts bases into in the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001821,,,,,,,,,,,,GRCh37,,,,,,
1668,EGFR,1956,P772_V774insPHV,,19,variant,106,inframe_insertion,Inframe Insertion,SO:0001821,An inframe non synonymous variant that inserts bases into in the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001821,,,,,,,,,,,,GRCh37,,,,,,
1669,LYN,4067,Y508F,,3359,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1670,ROS1,6098,S1986Y,,4941,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1671,ROS1,6098,S1986F,,4941,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1672,EGFR,1956,Y69FS*11,,19,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1673,ERBB4,2066,G1109C,,1734,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,2,212251734,212251734,C,A,ENST00000342788.4,,,,,75,GRCh37,,,,,,
1674,ESR1,2099,E380Q,,21,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1675,ESR1,2099,L536R,,21,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1676,FBXW7,55294,S668FS*39,,12903,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1677,FBXW7,55294,L403FS*34,,12903,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1678,FBXW7,55294,G579W,,12903,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1679,FBXW7,55294,R658Q,,12903,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1680,RAF1,5894,R391W,,4767,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1681,JAK2,3717,F547 SPLICE SITE MUTATION,,28,variant,41,splice_donor_variant,Splice Donor Variant,SO:0001575,A splice variant that changes the 2 base pair region at the 5' end of an intron.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001575,9,5070054,5070054,T,G,,,,,,,GRCh37,,,,,,
1682,ARID1A,8289,P1175FS*5,,6559,variant,,,,,,,,,,,,,,,,,,GRCh37,,,,,,
1683,ALK,238,R214H,,1,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,2,30142885,30142885,C,T,,,,,,,GRCh37,,,,,,
1684,PSMD4,5710,AMPLIFICATION,,4630,variant,,,,,,,,,,,,,,,,,,,,,,,,
1685,CDK6,1021,AMPLIFICATION,,12,variant,,,,,,,,,,,,,,,,,,,,,,,,
1686,ACVR1,90,G328V,,154,variant,,,,,,,,,,,,,,,,,,,,,,,,
1687,RET,5979,FUSION,,42,variant,,,,,,,,,,,,,,,,,,,,,,,,
1688,RET,5979,KIF5B-RET V804L,,42,variant,,,,,,,,,,,,,,,,,,,,,,,,
1689,RET,5979,KIF5B-RET G810A,,42,variant,,,,,,,,,,,,,,,,,,,,,,,,
1690,RET,5979,MUTATION,,42,variant,,,,,,,,,,,,,,,,,,,,,,,,
1691,FGFR3,2261,FGFR3 Fusion,,23,variant,,,,,,,,,,,,,,,,,,,,,,,,
1692,FGFR3,2261,G691R,,23,variant,,,,,,,,,,,,,,,,,,,,,,,,
1693,CHEK1,1111,OVEREXPRESSION,,981,variant,,,,,,,,,,,,,,,,,,,,,,,,
1694,VHL,7428,E12D (c.36G>C),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1695,TP53,7157,R158H,,45,variant,,,,,,,,,,,,,,,,,,,,,,,,
1696,TP53,7157,R249S,,45,variant,,,,,,,,,,,,,,,,,,,,,,,,
1697,TP53,7157,R280K,,45,variant,,,,,,,,,,,,,,,,,,,,,,,,
1698,TP53,7157,R280T,,45,variant,,,,,,,,,,,,,,,,,,,,,,,,
1699,TP53,7157,R158L,,45,variant,,,,,,,,,,,,,,,,,,,,,,,,
1700,RET,5979,C634R,,42,variant,,,,,,,,,,,,,,,,,,,,,,,,
1733,VHL,7428,E46fs (c.136G>T),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1734,VHL,7428,E52K (c.154G>A),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1735,VHL,7428,E52fs* (c.156G>T),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1736,VHL,7428,E55fs* (c.163G>T),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1737,VHL,7428,G39AfsTer26 (c.327delC),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1738,VHL,7428,L158P (c.473T>C),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1739,VHL,7428,R167Q (c.500G>A),R167Q is the most common point mutation in hereditary Von Hippel-Lindau (VHL) disease and disrupts the VHL genes binding to elongin C reducing the levels of the VHL-elongin B-elongin C (VBC) E3 ligase complex and inhibiting the ability of VHL to regulate HIF2. This partial function in turn leads to an increased risk of tumorgenesis. VHL derived clear cell renal cell carcinoma models however have shown the proteasome inhibitors bortezomib and carfilzomib can act to stabilize mutant VHL-R167Q leading to downregulation of HIF2 and suprressed tumorgenesis.,58,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,3,10191507,10191507,G,A,ENST00000256474.2,,,,,75,GRCh37,,,,,,
1740,VHL,7428,S183C (c.548delC),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1741,VHL,7428,Y98H (c.292T>C),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1742,VHL,7428,H115Q (c.345C>A),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1743,VHL,7428,F119L (c.357C>G),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1744,VHL,7428,A149T (c.445G>A),,58,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,3,10188302,10188302,G,A,ENST00000256474.2,,,,,75,GRCh37,,,,,,
1745,VHL,7428,T157I (c.470C>T),,58,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,3,10191477,10191477,C,T,ENST00000,,,,,75,GRCh37,,,,,,
1746,VHL,7428,R161Q (c.482G>A),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1747,VHL,7428,R167W (c.499C>T),,58,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,3,10191506,10191506,C,T,ENST00000,,,,,75,GRCh37,,,,,,
1748,VHL,7428,L178P (c.533T>C),,58,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,3,10191540,10191540,T,C,ENST0,,,,,75,GRCh37,,,,,,
1749,VHL,7428,F76I (c.226T>A),,58,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,3,10183757,10183757,T,A,ENST00000256474.2,,,,,75,GRCh37,,,,,,
1750,VHL,7428,V62C (c.180delG),,58,variant,107,inframe_deletion,Inframe Deletion,SO:0001822,An inframe non synonymous variant that deletes bases from the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001822,3,10183711,10183711,G,,ENST,,,,,75,GRCh37,,,,,,
1751,VHL,7428,S65W (c.194C>G),,58,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,3,10183725,10183725,C,G,ENST00000,,,,,75,GRCh37,,,,,,
1752,VHL,7428,Q73* (c.217C>T),,58,variant,50,stop_gained,Stop Gained,SO:0001587,"A sequence variant whereby at least one base of a codon is changed, resulting in a premature stop codon, leading to a shortened polypeptide.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001587,3,10183748,10183748,C,T,ENST00000,,,,,75,GRCh37,,,,,,
1753,VHL,7428,F76fs (c.226_228delTTC),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1754,VHL,7428,N78H (c.232A>C),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1755,VHL,7428,N78S (c.233A>G),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1756,VHL,7428,N78T (c.233A>C),,58,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,3,10183764,10183764,A,C,ENST000,,,,,75,GRCh37,,,,,,
1757,VHL,7428,S80I (c.239G>T),,58,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,3,10183770,10183770,G,T,ENST00000,,,,,75,GRCh37,,,,,,
1758,VHL,7428,N131* (c.255insC),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1759,VHL,7428,P86A (c.256C>G),,58,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,3,10183787,10183787,C,G,ENST00000256474.2,,,,,75,GRCh37,,,,,,
1760,VHL,7428,P86L (c.257C>T),,58,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,3,10183788,10183788,C,T,ENST00000256474.2,,,,,75,GRCh37,,,,,,
1761,VHL,7428,W88R (c.262T>A),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1762,VHL,7428,L158* (c.331delA),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1763,VHL,7428,S111N (c.332G>A),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1764,VHL,7428,S111R (c.333C>G),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1765,EGFR,1956,Gain-of-function,,19,variant,,,,,,,,,,,,,,,,,,,,,,,,
1766,VHL,7428,Y112* (c.336C>A),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1767,VHL,7428,W117C (c.351G>T),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1768,VHL,7428,L129Q (c.386insAGA),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1769,VHL,7428,L135* (c.404T>A),,58,variant,50,stop_gained,Stop Gained,SO:0001587,"A sequence variant whereby at least one base of a codon is changed, resulting in a premature stop codon, leading to a shortened polypeptide.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001587,3,10188261,10188261,T,A,ENST,,,,,75,GRCh37,,,,,,
1770,VHL,7428,N150I (c.448delA),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1771,VHL,7428,V155C (c.462delA),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1772,VHL,7428,C162R (c.484T>C),,58,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,3,10191491,10191491,T,C,ENST00000,,,,,75,GRCh37,,,,,,
1773,VHL,7428,C162F (c.485G>T),,58,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,3,10191492,10191492,G,T,ENST00000256474.2,,,,,75,GRCh37,,,,,,
1774,VHL,7428,C162W (c.486C>G),,58,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,3,10191493,10191493,C,G,ENST0,,,,,75,GRCh37,,,,,,
1775,VHL,7428,V166D (c.497T>A),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1776,VHL,7428,L184P (c.551T>C),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1777,VHL,7428,E186* (c.556G>T),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1778,VHL,7428,E186K (c.556G>A),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1779,VHL,7428,R167fs (c.502insTTGTTCGT),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1780,VHL,7428,Y175fs (c.526delA),,58,variant,134,frameshift_truncation,Frameshift Truncation,SO:0001910,A frameshift variant that causes the translational reading frame to be shortened relative to the reference feature.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001910,3,10191533,10191533,A,,ENST00000256474.2,,,,,75,GRCh37,,,,,,
1781,VHL,7428,Q145H (c.435_436delGC),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1782,VHL,7428,P154L (c.461C>T),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1783,VHL,7428,T157fs (c.472insT),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1784,VHL,7428,S183* (c.548C>A),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1785,VHL,7428,A56D (c.167insA),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1786,VHL,7428,P59R (c.175delC),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1787,VHL,7428,S65W (c.194C>G),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1788,VHL,7428,S65L (c.194C>T),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1789,VHL,7428,V66* (c.196delG),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1790,VHL,7428,C77L (c.228insC),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1791,VHL,7428,R79P (c.236G>C),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1792,VHL,7428,S80R (c.240T>G),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1793,VHL,7428,L89P (c.266T>C),,58,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,3,10183797,10183797,T,C,ENST0000,,,,,75,GRCh37,,,,,,
1794,VHL,7428,E94* (c.280G>T),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1795,VHL,7428,G104H (c.309_310delTG),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1796,VHL,7428,R113* (c.337C>T),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1797,VHL,7428,G114C (c.340G>T),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1798,VHL,7428,L118P (c.353T>C),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1799,VHL,7428,D126R (c.375insC),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1800,VHL,7428,N131P (c.390_391delTA),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1801,VHL,7428,F136S (c.407T>C),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1802,VHL,7428,L153C (c.457delC),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1803,VHL,7428,L158V (c.472C>G),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1804,VHL,7428,R161* (c.481C>T),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1805,VHL,7428,R167G (c.499C>G),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1806,VHL,7428,V170F (c.508G>T),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1807,VHL,7428,I180V (c.538A>G),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1808,VHL,7428,L184R (c.551T>G),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1809,VHL,7428,Y185* (c.555C>G),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1810,VHL,7428,Q195* (c.583C>T),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1811,VHL,7428,S65* (c.194C>A),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1812,VHL,7428,G93A (c.277delG),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1813,VHL,7428,D121G (c.362A>G),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1814,VHL,7428,F136C (c.407T>G),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1815,VHL,7428,V84L (c.250G>T),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1816,VHL,7428,S72P (c.214delT),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1817,VHL,7428,Q73* (c.214insGCCC),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1818,VHL,7428,Q96P (c.287A>C),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1819,VHL,7428,G185S (c.340+5G>C),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1820,VHL,7428,L116V (c.346C>G),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1821,VHL,7428,W117* (c.351G>A),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1822,VHL,7428,L118R (c.353T>G),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1823,VHL,7428,N141M (c.421delA),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1824,VHL,7428,C162Y (c.485G>A),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1825,VHL,7428,V166F (c.496G>T),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1826,VHL,7428,V170D (c.509T>A),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1827,VHL,7428,R177* (c.529A>T),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1828,VHL,7428,L188R (c.563delT),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1829,VHL,7428,E186del (c.558_560delAGA),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1830,POLE,5426,P286R,,4386,variant,,,,,,,,,,,,,,,,,,,,,,,,
1831,POLE,5426,V411L,,4386,variant,,,,,,,,,,,,,,,,,,,,,,,,
1832,POLE,5426,S459F,,4386,variant,,,,,,,,,,,,,,,,,,,,,,,,
1833,VHL,7428,V166F (c.498C>G),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1834,VHL,7428,E70* (c.208G>T),,58,variant,50,stop_gained,Stop Gained,SO:0001587,"A sequence variant whereby at least one base of a codon is changed, resulting in a premature stop codon, leading to a shortened polypeptide.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001587,3,10183739,10183739,G,T,ENST,,,,,75,GRCh37,,,,,,
1835,VHL,7428,F76S (c.227T>C),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1836,VHL,7428,L188V (c.562C>G),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1837,VHL,7428,P81S (c.241C>T),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1838,VHL,7428,L101G (c.301C>G),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1839,VHL,7428,T105P (c.313A>C),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1840,VHL,7428,R107P (c.320G>C),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1841,VHL,7428,L118T (c.352insA),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1842,VHL,7428,N167T (c.392A>C),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1843,VHL,7428,L132fs (c.395delA),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1844,VHL,7428,D143T (c.430delG),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1845,VHL,7428,Q164* (c.490C>T),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1846,VHL,7428,Y175D (c.523T>G),,58,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,3,10191530,10191530,T,G,ENST,,,,,75,GRCh37,,,,,,
1847,VHL,7428,V181G (c.540_543delCGTC),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1848,VHL,7428,Q96* (c.286C>T),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1849,VHL,7428,P86R (c.257C>G),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1850,VHL,7428,G144* (c.430G>T),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1851,VHL,7428,L128F (c.381-382GC>TT),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1852,VHL,7428,L188P (c.563T>C),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1853,VHL,7428,S111C (c.330CA>TT),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1854,EGFR,1956,Ex19 del L858R,,19,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,,,,,,,,,,,,,107,inframe_deletion,Inframe Deletion,SO:0001822,An inframe non synonymous variant that deletes bases from the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001822
1855,VHL,7428,R161P (c.482G>C),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1856,VHL,7428,Q164R (c.491A>G),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1857,VHL,7428,G114R (c.340G>C),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1858,VHL,7428,G93D (c.278G>A),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1859,VHL,7428,G93S (c.277G>A),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1860,VHL,7428,L101R (c.302T>G),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1861,VHL,7428,L188Q (c.563T>A),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1862,VHL,7428,K159E (c.475A>G),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1863,EGFR,1956,RARE EX 18-21 MUT,,19,variant,99,exon_variant,Exon Variant,SO:0001791,A sequence variant that changes exon sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001791,,,,,,,,,,,,,,,,,,
1864,VHL,7428,P192Q (c.573delC),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1865,VHL,7428,Y112H (c.334T>C),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1866,EGFR,1956,L861,,19,variant,,,,,,,,,,,,,,,,,,,,,,,,
1867,VHL,7428,R64P (c.191G>C),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1868,VHL,7428,N131fs (c.393CC>A),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1869,VHL,7428,E189L (c.565delG),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1870,VHL,7428,G114C (c.340+1G>A),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1871,VHL,7428,I151T (c.452T>C),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1872,VHL,7428,L158fs (c.473insT),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1873,VHL,7428,S68P (c.202T>C),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1874,VHL,7428,S80N (c.239G>A),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1875,VHL,7428,V130F (c.388G>T),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1876,CIC,23152,LOSS,,9326,variant,,,,,,,,,,,,,,,,,,,,,,,,
1877,ETV1,2115,OVEREXPRESSION,,1764,variant,,,,,,,,,,,,,,,,,,,,,,,,
1878,ETV5,2119,OVEREXPRESSION,,1768,variant,,,,,,,,,,,,,,,,,,,,,,,,
1879,ATXN1L,342371,LOSS,,22231,variant,,,,,,,,,,,,,,,,,,,,,,,,
1880,ATM,472,LOSS,,69,variant,,,,,,,,,,,,,,,,,,,,,,,,
1881,ATM,472,F858L,,69,variant,,,,,,,,,,,,,,,,,,,,,,,,
1882,VHL,7428,G132P (c.395A>C),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1883,VHL,7428,Q145* (c.433C>T),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1884,VHL,7428,E134* (c.400G>T),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1885,VHL,7428,H115P (c.344A>C),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1886,VHL,7428,L128R (c.383T>G),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1887,VHL,7428,L169P (c.506T>C),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1888,VHL,7428,L178R (c.533T>G),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1889,VHL,7428,M54* (c.162insT),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1891,EGFR,1956,L747P,,19,variant,,,,,,,,,,,,,,,,,,,,,,,,
1892,EGFR,1956,V774A,,19,variant,,,,,,,,,,,,,,,,,,,,,,,,
1893,VHL,7428,F91* (c.272T>A),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1894,EGFR,1956,V774M,,19,variant,,,,,,,,,,,,,,,,,,,,,,,,
1895,EGFR,1956,K806E,,19,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,7,55249118,55249118,A,G,ENST00000275493.2,,,,,75,GRCh37,,,,,,
1896,EGFR,1956,N826Y,,19,variant,,,,,,,,,,,,,,,,,,,,,,,,
1897,EGFR,1956,V834I,,19,variant,,,,,,,,,,,,,,,,,,,,,,,,
1899,EGFR,1956,N842S,,19,variant,,,,,,,,,,,,,,,,,,,,,,,,
1902,VHL,7428,P86S (c.256C>T),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1903,VHL,7428,S65P (c.193T>C),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1904,VHL,7428,S72P (c.214T>C),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1905,VHL,7428,G123fs (c.367delG),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1906,VHL,7428,L135fs (c.404delT),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1907,VHL,7428,R176fs (c.528delG),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1908,VHL,7428,W88* (c.264G>A),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1909,VHL,7428,V155E (c.464T>A),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1910,VHL,7428,V170G (c.509T>C),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1911,VHL,7428,R58fs (c.173_174_insC),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1912,VHL,7428,V74fs (c.223_224insT),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1913,VHL,7428,K196* (c.586A>T),,58,variant,50,stop_gained,Stop Gained,SO:0001587,"A sequence variant whereby at least one base of a codon is changed, resulting in a premature stop codon, leading to a shortened polypeptide.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001587,3,10191593,10191593,A,T,ENST,,,,,75,GRCh37,,,,,,
1914,VHL,7428,R120G (c.358A>G),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1915,VHL,7428,R161G (c.481C>G),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1916,VHL,7428,R167L (c.500G>T),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1917,VHL,7428,N141fs (c.422_440del19),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1918,VHL,7428,D126fs (c.375_376insC),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1919,VHL,7428,E160fs (c.479_480delAG),,58,variant,134,frameshift_truncation,Frameshift Truncation,SO:0001910,A frameshift variant that causes the translational reading frame to be shortened relative to the reference feature.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001910,3,10191486,10191487,AG,,ENST00000256474.2,,,,,75,GRCh37,,,,,,
1920,VHL,7428,G93R (c.277G>C),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1921,VHL,7428,H115Y (c.343C>T),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1922,VHL,7428,I109fs (c.326delT),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1923,VHL,7428,L153P (c.458T>C),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1924,VHL,7428,L188R (c.563T>G),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1925,VHL,7428,L85fs (c.253_254ins38),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1926,VHL,7428,F76del (c.227_229delTCT),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1927,VHL,7428,P103A (c.307C>G),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1928,VHL,7428,P138T (c.412C>A),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1929,VHL,7428,P59fs (c.176delC),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1930,VHL,7428,P59S (c.175C>T),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1931,VHL,7428,P61P (c.183C>G),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1932,VHL,7428,Y175* (c.525C>A),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1933,VHL,7428,Y98C  (c.293A>G),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1934,VHL,7428,V155G (c.464T>G),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1935,VHL,7428,V170G (c.509T>G),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1936,VHL,7428,V66G (c.197T>G),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1937,VHL,7428,V84L (c.250G>C),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1938,VHL,7428,EXON 2 DELETION,,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1939,VHL,7428,EXON 3 DELETION,,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1940,VHL,7428,EXON 2-3 DELETION,,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1941,VHL,7428,S168T (c.503G>C),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1942,VHL,7428,P86S (c.257C>T),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1943,VHL,7428,Q164H (c.492G>C),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1944,VHL,7428,L63P (188T>C),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1945,VHL,7428,p.Phe119Glnfs*12 (c.354_355delCT),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1946,VHL,7428,Y156C (c.467A>G),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1947,VHL,7428,Partial deletion of 4.6 Kb,,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1948,VHL,7428,S68fs (c.204InsG),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1949,VHL,7428,G144fs (c.432insG),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1951,VHL,7428,Null (Partial deletion of Exon 2),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1952,VHL,7428,Null (Partial deletion of Exon 3),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1953,VHL,7428,N131K (c.393C>A),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1954,VHL,7428,T105fs (c.315insAC),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1955,VHL,7428,P71fs (c.211insT),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1956,VHL,7428,E70L (c.208G>A),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1957,VHL,7428,H115Q (c.345C>G),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1958,VHL,7428,H191fs (c.571delC),,58,variant,134,frameshift_truncation,Frameshift Truncation,SO:0001910,A frameshift variant that causes the translational reading frame to be shortened relative to the reference feature.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001910,3,10191578,10191578,C,,ENST00000256474.2,,,,,75,GRCh37,,,,,,
1959,VHL,7428,Null (c.1-?_463+?del),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1960,VHL,7428,L140fs (c.417_to_418delTC),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1961,VHL,7428,M54fs (c.161insT),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1962,VHL,7428,P154P (c.462A>C),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1963,VHL,7428,S80R (c.238A>C),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1964,VHL,7428,R60fs (c.179delG),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1965,VHL,7428,p.Ile109ThrfsX50 (c.326delT),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1966,VHL,7428,W88S (c.263G>C),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1967,VHL,7428,Y156D (c.466T>G),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1968,VHL,7428,Y156* (c.468T>G),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1969,VHL,7428,Y175* (c.525C>G),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1970,VHL,7428,V130L (c.388G>C),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1971,VHL,7428,Null (c.341-?_642+?del),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1972,VHL,7428,Splicing alteration (c.463+1G>A),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1973,VHL,7428,Null (c.464-?_642+?del),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1974,VHL,7428,Splicing alteration (c.464-1G>A),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1975,VHL,7428,R167fsX4 (c.499_504delinsT),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1976,VHL,7428,Q173* (c.517G>T),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1977,VHL,7428,V194fsX39 (c.579_580delTG),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1978,VHL,7428,Null (c.-678-?_340+?del),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1979,VHL,7428,Null (c.-678-?_642+?del),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1980,VHL,7428,R82P (c.245G>C),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1981,VHL,7428,N100fsX131 (c.298_299InsA),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1982,SUFU,51684,DELETION,,12074,variant,,,,,,,,,,,,,,,,,,,,,,,,
1983,PTCH1,5727,DELETION,,4645,variant,,,,,,,,,,,,,,,,,,,,,,,,
1984,VHL,7428,Splicing alteration (c.553+1G>A),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1985,VHL,7428,Splicing alteration (c.553+5G>C),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1986,VHL,7428,X214L (c.641G>T),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1987,VHL,7428,*214Wext*15 (c.642A>G),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1988,VHL,7428,X214C (c.642A>T),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1989,VHL,7428,G144fs (c.431delG),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1990,VHL,7428,Splicing alteration (c.464-1G>T),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1991,PIK3CA,5290,EXON 9 + EXON 20 MUTATIONS,,37,variant,,,,,,,,,,,,,,,,,,,,,,,,
1992,VHL,7428,Splicing alteration (c.464-2A>T),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1993,VHL,7428,Splicing alteration (c.463+2C>T),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1994,VHL,7428,Q132* (c.394C>T),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1995,VHL,7428,C77fs (c.230_insTCT),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1996,VHL,7428,L129fs (c.384delT),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1997,VHL,7428,L178Q (c.533T>A),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1998,VHL,7428,Splicing alteration (c.463+1G>C),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
1999,VHL,7428,V74G (c.221T>G),,58,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,3,10183752,10183752,T,G,ENST,,,,,75,GRCh37,,,,,,
2000,VHL,7428,H115R (c.344A>G),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2001,VHL,7428,R131S (c.392A>G),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2002,VHL,7428,Q73fs (c.215delC),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2003,VHL,7428,S111R (c.333C>A),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2004,VHL,7428,S168fs (c.503delG),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2005,VHL,7428,P172fs  (c.516delT),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2006,VHL,7428,Y112N (c.334T>A),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2007,VHL,7428,R107G  (c.319C>G),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2008,VHL,7428,G93C (c.277G>T),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2009,VHL,7428,G93V (c.278G>T),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2010,VHL,7428,L198Q  (c.593T>A),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2011,VHL,7428,S65A (c.193T>G),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2012,VHL,7428,S65W (c.203C>G),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2013,VHL,7428,Y156N (c.466T>A),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2014,VHL,7428,P61fs (c.183insC),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2015,VHL,7428,F76del (c.226_228delTTC),,58,variant,107,inframe_deletion,Inframe Deletion,SO:0001822,An inframe non synonymous variant that deletes bases from the coding sequence.,http://www.sequenceontology.org/browser/current_svn/term/SO:0001822,3,10183757,10183759,TTC,,ENST00000256474.2,,,,,75,GRCh37,,,,,,
2016,VHL,7428,Null (Complete deletion),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2017,VHL,7428,Splicing alteration (IVS1-1G>A),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2018,VHL,7428,I75fs (c.227_229delTCT),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2019,VHL,7428,Splicing alteration (IVS2-1G>C),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2020,VHL,7428,L85P (c.254T>C),,58,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,3,10183785,10183785,T,C,ENST00000256474.2,,,,,75,GRCh37,,,,,,
2021,VHL,7428,R108ins (c.324InsCGC),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2022,VHL,7428,V194fs (c.581_582delTG),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2023,VHL,7428,A149fs (c.449del14-nt),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2024,VHL,7428,3'UTR alteration (c.639+10C>G),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2026,VHL,7428,G114S (c.340G>A),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2027,VHL,7428,W117fs (c.349dupT),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2028,VHL,7428,A121I (c.364_365GC>AT),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2029,VHL,7428,N150fs (c.445_458del),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2030,VHL,7428,I151M (c.453>G),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2031,VHL,7428,Splicing alteration (c.462-2A>G),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2032,VHL,7428,E160fs (c.478_479delGA),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2033,VHL,7428,L163H (c.488T>A),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2034,VHL,7428,L129P (c.386T>C),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2035,VHL,7428,C162fs (c.483delA),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2036,VHL,7428,Null (Partial deletion of Exons 2 & 3),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2037,VHL,7428,N78I (c.233A>T),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2038,VHL,7428,I147V (c.439A>G),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2039,VHL,7428,W88fs (c.263_265delGGCinsTT),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2040,VHL,7428,K159fs (c.477_478insCA),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2041,VHL,7428,Q73fs (c.217delC),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2042,VHL,7428,A149fs (c.445delG),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2043,VHL,7428,G104A (c.311G>C),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2044,VHL,7428,R107H (c.320G>A),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2045,VHL,7428,S111C (c.331A>T),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2046,VHL,7428,V155L (c.463G>C),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2047,CTNNB1,1499,EXON 3 DELETION,,1290,variant,,,,,,,,,,,,,,,,,,,,,,,,
2048,VHL,7428,Splicing alteration (c.463+1G>T),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2049,VHL,7428,Null (Deletion of Exon 2),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2050,DICER1,23405,E1705K,,9533,variant,,,,,,,,,,,,,,,,,,,,,,,,
2051,DICER1,23405,D1709N,,9533,variant,,,,,,,,,,,,,,,,,,,,,,,,
2052,DICER1,23405,E1813Q,,9533,variant,,,,,,,,,,,,,,,,,,,,,,,,
2053,VHL,7428,D126Y (c.376G>T),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2054,VHL,7428,T124I (c.371C>T),,58,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,3,10188228,10188228,C,T,ENST00000256474.2,,,,,75,GRCh37,,,,,,
2055,VHL,7428,P146fs (c.436delC),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2056,VHL,7428,W88R (c.262T>C),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2057,VHL,7428,H115fs (c.344delA),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2058,VHL,7428,P102fs (c.305delC),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2059,VHL,7428,G144R (c.430G>A),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2060,VHL,7428,H125P (c.374A>C),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2061,ACVR1,90,Gain-of-Function,,154,variant,,,,,,,,,,,,,,,,,,,,,,,,
2062,VHL,7428,Q164H (c.491G>C),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2063,STK11,6794,F354L,,5534,variant,,,,,,,,,,,,,,,,,,,,,,,,
2064,VHL,7428,P192S (c.574C>T),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2065,VHL,7428,Splicing alteration (IVS2+3A>G),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2066,VHL,7428,Y175N (c.523T>A),,58,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,3,10191530,10191530,T,A,ENST00000256474.2,,,,,75,GRCh37,,,,,,
2067,VHL,7428,Y175C (c.524A>G),,58,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,3,10191531,10191531,A,G,ENST00000256474.2,,,,,75,GRCh37,,,,,,
2068,VHL,7428,V87A (c.260T>C),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2069,VHL,7428,P97L (c.290C>T),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2070,VHL,7428,L184H (c.551T>A),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2071,VHL,7428,R69fs (c.204insG),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2073,VHL,7428,G106fs (c.316insA),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2074,VHL,7428,Splicing alteration (c.340+1G>T),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2075,VHL,7428,Splicing alteration (c.463+2T>C),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2076,VHL,7428,V155M (c.463G>A),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2077,VHL,7428,Splicing alteration (c.464-1G>C),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2078,VHL,7428,Splicing alteration (c.464-2A>G),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2079,VHL,7428,Q164L (c.491A>T),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2080,VHL,7428,R176fs (c.527delG),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2081,VHL,7428,V194fs (c.581_582delGT),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2082,VHL,7428,Null (Partial deletion of Exon 1),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2083,VHL,7428,Null (Partial deletion of Exons 1 & 2),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2084,VHL,7428,P81L (c.242C>T),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2085,VHL,7428,T152I (c.455C>T),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2086,VHL,7428,V130I (c.388G>A)/ R200W (c.598C>T),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2087,VHL,7428,L63fs (c.189_192delGCGC),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2088,VHL,7428,F76del (c.224_226delTCT),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2089,VHL,7428,P81delRVV (c.243_251delGCGCGTCGT),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2090,VHL,7428,P40fs (c.118ins),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2091,VHL,7428,T152fs (c.455insA),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2092,VHL,7428,T157fs (c.472ins),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2093,VHL,7428,Splicing alteration (c.464-2A>C),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2094,VHL,7428,T157fs (c.472ins1-nt),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2095,VHL,7428,I151fs (c.452insA),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2096,VHL,7428,F158ins (c.472insTTT),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2097,VHL,7428,D92fs (c.275del18-nt),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2098,VHL,7428,K159fs (c.475delA),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2099,VHL,7428,V66fs (c.197_220delTGA),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2100,VHL,7428,S183fs (c.548delC),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2101,VHL,7428,V84M (c.250G>A),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2102,VHL,7428,Splicing alteration (IVS1+5G>C),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2103,VHL,7428,Null (Partial deletion),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2104,VHL,7428,Splicing alteration (c.340+5G>C),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2105,VHL,7428,D197N (c.591G>A),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2106,VHL,7428,S80G (c.238A>G),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2107,VHL,7428,F76L (c.228C>G),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2108,ARID1A,8289,UNDEREXPRESSION,,6559,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,1,27022524,27108595,,,ENST00000324856.7,,,,,75,GRCh37,,,,,,
2109,EZH2,2146,Y646 or Y641,,63,variant,,,,,,,,,,,,,,,,,,,,,,,,
2110,VHL,7428,R82L (c.245G>T),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2111,VHL,7428,F76fs (c.227_229delTCT),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2112,VHL,7428,N78D (c.232A>G),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2113,VHL,7428,N78Y (c.232A>T),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2114,VHL,7428,Splicing alteration (c.340+1G>A),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2115,VHL,7428,Y185* (c.555C>A),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2116,VHL,7428,R167Q (c.499C>T),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2117,VHL,7428,P95R (c.284C>G),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2118,VHL,7428,P103L (c.308C>T),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2119,VHL,7428,F119S (c.356T>C),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2120,VHL,7428,P138L (c.413C>T),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2121,VHL,7428,P61fs (c.181delCCGT),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2122,VHL,7428,S65* (c.203C>A),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2123,VHL,7428,C77del (c.229_231delTGC),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2124,VHL,7428,W88C (c.264G>C),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2125,VHL,7428,Q132P (c.395A>C),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2126,VHL,7428,D198fs (c.592delCT),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2127,VHL,7428,G93fs (c.279delC),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2128,VHL,7428,P97P (c.291C>G),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2129,VHL,7428,G114dup (c.342dupGGT),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2130,VHL,7428,S65fs (c.194delC),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2131,VHL,7428,Q73fs (c.214insGCCC),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2132,VHL,7428,F76fs (c.227insC),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2133,VHL,7428,Splicing alteration (c.341-2A>C),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2134,VHL,7428,G114fs (c.341delCGTTTCCAACAATTTCTCGGTGT),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2135,VHL,7428,G123fs (c.369delGACACAC),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2136,VHL,7428,H125fs (c.374insA),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2137,VHL,7428,L158fs (c.474_476delGAAinsC),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2138,VHL,7428,Y175fs (c.525delC),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2139,VHL,7428,L188fs (c.562delC),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2140,VHL,7428,Q195fs (c.584_585delAG),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2141,VHL,7428,D197fs (c.589delG),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2142,VHL,7428,T202fs (c.606insA),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2143,VHL,7428,R113fs (c.337delC),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2144,VHL,7428,E55fs (c.165_166dupG),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2145,VHL,7428,P61fs (c.182_185delCCGT),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2146,VHL,7428,Splicing alteration (c.463+3A>T),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2147,VHL,7428,K196E (c.586A>G),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2148,VHL,7428,R161R (c.481C>A),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2149,VHL,7428,N90I (c.269A>T),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2150,VHL,7428,I151F (c.451A>T),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2151,VHL,7428,W88* (c.263G>A),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2152,VHL,7428,3'UTR alteration (c.642+70C>A),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2153,VHL,7428,G114fs (c.326_339dupTCCACAGCTACCGA),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2154,VHL,7428,D121H (c.361G>C),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2155,VHL,7428,R145fs (c.432_433insA),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2156,VHL,7428,S111R (c.331A>C),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2157,VHL,7428,L128P (c.383T>C),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2158,VHL,7428,F76fs (c.222_225dupCATC),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2159,AR,367,"V9, truncated variant, contiguous splicing of exons 1, 2, 3, and CE5",,67,variant,,,,,,,,,,,,,,,,,,,,,,,,
2160,VHL,7428,Y98fs (c.291delC),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2161,VHL,7428,S183L (c.548C>T),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2162,VHL,7428,N150S (c.449A>G),,58,variant,,,,,,,,,,,,,,,,,,,,,,,,
2163,CTLA4,1493,EXPRESSION,,1285,variant,183,N/A,N/A,N/A,No suitable Sequence Ontology term exists.,http://www.sequenceontology.org/browser/current_svn/term/N/A,2,204732509,204738683,,,ENST00000302823.3,,,,,75,GRCh37,,,,,,
2164,CX3CL1,6376,UNDEREXPRESSION,,5167,variant,,,,,,,,,,,,,,,,,,,,,,,,
2165,FANCA,2175,S1088F,,1810,variant,47,missense_variant,Missense Variant,SO:0001583,"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",http://www.sequenceontology.org/browser/current_svn/term/SO:0001583,16,89815152,89815152,G,A,ENST00000568369.1,,,,,75,GRCh37,,,,,,
2166,NRG1,3084,SLC3A2-NRG1,,2593,variant,,,,,,,,,,,,,,,,,,,,,,,,
2167,FGFR4,2264,OVEREXPRESSION,,1887,variant,,,,,,,,,,,,,,,,,,,,,,,,
2168,RAD50,10111,L1237F,,8032,variant,,,,,,,,,,,,,,,,,,,,,,,,
2169,BTK,695,MUTATION,,65,variant,,,,,,,,,,,,,,,,,,,,,,,,
2170,PLCG2,5336,MUTATION,,4327,variant,,,,,,,,,,,,,,,,,,,,,,,,
2171,TSC2,7249,LOSS-OF-FUNCTION,,47,variant,,,,,,,,,,,,,,,,,,,,,,,,
2172,MTOR,2475,Gain-of-Function,,2073,variant,,,,,,,,,,,,,,,,,,,,,,,,
